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ABSTRACT  
BACKGROUND: Rheumatic Diseases (RD) are characterized by pain and reduction 
in the range of motion and function in one or more areas of the musculoskeletal 
system. RD are prominent causes of morbidity and disability throughout the world, 
giving rise to enormous healthcare expenditures. RD may also lead to early 
retirement, generating indirect costs to society, namely through its most prevalent 
nosologic entity, osteoarthritis (OA).  
OBJECTIVES: This study primarily aimed: 1) To examine the association between 
RD and early retirement in the Portuguese population; 2) To measure the 
productivity loss associated with early retirement attributable to RD in Portugal; and 
3) To review possible effective interventions targeting early retirement due to RD. 
METHODS: In order to achieve these objectives individual level data from two 
national, cross-sectional, population-based surveys were used - the National Health 
Survey, conducted in 2005-2006 (INS) and the first nationwide study on RD, 
conducted in 2011-2013 (EpiReumaPt). Both surveys had samples considered to be 
representative of the regions of mainland Portugal (North, Center, Lisbon region, 
Alentejo, and Algarve) and the autonomous regions of the Azores and Madeira. All 
participants aged between 50 and 64 years old, approaching the statutory pension 
age, were included in the analysis (INS: 3762 men and 4241 women; EpiReumaPt: 
1065 men and 1727 women). The presence of RD was based on self-report by the 
surveys’ participants. Due to its prevalence and associated disability a special 
interest was devoted to OA, which was defined by the clinically diagnosis of OA 
initially done by a rheumatologist in a patient interview and further validated by other 
3 experienced rheumatologists in the EpiReumaPt study, according with the 
American College of Rheumatology (ACR) classification criteria. Regarding the main 
dependent variable, a lato and stricto sensu definition of premature job loss was 
adopted, which enabled taking into consideration the existence of different pathways 
to early retirement. In addition, anticipated retirement due to RD directly reported by 
the EpiReumaPt participants was analysed. Other variables of interest, in particular 
those potentially influencing early retirement, were described and analysed as well. 
These included sociodemographic, ill-health, lifestyle, and socioeconomic factors. 
The effects of self-reported RD and OA on the likelihood of early retirement were 
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obtained at the individual level by logistic regression, using a manual stepwise 
technique (backward elimination). The population attributable fractions (PAF) were 
also calculated as the resulting proportional change in the probability of retirement 
after a counterfactual exercise where the presence of a RD was artificially eliminated 
from the sample. In order to calculate indirect costs following early retirement 
attributable or due to RD, an official national public source (Quadros do Pessoal / 
Personnel Records from the Ministry of Solidarity and Social Security) was used to 
estimate unit values of production by gender, age-group and region, using the 
human capital approach, which values healthy time lost due to RD using market 
wage rates (adjusted for social security contributions). Years of working life lost 
(YWLL) were estimated as the difference between each participant’s current age and 
the respective retirement age, while the potential years of working life lost (PYWLL) 
were given by the difference between official and actual retirement ages. The share 
of time in inactivity was also calculated (Inactivity ratio=YWLL/active age-range). All 
results were computed as weighted data, in order to take into account the stratified 
sampling design of the surveys. Statistical analyses were carried out using Stata 
12.0.  
Finally, a comprehensive review using PubMed, the Cochrane Library and the 
Portuguese institutional repositories was done to identify and analyse studies either 
in English or Portuguese published between January 2000 and June 2016 that 
evaluated the impact of interventions targeting early retirement in RD patients. 
RESULTS: In 2005-2006 (INS), 37.2% of the Portuguese population aged 50-64 
years self-reported at least one RD and among these 52.6% were not employed, 
compared with 40.7% of those without RD (p<0.001). 45.1% of the studied 
population was not employed and more frequently self-reported “poor” to “very poor” 
health than those employed (31.6% vs. 16.4%, respectively; p<0.001). A larger 
average number of major chronic diseases per capita was also found in those not 
employed (1.9 vs. 1.4, p<0.001). RD were more prevalent (43.4% vs. 32.1%; 
p<0.001) and independently associated with early retirement (OR: 1.24; CI: 1.01-
1.52) and broad early exit from work (OR: 1.31; CI: 1.12-1.52). The annual indirect 
costs following premature exit from work attributable to RD were €650 million (€892 
per RD patient), while early retirement amounted to €367 million (€504 per RD 
patient).  
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In 2011-2013 (EpiReumaPt), 34.2% of the studied population self-reported at least 
one RD and among these 58% were not employed. 51.6% of the studied population 
was not employed and 29.9% were retired. Among the early retirees, 43.2% were on 
grounds of ill-health (12.9% of the overall sample), of which in turn about a third 
(30.4%) was specifically due to RD. Thus, 13.1% of all retirees and 3.9% of the 
Portuguese population within the studied age-range self-reported RD as the main 
reason for early retirement. Those who were employed (48%) had higher levels of 
education, were less obese and had a lower number of chronic diseases compared 
with participants out of work, in particular those early retired due to RD. Employed 
people also have less RD than the early retirees (30.0% vs. 40.2%, respectively; 
p<0.001). In fact, as in 2005-2006 with the INS database, self-reported RD was 
independently associated with early retirement (OR: 1.37; CI: 1.01-1.84). 
The majority of the early retirement due to RD was observed in females (81.6% vs. 
41.5% of females in the early retirement group unrelated with RD). The estimated 
early retirement self-reportedly to be caused by RD is potentially associated with an 
annual cost of up to €910 million (€555 per capita; €1625 per self-reported RD 
patient and €13,592 per early retiree due to RD). Females contributed with the 
majority of these costs (€766 million; €882 per female versus €187 per male). We 
observed a total number of 389,939 accumulated YWLL (228 per 1000 inhabitants) 
and 684,960 PYWLL (401 per 1000 inhabitants). The mean YWLL and PYWLL 
inactivity ratios were 12% and 21%, respectively. Participants with higher values of 
disability, measured by the Health Assessment Questionnaire (HAQ), have the 
highest risk of early retirement (OR: 1.58; CI: 1.27-1.97). The individuals with RD 
and highest levels of disability (i.e. HAQ scores ≥ 2) are at the utmost risk of early 
retirement (55.3% vs. 35.1% for all RD population and 31.9% for those with HAQ 
scores ≥ 2 but without RD). An almost linear relationship between levels of disability 
and the probability of early retirement was observed, with its y-intercept and slope 
being increased by RD, which is consistent with the results obtained with OA.  
Still using the EpiReumaPt survey, it was estimated a prevalence of clinically 
confirmed OA in the studied age-group of 29.7% (men: 16.2% and women: 43.5%. 
Knee OA: 18.6%; hand: 12.6%; hip: 3.6%). OA was associated with early exit from 
paid employment, specifically knee OA (OR: 2.25; CI: 1.42-3.59), but not with early 
retirement stricto sensu, since unemployment seems to be a major channel of work 
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loss for patients with OA. Other OA locations did not have a statistically significant 
effect on work loss. Early exit from paid employment due to OA led to a total of 
143,262 YWLL and 338,822 PYWLL (84 and 198 per 1000 inhabitants in the studied 
age-group, respectively). The estimated annual indirect cost attributable to OA was 
€656 million (€384 per capita; €1294 per OA patient and €2095 per OA patient out of 
work).  
Knee OA patients with worst scores on symptoms, pain, quality of life and ability to 
perform activities of daily living, measured by the Knee injury and Osteoarthritis 
Outcome Score (KOOS), were more likely to be found out of work. This particularly 
applies for pain, which seems to play a key role in the risk of workforce withdrawal. A 
strong association was seen between pain interference and premature work loss, 
especially within the knee OA population (OR: 1.52; CI: 1.16-1.99).  
Concerning the literature revision on possible interventions aiming to reduce early 
retirement, several published studies testing pharmacologic and non-pharmacologic 
vocational rehabilitation interventions were identified. None was specifically identified 
for Portugal. The general low quality of the literature and its inconsistency makes it 
unfeasible to draw definitive conclusions. However, some broad recommendations 
were outlined. Despite the lack of good quality evidence on this field, there seems to 
be a growing interest in the international scientific community with several ongoing 
promising studies promoting such interventions.  
CONCLUSIONS: In Portugal, self-reported RD are associated with early exit from 
paid work, specifically early retirement. Currently, there is a meaningful number of 
people who claimed to be retired prematurely due to RD. This translates in many 
years of working life already lost and many others still potentially to be lost. Indirect 
costs due to self-reported RD are also substantial, equivalent to at least 0.5% of the 
Portuguese GDP. By specifically analysing OA, the most prevalent rheumatic 
disorder, it was possible to verify that the productivity loss due to RD is potentially 
even higher than the one obtained when analysing self-reported RD as a whole. 
Regardless the exact magnitude of the estimates, it seems undisputable that the 
foregone productivity caused by RD is enormous. Due to the lack of good quality 
data and the inconsistency currently found in the literature, it is difficult to 
recommend an intervention expected to be inevitably effective. Given the lack of 
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longitudinal assessments, it is utterly important to promote further research based on  
long-term cohorts aiming to collect occupational and health information in our 
country, as well as data on the impact of interventions targeting early retirement 
caused by rheumatic disorders. 
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RESUMO  
INTRODUÇÃO: As doenças reumáticas (DR) são caracterizadas por dor e redução 
na amplitude de movimento e função em uma ou mais áreas do sistema músculo-
esquelético. As DR são causas importantes de morbilidade e incapacidade em todo 
o mundo, dando origem a enormes gastos com saúde. As DR também podem 
conduzir à reforma antecipada, gerando custos indiretos para a sociedade, 
nomeadamente através da entidade nosológica mais prevalente, a osteoartrose 
(OA). 
OBJETIVOS: Este estudo teve como principais objetivos: 1) Analisar a associação 
entre DR e reforma antecipada na população Portuguesa; 2) Calcular a perda de 
produtividade associada à reforma antecipada atribuível às DR em Portugal; e 3) 
Identificar possíveis intervenções efetivas que visem a reforma antecipada devido às 
DR. 
MÉTODOS: De modo a alcançar os objetivos pretendidos foram utilizados os dados 
individuais de dois inquéritos nacionais, transversais, de base populacional - o 
Inquérito Nacional de Saúde (INS), realizado em 2005-2006, e o primeiro estudo 
epidemiológico de âmbito nacional sobre DR, realizado em 2011-2013 
(EpiReumaPt). Ambos os inquéritos tiveram amostras consideradas representativas 
das regiões de Portugal Continental (Norte, Centro, a região de Lisboa, Alentejo e 
Algarve) e as regiões autónomas dos Açores e da Madeira. Todos os participantes 
com idade entre 50 e 64 anos, que se aproximam da idade legal de reforma, foram 
incluídos na análise (INS: 3762 homens e 4241 mulheres; EpiReumaPt: 1065 
homens e 1727 mulheres). A presença de RD foi considerada quando a 
autodeclarada pelos participantes. Devido à sua elevada prevalência e incapacidade 
associada, dedicou-se especial atenção à OA, que foi considerada quando o seu 
diagnóstico era clinicamente confirmado primeiro por um reumatologista numa 
consulta ao doente e posteriormente validado por outros 3 reumatologistas no 
estudo EpiReumaPt, de acordo com os critérios de classificação definidos pelo 
Colégio Americano de Reumatologia (ACR). No que diz respeito à variável 
dependente principal, utilizou-se uma definição lato e stricto sensu de perda de 
emprego prematura, o que permitiu ter em consideração a existência de diferentes 
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percursos no sentido da reforma antecipada. Além disso, foi analisada a reforma 
antecipada devido a DR, tal como diretamente relatado pelos participantes do 
estudo EpiReumaPt. Outras variáveis de interesse, em particular aquelas que 
potencialmente podem influenciar a reforma antecipada, foram também descritas e 
analisadas, incluindo aquelas de natureza sociodemográfica, saúde, estilos de vida 
e fatores socioeconómicos. Os efeitos da DR autodeclarada e da OA sobre a 
probabilidade de reforma antecipada foram obtidos a nível individual através da 
regressão logística. A Fração Atribuível na População (PAF) foi também calculada 
como a variação proporcional resultante na probabilidade de reforma após um 
exercício contrafatual em que as DR são artificialmente eliminadas da amostra em 
estudo. Para estimar os custos indiretos recorreu-se à base de dados salariais 
“Quadros do Pessoal” do Ministério da Solidariedade e Segurança Social, usando-
se estimativas dos custos salariais médios por sexo, região e grupos etários para os 
anos dos inquéritos, utilizando a abordagem do capital humano, que valoriza o 
tempo perdido devido às DR usando os salários do mercado (ajustados para as 
contribuições para a segurança social). Os anos de vida laboral perdidos (YWLL) 
foram estimados como a diferença entre a idade atual de cada participante e a 
respetiva idade de reforma, enquanto os anos potenciais de vida laboral perdidos 
(PYWLL) foram obtidos através da diferença entre as idades oficiais e reais de 
reforma. A percentagem de tempo em inatividade também foi calculada (rácio de 
inatividade=YWLL/grupo etário de idade ativa). Todos os resultados foram 
calculados como dados ponderados, de forma a ter em conta o esquema de 
amostragem estratificada utilizada nos inquéritos. As análises estatísticas foram 
realizadas utilizando Stata 12.0. 
Finalmente, uma revisão abrangente, recorrendo à PubMed, à Cochrane Library e 
aos repositórios institucionais portugueses, foi realizada para identificar e analisar 
estudos em Inglês ou Português publicados entre janeiro de 2000 e junho de 2016, 
que tenham avaliado o impacto de intervenções que visem a reforma antecipada 
devido às DR.  
RESULTADOS: Em 2005-2006 (INS), 37,2% dos Portugueses com idade 
compreendida entre os 50 e os 64 anos autodeclararam pelo menos uma DR, dos 
quais 52,6% não estavam empregados, em comparação com 40,7% daqueles sem 
qualquer DR (p<0,001). 45,1% da população estudada não tinha um trabalho 
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remunerado, pelo que este grupo notificou mais frequentemente um estado de 
saúde “mau” a “muito mau” comparativamente àqueles que tinham trabalho (31,6% 
vs. 16,4%, respetivamente; p<0,001). Um número médio superior de doenças 
crónicas principais per capita foi observado entre aqueles que estavam fora do 
mercado de trabalho (1,9 vs. 1,4, p<0,001). A presença de DR foi mais prevalente 
(43,4% vs. 32,1%; p<0,001) e estatisticamente associada à reforma antecipada (OR: 
1,24; IC: 1,01-1,52) e à saída precoce do mercado de trabalho (OR: 1,31; IC: 1,12-
1,52). Os custos indiretos anuais decorrentes da saída antecipada do trabalho 
atribuível às DR foram €650 milhões (€892 por doente com DR), enquanto aquelas 
mais especificamente decorrentes da reforma antecipada ascenderam a €367 
milhões (€504 por doente com DR). 
Em 2011-2013 (EpiReumaPt), 34,2% dos Portugueses com idade compreendida 
entre os 50 e os 64 anos autodeclararam pelo menos uma DR, dos quais 58% não 
estavam empregados. 51,6% da população estudada não tinha qualquer trabalho 
pago e 29,9% eram reformados. Entre os reformados, 43,2% referiu que a sua 
reforma antecipada tinha sido devido a doença (12,9% da amostra total), dos quais, 
cerca de um terço (30,4%) referiram ter sido especificamente devido a DR. Assim, 
13,1% de todos os reformados e 3,9% da população Portuguesa na faixa etária 
estudada referiram a DR como a principal razão para a sua reforma antecipada. 
Aqueles que estavam empregados (48%) tinham níveis educacionais mais elevados, 
eram menos obesos e tinham um menor número de doenças crónicas em 
comparação com os participantes que estavam fora do mercado de trabalho, em 
especial os reformados antecipadamente devido a DR. Os participantes 
empregados também apresentaram menos DR que aqueles com reforma 
antecipada (30,0% vs. 40,2%, respetivamente; p<0,001). Tal como em 2005-2006 
no INS, a DR autodeclarada apresentou-se estatisticamente associada com a 
reforma antecipada (OR: 1,37; IC: 1,01-1,84). 
A maior parte da reforma antecipada devido a DR foi observada no sexo feminino 
(81,6% vs. 41,5% de mulheres no grupo de reforma antecipada não relacionada 
com DR). A reforma antecipada que de acordo com os participantes do EpiReumaPt 
foi devida a DR está potencialmente associada a um custo anual que ascende aos 
€910 milhões (€555 per capita; €1625 por doente com DR autodeclarada e € 13.592 
por reformado devido a DR). As mulheres contribuíram com a maior parte destes 
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custos (€766 milhões; €882 por cada mulher versus €187 por cada homem). 
Observou-se um número total de 389.939 YWLL acumulados (228 por cada 1000 
habitantes) e 684.960 PYWLL (401 por 1000 habitantes). Os rácios de inatividade 
resultantes dos YWLL e PYWLL foram 12% e 21%, respetivamente. Os 
participantes com maiores valores de incapacidade funcional, medida pelo Health 
Assessment Questionnaire (HAQ), têm maior probabilidade de reforma antecipada 
(OR: 1,58; IC: 1,27-1,97). Os indivíduos com DR e níveis muito elevados de 
incapacidade (ou seja, HAQ com pontuações iguais ou superiores a 2) têm maior 
risco de reforma antecipada (55,3% vs. 35,1% para toda a população DR e 31,9% 
para aqueles com HAQ ≥ 2, mas sem DR). Foi observada uma relação quase linear 
entre os níveis de incapacidade e a probabilidade de reforma antecipada, com o 
declive e interceção no eixo das ordenadas aumentados na presença de DR, algo 
que é consistente com os resultados obtidos com a OA. 
Na base de dados do EpiReumaPt estimou-se uma prevalência de OA clinicamente 
confirmada de 29,7% na faixa etária estudada (homens: 16,2% e as mulheres: 
43,5%. OA do joelho: 18,6%; mão: 12,6%; anca: 3,6%). A OA está associada à 
saída precoce do mercado de trabalho, mais especificamente a OA do joelho (OR: 
2,25; IC: 1,42-3,59. As outras localizações anatómicas com OA não apresentaram 
qualquer associação), mas não com a reforma antecipada stricto sensu, dado que o 
desemprego parece ser um canal importante de saída antecipada do mercado de 
trabalho nos doentes com OA. A saída precoce do emprego remunerado devido à 
OA causou potencialmente um total de 143.262 YWLL e 338.822 PYWLL (84 e 198 
por 1000 habitantes na faixa etária estudada, respetivamente). Os custos indiretos 
anuais atribuíveis a OA ascenderam a €656 milhões (€384 per capita; €1294 por 
cada doente com OA e €2095 por cada doente com OA e fora do mercado de 
trabalho). 
Nos doentes com OA no joelho com piores pontuações nos sintomas, dor, qualidade 
de vida e capacidade de realizar atividades da vida diária, medida pela escala 
KOOS (Knee injury and Osteoarthritis Outcome Score), tinham maior probabilidade 
de se encontrarem fora do mercado de trabalho. Isto aplica-se particularmente no 
caso da dor, que parece desempenhar um papel basilar no risco desta perda de 
produtividade. Verificou-se uma forte associação entre a interferência da dor em 
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atividades laborais da vida diária e a saída do mercado de trabalho antecipada, 
especialmente entre a população com OA do joelho (OR: 1,52; IC: 1,16-1,99). 
Relativamente à revisão da literatura sobre possíveis intervenções com o objetivo de 
reduzir a reforma antecipada devido a DR, foram identificados estudos publicados 
sobre medidas farmacológicas e não-farmacológicas, pelo que nenhum dizia 
respeito especificamente a Portugal. A inconsistência encontrada na literatura 
disponível, bem como a genérica fraca qualidade da evidência, tornam inviáveis 
quaisquer conclusões definitivas. No entanto, algumas recomendações gerais foram 
identificadas, pelo que parece existir um interesse crescente na comunidade 
científica internacional sobre este assunto, algo que é acompanhado por diversos 
estudos promissores que estão actualmente a decorrer.  
CONCLUSÕES: Em Portugal, as DR autodeclaradas estão associadas ao 
abandono precoce do mercado de trabalho, e mais especificamente à reforma 
antecipada. Atualmente, há um número expressivo de pessoas que afirmam ter tido 
reforma antecipada devido a DR. Algo que se traduz em muitos anos de vida laboral 
já perdidos e muitos outros ainda potencialmente por perder. Os custos indiretos 
devidos à DR autodeclarada também são substanciais, o equivalente a pelo menos 
0,5% do PIB Português. Ao analisar especificamente a OA, a doença reumática 
mais prevalente em todo o mundo, foi possível verificar que a perda de 
produtividade devido a DR é potencialmente ainda mais elevada do que aquela 
obtida quando se analisam as DR autodeclaradas no seu todo. Independentemente 
da magnitude exata das estimativas, parece indiscutível que a produtividade perdida 
causada por DR é imensa. Devido à lacuna de evidência com boa qualidade e a 
inconsistência encontrada atualmente na literatura, é difícil recomendar uma 
intervenção inevitavelmente efetiva com vista a evitar a reforma antecipada devido 
às DR. Dada a falta de avaliações longitudinais, é fundamental que a investigação 
futura se fundamente em coortes de doentes de longo-prazo com o fim de recolher 
dados sobre saúde e de natureza ocupacional no nosso país, bem como informação 
sobre o impacto das intervenções que tenham como objetivo evitar a reforma 
antecipada causada por distúrbios reumáticos. 
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SCOPE AND CONTEXT  
In late 2010, just after finishing my Master of Science in Epidemiology, I was invited 
by Professor Jaime Branco to join the EpiReumaPt research team. At that time the 
project was just starting so I had the privilege to make a contribution almost from the 
very beginning. It allowed me to experience first-hand all steps of a nationwide, 
large-scale epidemiologic study. Indeed, it was an invaluable opportunity that I shall 
never forget with a great learning curve with a brilliant team, composed by renowned 
rheumatologists and led by Professor Jaime Branco and Professor Helena Canhão. 
In addition to all this, a few months later, I became responsible for setting up and 
writing the protocol for the CoReumaPt study to follow-up the EpiReumaPt 
participants. It was a challenge not only from the technical point of view, but also a 
tough test of informal leadership, as it was not always straightforward to establish 
consensus among the experts who co-autorship this protocol. After finishing this task 
and as soon as EpiReumaPt was moving to the field work, I became more focus in 
pursuing my PhD. I had some ideas, but I wasn’t sure if any would meet the 
standards of a PhD. This is when I came across with another brilliant mind, 
Professor Miguel Gouveia, who generously gave me the embryonic ideia from where 
all this research would evolve. Professor Miguel Gouveia also accepted to be my 
PhD supervisor along with Professor Helena Canhão (and more recently Professor 
João Eurico da Fonseca, with whom I shared some projects in the past, including my 
Master’s thesis). I believe I couldn’t be better served concerning the project and its 
supervision.  
Our first approach was the INS database followed by EpiReumaPt - our steps were 
synchronized with the EpiReumaPt’s phasing. I continuously presented preliminary 
results of EpiReumaPt in international congresses and also published articles in 
international, peer-reviewed journals, always carrying in mind the main output of all 
this work – this thesis and, hopefully, some useful knowledge for the scientific 
community and for the Portuguese society. 
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THESIS OUTLINE  
This thesis is divided into three sections: 
Section A addresses the General Introduction, the Hypotheses and the main and 
secondary research Objectives. The General Introduction describes the context of 
the research, providing the etiological model and the theoretical foundation for the 
thesis. It presents background information on RD, its known burden and 
epidemiology, and summarizes the current knowledge about its relationship with 
early retirement and due impact. This Section also contains a brief description of the 
general methods used during the research and the respective sources of data.   
Section B presents three distinct Parts with the results of this thesis, published or 
submitted to international peer-reviewed journals. Part 1 includes one article, which 
describes the first approach in this research to explore the relationship between 
chronic diseases, particularly self-reported RD, and early withdrawal from work. Part 
2 comprises three articles that detailed the in-depth findings about the economic 
impact of early retirement attributable to self-reported RD and, more specifically, to 
clinically confirmed OA. Part 3 includes one article describing a literature review 
about the current knowledge of interventions aiming to reduce early retirement due 
to RD.  
Broadly, Part 1 addresses the causes of early retirement, Part 2 its consequences, 
while Part 3 its possible solutions.       
Section C is composed by the General Discussion, the Conclusions and Future 
Perspectives. The General Discussion complements the Discussion section of each 
individual article included in the previous Section and aims to build a global picture 
from the whole research. It also deliberates around the potential limitations of the 
research and draws attention for possible avenues to study this topic. 
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GENERAL INTRODUCTION 
RHEUMATIC AND MUSCULOSKELETAL DISEASES 
Rheumatic diseases (RD), also called musculoskeletal (MSK) diseases, are 
characterized by pain and a consequent reduction in the range of motion and 
function in one or more areas of the MSK system; in some diseases there are signs 
of inflammation: swelling, redness, warmth in the affected areas.1 RD encompass a 
wide spectrum of conditions, from those of acute onset and short duration to chronic 
progressive course disorders including osteoarthritis (OA), rheumatoid arthritis (RA), 
osteoporosis (OP) and low back pain (LBP). RD have a broad array of clinical 
manifestations, but are generally characterized by inflammation, damage and/or pain 
of the joints and connective tissues. Overall, women are more often affected and the 
incidence increases with age. 2,3 
RD have a profound negative impact on many aspects of a patient’s life as well as 
on the society as a whole.4 Patients are hampered in their daily activities by pain,5 
physical disability,6 and fatigue,7 seriously affecting their quality of life.5  
RD are leading causes of morbidity and disability throughout the world, giving rise to 
enormous healthcare expenditures and loss of work.6,8  
The rheumatic conditions with the greatest impact on society include:  
 
Osteoarthritis: 
OA is the most common degenerative joint disorder in the world. It is associated with 
ageing and affect the joints that have been continually stressed throughout the years 
including the knees, hips and hands. 9 OA has been designated as one of the key 
conditions for special attention during the WHO’s Bone and Joint Decade (2000-
2010).10 
OA is characterized by inflammation, softening, fibrillation and degradation of 
articular cartilage, as well as abnormal bone growth in the form of osteophytes. 
Other anatomical changes involve the appearance of subchondral cysts, abnormal 
remodelling of subchondral bone, muscle weakness and joint space narrowing 
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(Figure 1).11 OA is a leading cause of chronic pain and mobility limitation, particularly 
in women and older individuals.12 
 
Figure 1 - The joints’ alterations that occur in OA 
 
 
Source: Musumeci G et al. 201513 
 
The precise etiology of OA is unknown, however, it is considered by many to be a 
multi-factorial disease that may be attributable to: 1) systemic factors such as age, 
gender, hormones, metabolism, genetics and nutritional factors;11 2) mechanical 
factors including previous joint injury, leg misalignment, muscle weakness and 
obesity.14 Of the identifiable risk factors, overweight is considered to be the number 
one modifiable risk factor for the development and progression of knee OA, with one 
model estimating that approximately a quarter of all cases of total knee arthroplasty 
for end stage knee OA could be avoided with weight reduction.15 
From the epidemiological point of view, because of the high percentage of people 
suffering from this disease and the increase in life expectancy, OA is one of the most 
significant causes of disability in the world, making the social and economic cost to 
the healthcare system vast. Ageing of the population is expected to place OA as a 
leading cause of disability in the coming future.4,16 
The economic burden of OA is largely attributable to medication, much of which goes 
toward pain-related agents, and hospitalization costs (comprising nearly half of direct 
costs).17 However, indirect costs for OA are also high, largely a result of work-related 
losses, an area of study which has received insufficient research attention.18 In fact, 
although direct and indirect costs attributable to OA are substantial, it seems that 
productivity related costs are predominant.19 
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Worldwide estimates are that 9.6% of men and 18.0% of women aged ≥60 years 
have symptomatic OA.20 Results from a systematic review showed a prevalence of 
knee OA, from 6.3% in Greece to 68.4% in the UK; in hip, from 0.9% in Greece to 
23% in Croatia; in hand from 2% in Greece to 77.1% in Israel.21,22 The considerable 
variation in these estimates largely depend on the case definition used (i.e. self-
reported, radiographic and symptomatic OA).21,22 
In Portugal the latest estimates for the prevalence of OA in the adult population are: 
12.4% for knee OA (females: 15.8%; males: 8.6%); 8.7% for hand OA (females: 
13.8%; males: 3.2%); and 2.9% for hip OA (females: 3.0%; males: 2.9%).23  
 
Rheumatoid Arthritis: 
RA is a chronic immune mediated inflammatory disease that preferentially affects the 
joints, leading to cartilage damage and bone erosions. It tends to strike during the 
most productive years of adulthood, between the ages of 20 and 40, and is a chronic 
disabling condition, causing pain and deformity.9 RA patients have an increased risk 
of being without a paid job compared to well-adjusted reference groups (odds ratios 
[OR] 1.2 to 3.4).24,25 Within 10 years on onset, at least 50% of patients in developed 
countries are unable to hold down a full-time job.9 This translates to high costs to 
society and individual stakeholders, including patients/employees, employers, family 
members/caregivers, and governments.26 RA prevalence varies between 0.3% and 
1% and is more common in women and in developed countries.6,27,28 In Portugal, it 
is estimated to be 0.7% (95% CI: 0.5%-0.9%).23 
 
Osteoporosis: 
OP is a disease characterized by low bone mass and structural deterioration of bone 
tissue, leading to bone fragility and an increased susceptibility to fractures of the hip, 
spine and wrist.9 The most costly result of OP is the hip fracture, which always 
requires hospitalization. It is estimated that within one year, 20 to 30% of the patients 
affected by a hip fracture die, 50-60% become disabled and only 30-40% fully 
recover their previous functional levels.29 1.7 million hip fractures occurred worldwide 
in 1990; this figure is expected to rise to 6 million in 2050.9 In Portugal there have 
been 77,083 hip fractures reported between 2000 and 2008, with annual hospital 
costs of around 52 million euros.25,30  
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Based on measures of bone mineral density in caucasians, OP is present in 15% of 
those 50–59 years of age, but these figures increase quickly to 70% of those over 80 
years of age.9 The prevalence of OP in the Portuguese adult population is estimated 
to be 10.2% (95% CI: 9.0%-11.3%).23 
 
Low Back Pain: 
LBP is a major health and socioeconomic problem in western countries. LBP can be 
classified as “specific” (suspected pathological cause) or “non-specific” (about 90% 
of cases) and is usually defined as acute if it lasts less than 3 months or chronic 
otherwise.31 LBP interferes with quality of life and work performance and is the most 
common reason for medical consultations. 32  It constitutes a major public health 
problem (as classified by the World Health Organization [WHO]) in industrialized 
societies, affecting a substantial proportion of the working age population and 
leading to significant productivity losses (e.g. loss of working days).33 
The occurrence of LBP is associated with age, physical fitness, excess body weight 
and strength of back and abdominal muscles. Psychological factors associated with 
occurrence of back pain are anxiety, depression, emotional instability and pain 
behaviour (e.g. outward display of pain). Occupational factors, such as heavy work, 
lifting, bending, twisting, pulling and pushing, may also have a relationship with LBP, 
as do psychological workplace variables, such as job dissatisfaction. Psychosocial 
aspects of health and work in combination with economic aspects seem to have 
more impact on work loss than physical aspects of disability and physical 
requirements of the job. LBP is the most prevalent MSK condition and affects almost 
everyone at some stage of life.4,34 In our country, the latest prevalence estimate is 
26.4% (95% CI: 23.3%-29.5%).23 
THE EPIDEMIOLOGY OF RHEUMATIC DISEASES  
In several countries epidemiological studies were already performed in order to 
specifically ascertain their RD epidemiologic profile as a whole,35,36,37 or for specific 
forms of RD, such as spondyloarthritis38,39 and RA.40,41,42 
In 1981 the International League of Associations for Rheumatology (ILAR) and the 
WHO together launched the Community Oriented Programme for Control of 
Rheumatic Diseases (COPCORD) to fill the gap in the lack of epidemiological data 
GENERAL INTRODUCTION  
 6 
about MSK pain and arthritis in developing countries. COPCORD is a low-cost, low-
infrastructure programme based on regional resources, which already provided data 
for many countries worldwide, including Bangladesh, Brazil, Chili, China, Cuba, 
Egypt, Guatemala, India, Indonesia, Iran, Kuwait, Lebanon, Malaysia, Mexico, 
Pakistan, Peru, Philippines, Thailand, Tunisia and Vietnam.43,44  
Many other epidemiologic studies had already been put in place around the globe 
with a diversity of methodological approaches, RD case definition (e.g. self-reported 
data or clinical diagnosis) and used settings (e.g. community- or clinical-based). 
Naturally, these studies provided a wide range of prevalence figures and 
comparisons must be done prudently.  
Until recently the epidemiologic studies to determine the frequency, the distribution 
and the impact of RD in Portugal were limited to small and non-representative 
samples, resulting in a considerable gap of knowledge around this relevant matter in 
our country.45,46,47,48  
However, the development of the National Program Against Rheumatic Diseases 
(2004-2010) 49  allowed the planning and implementation of the Portuguese 
Epidemiologic Study of Rheumatic Diseases (EpiReumaPt) 50 , 51  from September 
2011 to December 2013. EpiReumaPt was the first nationwide project studying RD 
in the Portuguese population, mainly designed to determine the prevalence of RD 
covered by the abovementioned Governmental Program: hand, knee and hip OA, 
LBP, RA, OP, fibromyalgia, gout, spondyloarthritis, periarticular disease, systemic 
lupus erythematosus and polymyalgia rheumatica. EpiReumaPt found that more 
than half (56%) of the adult Portuguese population suffers from at least one form of 
RD. Disease-specific prevalence was reportedly similar to that found in other 
countries, namely Spain.23,52 As it occurs everywhere else, prevalence was higher in 
females compared to males (64.1% versus 47.1%, respectively) and increases with 
age.23 EpiReumaPt also aimed at assessing the impact of RD in patients’ quality of 
life, pain, function and productivity.50,51 Further details regarding this study are given 
below in this thesis (Brief Methodology – Data Sources). 
Cohort studies are one of the best ways to assess and understand the course of RD 
and its impact in relevant outcomes. Thus, to complement information obtained from 
cross-sectional prevalence studies and randomized clinical trials, various cohorts 
and registries of RD patients have been established in the last decade (for instance, 
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the National Data Bank for Rheumatic Diseases [NDB], 53  the Consortium of 
Rheumatology Researchers of North America [CORRONA]54 and the British Society 
for Rheumatology Biologics Register [BSRBR]55). Large prospective cohorts have 
increasingly contributed to pivotal research in the field of RD, which would have been 
difficult to obtain elsewhere. Actually, they constitute one of the major sources of 
clinical research publications and communications in rheumatology.56 Prospective 
cohort studies describe the disease course and may record long-term outcomes, 
such as early retirement. The Portuguese Society of Rheumatology (SPR) already 
detains a national register (Reuma.pt) 57  for some rheumatic diseases, but only 
recently, following the EpiReumaPt study, efforts have been made to create a large 
prospective cohort for the main RD occurring in the Portuguese population, as 
explained bellow in this thesis. 
BURDEN OF RHEUMATIC DISEASES 
MSK conditions are the most common cause of severe long-term pain and physical 
disability, and they affect hundreds of millions of people around the world. The 
Global Burden of Disease (GBD) Study 58  - an international project ranking the 
diseases and risk factors that cause death and disability - estimated the burden 
disability in 188 countries for the years 1990, 2010 and 2013 – analysed RD as well. 
Throughout the world, the burden from MSK conditions was exceptionally high. All 
MSK disorders combined caused 21.3% of the total years lived with disability (YLD) 
globally - second to mental and behavioural problems (23.2%). When taking into 
account both death and disability, all MSK disorders combined accounted for 6.7% of 
the total global disability-adjusted life years (DALY), which was the fourth greatest 
burden on the health of the world's population (third in the developed countries).59 
Out of all the conditions studied, LBP ranked first (highest) for the disability (YLD), 
and sixth for the overall burden (DALY). ‘Other MSK disorders’ and OA ranked tenth 
and 13th highest for YLD, respectively.58 
In addition to this burden of disability as estimated by the aforementioned measures 
of health, there is a considerable impact on the individual's quality of life suffering 
from a RD.60,61,62,63 In these patients, percentages of depressed mood and anxiety 
may be twice as high as in the general population.64  
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RD can also hamper everyday activities, and people with MSK conditions are less 
likely to be employed than people in good health. It is estimated that in Europe MSK 
disorders constitutes around half of all absences due to disease or health 
condition.65  
THE ECONOMIC BURDEN OF RHEUMATIC DISEASES 
The economic burden caused by RD is tremendous, both via direct and indirect 
costs.25 The direct costs reflect the diversion of resources consumed towards the 
diagnosis, treatment and management of the illness. 66  It includes medical 
expenditures (inpatient, outpatient, drugs and the extra costs due to the side effects 
of drugs) and non-medical ones (formal caregiver, travelling and community 
services). Indirect costs on the other hand, are productivity losses or the illness-
related morbidity and mortality that render human resources unavailable for 
productive uses.67 Major cost components for the indirect costs include productivity 
losses of employed patients because of short or long-term work disability (including 
absenteeism and presenteeism) and early retirement due to the disease.  
In an ad hoc analysis of the European Labour Force Survey, RD accounted for 53% 
of all work-related diseases in the EU-15. Work-related RD resulted in most lost days 
and permanent incapacity to work. Overall, they accounted for 50% of all absences 
from work lasting for more than three days, 49% of all absences lasting two weeks or 
more and about 60% of all reported cases of permanent incapacity.68,69 Moreover, 
some RD patients are reluctant to disclose their condition because they fear 
discrimination (this was seen in 30% of workers with conditions such as RA),70 which 
may lead to increased mental distress as well as presenteeism - workers who go to 
work when they are ill enough to stay at home.  
Studies of the economic impact of RD as a whole have been conducted since the 
early 1960s using several available data sources.71 Such studies indicated that the 
economic impact of RD increased sharply. In US between the years 1996 and 2011, 
total direct and indirect costs of RD increased by 121%, or nearly four times the rate 
of increase of the US GDP. As a share of US GDP, total direct and indirect costs for 
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MSK conditions increased by 67%, from 3.4% to 5.7%. Indirect costs saw an acuter 
rate of increase of slightly more than 100%. However, in US indirect costs are a 
smaller share of total costs than direct costs, constituting 0.3% of GDP in 1996 and 
0.5% in 2011. Direct costs rose from a 3.2% share to a 5.2% share over the same 
time period.72 Other countries have measured the economic impact of RD, such as 
Canada,73,74 Australia,75 the UK,76 Sweden,77 and the Netherlands;78 and contrary to 
the aforementioned figures for US, some of them came up with a superior relative 
share of indirect costs, especially when consider arthritis only.79 In fact, disability and 
productivity costs can be up to 4 times greater than direct health care costs.80 This 
may be partly explained because, as mentioned, MSK complaints are a major cause 
of work absence due to sickness in developed countries.4 
In particular, as the most common form of joint disease and a leading cause of 
disability, OA is associated with an extremely high economic burden.17,25 This burden 
is largely attributable to the effects of work disability, comorbid disease, and the 
expense of treatment. Although typically associated with less per capita expenditures 
than RA, for example, OA translates in overall higher economic burden because of 
its vast prevalence, which is expected to further escalate (Figure 2), partly a function 
of the increase in 2 major risk factors: aging and obesity.17  
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Figure 2 – Projected Prevalence of Diagnosed Arthritis in US from 2005 to 2030 
 
 
Data Source: Bitton R et al. 2009.17 Based on the US Health Interview Survey. 
OA costs seem to increase proportionally with disease severity, for instance a 2009 
Spanish study compared costs based on radiographic severity and found that more 
severe OA patients had higher direct annual costs compared with remaining OA 
patients.81 This was consistent with previous research done in Canada by Gupta S et 
al. who found that greater disability, based on the Western Ontario and McMaster 
Universities Osteoarthritis Index (WOMAC) scores, was associated with higher costs 
in a linear fashion.82 
DIAGNOSIS AND TREATMENT OF RHEUMATIC DISEASES 
The definitive diagnosis of RD must be done by a rheumatologist, by assessing the 
medical history, performing a physical examination and ordering specific laboratory 
tests and imaging investigations. RD patients require prompt diagnosis and 
treatment, as any delay may result in irreversible joint destruction and disability. 
There is no single medication or treatment which is optimal for everyone. There are 
treatment options that help manage pain and control arthritis symptoms. Most 
inflammatory rheumatic diseases are treated with the so-called Disease-Modifying 
Antirheumatic Drugs (DMARDs), which include also biotechnological drugs, usually 
called biologics. 
In addition to pharmacologic treatment other methods may play a role in RD 
management as well: injections into a joint or the soft tissues, physiotherapy and 
rehabilitation interventions and surgical procedures.1 
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It is crucial to guarantee timely diagnosis and patient access to effective care, aiming 
to delay or to limit the impact of an established RD. Primary prevention of RD is still 
beyond our grasp, nonetheless emerging data from natural history studies show that 
for most RD there is a period of ‘preclinical’ disease development during which 
abnormal biomarkers or other processes can be detected and, based on this, 
perhaps in the near future, it will be possible to implement effective screening and 
preventive approaches for some RD.83 Until then, effective postponement of RD 
progression must be carried out with the most adequate treatments, in order to 
achieve the best possible clinical and occupational outcomes. In Portugal, despite a 
clear progression in the last decade, a delay in the access to innovative medications 
has been observed, mostly due to economic constraints and lack of integration of the 
different layers across our healthcare system. 84 , 85  On this regard, the current 
expansion of the rheumatology referral network in our National Health Service 
(NHS)86 may be a fundamental step to provide the best possible care to RD patients 
limiting the burden of the disease and reducing early retirement.  
 
EARLY RETIREMENT 
Societies are currently facing one of the greatest challenges ever with the increasing 
population ageing. In Europe, it is estimated that the proportion of people over 65 
years of age will triple between 1950 and 2050. 87  Aggravating this economic 
pressure, in the last decades, most of developed countries faced a declining of the 
effective age of retirement and the number of retired people has been growing, 
including in Portugal (Figure 3),88 which is amongst the countries with the highest 
generosity of public pensions (e.g. high net replacement rate - defined as the 
individual net pension entitlement divided by net pre-retirement earnings – 90% 
versus 71% of the EU28 average and 63% of OECD).89  
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Figure 3 – Evolution on the number of pensions in Portugal  
 
Source: PORDATA; Data Sources: CGA/MTSSS & IGFSS/MTSSS (until 1998) | ISS/MTSSS (as from 1999) 
The old-age dependency ratio (i.e. the ratio of the number of elderly persons of an 
age when they are generally economically inactive to the number of persons of 
working age) is progressively increasing in Portugal and by 2050 it will double versus 
2015 (Figure 4). 
Figure 4 – The evolution of old-age dependency ratio 
 
OECD, Organisation for Economic Co-operation and Development; EU28, European Union comprising 28 member states. The 
demographic old-age dependency ratio is defined as the number of individuals aged 65 and over per 100 people of working 
age defined as those aged between 20 and 64. 
Source: Pensions at Glance, OECD.89 Data sources: United Nations, World Population Prospects – 2012 Revision.  
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As a response to the challenges, politicians in OECD and EU countries have begun 
to reform their countries’ pension systems to induce people to work longer, 
particularly by reducing financial incentives to retire. In our country, among other 
alterations, the retirement age was raised from 65 to 66 years and will be linked to 
changes in life expectancy. The effective old-age mean retirement age was 63.4 for 
the private sector workers and 60.9 for the public servants in 2013 (Figure 5) 
 
Figure 5 – The evolution of effective retirement age in Portugal 
 
Source: PORDATA; Data Sources: ISS/MTSSS 
Nowadays, the dissuasion of early retirement is a crucial aim for policymakers. The 
reversion of the cumulative number of retirees has led to the development of policies 
to extend the duration of working life, including postponing the retirement age, as it 
happened recently in Portugal, where the demographic shift has been particularly 
intensified by persistent low fertility rates. However, isolated measures without taking 
in consideration the multiple factors, including health status, that affect retirement 
decisions may be ineffective or even have a long-term deleterious effect on society.  
Retirement is a complex process by which individuals withdraw from full-time 
participation in a job. It is a major transition in peoples’ lives, which for some, who 
sees the opportunity to let go many restrictions and professional harsh conditions, 
might be a long-awaited life-changing event, while feared by others, who have turned 
their professional activity into a source of pleasure, personal investment and/or 
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social acknowledgement.90,91 Many factors may interfere with retirement decisions. 
Understanding roots of such decisions might help the individuals to clarify and deal 
with them and support society to mitigate this highly impactful issue.  
All this resulted in a substantial increase in the dedicated research and the number 
of publications about retirement (Figure 6). Between 2000 and 2015, there was an 
increase of 75.5% in the growth rate of publications about retirement versus the 
general growth of all sorts of publications.  
Figure 6 – Annual publications with “retirement” in Title and/or Abstract searchable in Pubmed 
 
Data Sources: Pubmed (www.ncbi.nlm.nih.gov/pubmed/)  
FACTORS INFLUENCING EARLY RETIREMENT  
There is a large literature about potential influencing factors on the retirement 
decisions. Many of these determinants may be grouped in several categories (Table 
1). First, the financial and economic ones, such as the overall economy and the 
household income; second, the occupational, such as the type of work; third, the 
sociodemographic factors, such as sex, education and marital status, and lifestyle 
factors, such as alcohol consumption, smoking, and obesity; and lastly, health-
related determinants, such as the self-reported health status and chronic diseases 
(Table 1).  
 
 
0100
200300
400500
600700
2015201420132012201120102009200820072006200520042003200220012000
GENERAL INTRODUCTION  
 15 
Table 1 - Potential Determinants of Early Retirement 
 
 Determinants References 
Financial 
Economic Environment 92 
Income / Household Income 93 94 95 96 97 98 99 100 
Pension Wealth 93 101 
Saving Habits / Asset Accumulation 102 103 
Occupational 
 
Occupational class 97 104 105 106 107 108 109 
High Physical Work Demand 110 111 112 113 114 115 116 117 
118 
Work Stress (Demand-Control Imbalance) 96 100 104 111 112 119 120 121 
Work Stress (Effort-Reward Imbalance) 96 100 104 119 120 121  
Job Satisfaction 100 105 110  112 
115 122 123 124 125 
Sociodemographic 
 
Age 92 93 96 97 98 101 108 109 113 114 
119 120 121 
124 126 127 128 129 130 131 132 
Gender 96 101 100 106 109 116 118 120 122 
126 127 128 129 
130 133 134 135 136 137 138 139 
140 141 142 143 144 
Education 95 96 97 98 102 109 114 120 121 
126 127 129 140 141 143 145 
Marital Status 98 112 126 146 
Partner’s Working Status / Couple 
Decisions 
101 124 147 148  
Social Network / Social Support  118 129 133 
Geographic Area (Urban/Rural) 127 
Ethnic Origin 128 
Lifestyle 
 
Obesity / Body Mass Index 120 121 126 128 131 134 
143 149 150 151  
Exercise / Sedentarism  112 120 126 129 131 150 
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Alcohol Consumption  101 120 121 126 152 153 
Smoking  113 118 129 131 153 154 
Ill-Health 
Comorbidity 97 103 121 126 101 126 127  129  
135 137 138 139 155  
Self-Perceived Health Status  98 101 104 105 106 106 112 116 
119 120 121 122 124 125 130 135 
136 136 140 141  153 155 156 157  
Chronic Pain 107 109 113 131 143 145 156 158  
Mobility 101 121  
Quality of Life (EQ-5D/SF-36) 104 
Rheumatic Diseases 75 108 115 126 127 132 135 136 137 
142 143 144 145 152 154 153 155 
156 159 160 161 162 163 164 165  
Diabetes 126 137 166 167 168 
Respiratory Diseases 108 126 142 154 155 169 170 
Cancer 97 99 127 135 137 171  
Coronary Heart Disease 108 127 135 136 137 138 
142 172 173 174 
Stroke 126 127 135 173 175 
Neurologic Diseases 108 127 176 177 178 
Depression 99 100 101 104 108 114 116 117 126 
132 135 136 137 138 139 142 152 
153 154 155 179 180 181 
Anxiety 100 108 114 116 132 135 136 137 
139 142 143 152 154 158 182 
Other 101 108 113 126 153 155 165 189 
179 183 184 185 186 187 188 189 
 
Several studies have found that health status may have a profound impact on the 
ability of workers to be actively engaged in paid employment and to prolong their 
meaningful contribution to a productive society. There is evidence from different 
longitudinal studies that poor health plays a role in exit from paid employment, due to 
GENERAL INTRODUCTION  
 17 
disability pension,120,136,155 unemployment140,155 and official early retirement.120,136,155 
This impact may be detected through broad self-reported health or by studying the 
presence of specific chronic diseases (Table 1).  
It is important to understand that determinants of retirement may present distinct 
roles depending on the context they operate. Ill-health may have a smaller impact on 
the hazard of retirement in countries that have strong economic factors taking place. 
In the past, some authors found that health plays a less important role than the 
economic variables, 190  whilst others found the opposite. 191  An example of the 
interplay of determinants of retirement is well depicted in a recent publication that 
describes some outcomes of the Finnish statutory pension age reform introduced in 
2005, which aimed at extending working lives. Contrary to the initial expectations, it 
seems that offering choice with respect to the timing of retirement may actually 
encourage healthy workers to choose earlier retirement regardless of the provided 
economic incentives for continuing in work. The authors concluded that poor health 
became a weaker predictor of retirement after the statutory pension age reform.192  
Hence, it is of paramount importance to analyse potential determinants of retirement 
within the specific setting for which the research is pointing to provide its results.  
As it happens with the international literature, it is difficult to reach a final general 
conclusion about the relationship between health and retirement in Portugal, since 
few and conflicting results have also been found and published. Uva MS and 
colleagues have recently summarized the available literature about the relationship 
between health and retirement, with a particular focus in the Portuguese studies. The 
authors concluded that, concerning our population, the few studies about health and 
retirement were focused on different health status indicators, making it difficult to 
reach a general conclusion (in addition, these studies were primarily looking for the 
effects of retirement in health). Consequently, the same authors highlighted the need 
for the establishment of more methodologically valid research studies in Portugal, 
mainly epidemiologic studies involving the quantification of association and impact 
measures.193 
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RHEUMATIC DISEASES & EARLY RETIREMENT  
RD may play a key role on early retirement because, as explained, usually they are 
both highly prevalent and disabling. Some studies have analysed the RD effect on 
early retirement,10,40,41 but its precise role is inconclusive, reflecting differences on 
the type of study performed, the setting (with its own labour market and laws 
regarding work and retirement), the population under study, and the explanatory 
variables and confounding addressed in the analysis. In 2014, Rogier van Rijn and 
colleagues performed a systematic literature review on associations between poor 
health/comorbidities and exit from paid employment through disability pension, 
unemployment and early retirement. The authors found that most but not all studies 
were significant when testing RD or MSK complaints with early exit from work.155 
Thus, final conclusions about this relationship are still waiting to be achieved. In 
addition, most studies of early retirement and health status have been carried out in 
America, Australia and Northern European countries, but little is known about 
Southern European countries, such as Portugal.  
Bellow, is a summary of some of the most important studies which have addressed 
the role of RD in early retirement: 
• In 2001, Lacaille D and Hogg RS measured the effect of self-reported RD on 
the working life expectancy of the Canadian population. After analysing cross-
sectional data from 58,439 participants (15-65 years) of the 1994 Canadian 
National Population Health Survey (NPHS) the authors concluded that the 
working life expectancy of people self-reporting RD is significantly reduced 
compared to the general Canadian population (4.2 years on average for men 
and 3.1 for women).144 
• 2 years later in Denmark, Lund T and Csonka A examined the association 
between health and work disability (defined as disability pension or long-term 
sick leave, which has been shown to be associated with transition to disability 
pension) and found that although the initial univariate analysis confirmed the 
association between MSK symptoms and work disability, statistical 
significance was not reached in the multivariate analysis.154  
GENERAL INTRODUCTION  
 19 
• In 2004, Karpansalo M et al. by studying the perceived health effect on early 
retirement in a cohort of 1748 men aged 42 to 60 years from eastern Finland, 
found that after adjustment for potential confounders those with poor 
perceived health had a superior risk for disability pensioning, particularly due 
to chronic illnesses, including MSK disorders.136  
• In 2007, Solomon C et al., collected data on lifetime occupational history, 
including any health-related job loss, obtained as part of a postal survey of 
10,559 men aged 24–70 years old in three rural areas of England and Wales. 
The authors found that this type of job loss had become increasingly common, 
especially in relation to RD and mental illness.108 
• One year later, Schofield DJ and colleagues published a cross-sectional 
analysis from the Australian Bureau of Statistics 2003 Survey of Disability, 
Ageing and Carers for people aged 45–64 years. The authors found that, alike 
other chronic health conditions, arthritis and related disorders, when adjusted 
for age and sex, were significantly associated with being out of the labour 
force.162 
• In the same year, Westhoff G et al. described a significant association 
between morning stiffness and early retirement in German patients with early 
RA using data from a prospective RA cohort of 916 patients with disease 
duration ≤24 months.161  
• Still in 2008, Seyed M. Alavinia & Alex Burdorf, using the Survey of Health, 
Ageing, and Retirement in Europe (SHARE), studied 11,462 participants who 
were 50-64 years old. Long-term illnesses, including arthritis and OP, were 
significantly more common among those persons not having paid 
employment. However, these authors found a much stronger association with 
perceived poor health status.126 
• In 2010, Pit SW and colleagues, analysed which health problems were 
associated with retirement due to ill-health in Australia. In a cross-sectional 
analysis of self-reported data of 1993 retired men and 3160 women aged 45-
64, OA was significantly associated with this sort of retirement.135 This finding 
was later confirmed by the same research team using a larger sample. The 
analysis of self-reported data of 21,719 women and 16,393 men in the same 
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age-group showed a significant relationship between OP and OA with early 
retirement.137 
• In 2012, Alexanderson K et al., studying a prospective cohort of 20,434 
persons employed by the French national gas and electric company, found an 
elevated risk of disability pension among persons with sick-leave due to MSK 
disorders.142 This finding was consistent with a population-based prospective 
cohort study from Sweden.164 
• Also in 2012, Jensen LD et al. analysed a Danish prospective cohort of 
nurses’ aides and found that general rheumatic complaints predicted disability 
pension but not voluntary early retirement, while inflammatory RD predicted 
both forms of work withdrawal.145   
• In 2013, Ranzi TL et al., in one of the few studies in this research area 
performed in Southern Europe, found a significant association between 
arthritis and early retirement by using the “Italian Health Interview Survey” 
with a representative sample of 18,547 people (45-59 years), employed at 
some time in the past.127  
• More recently, Leijten FRM et al., using self-reported data of employees aged 
45–64 years (N=8149) from the Dutch longitudinal Study on Transitions in 
Employment, Ability and Motivation with 3 years of follow-up (2010–2013), 
found that RD were associated with disability pensions, early retirement, but 
not unemployment.165   
ETIOLOGIC MODEL 
Figure 7 depicts the adopted etiologic model that may underlie the connection 
between RD and early retirement. Throughout the natural history of RD, pain and 
impairment (e.g. joint inflammation and deformity) usually take place,1 which in turn 
may lead to functional limitations (i.e. measures of behaviours that deviate from what 
is normally expected, in contrast to impairments, which indicate aberrant conditions 
of tissues, organs, and systems) 194  and disability (i.e. a gap between personal 
capability and environmental demand), 195 , 196  all known predictors of work 
disability,113,197, 198,199 meaning that the patient is no longer able to cope with the job 
requirements. Exit from work and early retirement may then occur if nothing is done 
to adapt the working conditions to the rheumatic symptomatology and disability. In 
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each step of this theoretical framework there are influencing factors and some may 
be changeable to some extent (e.g. pain and disease activity control or job 
accommodations).  
 
Figure 7 - Etiological model on the relationship between RD and Early Retirement 
 
Adapted from Nagi S195 and Stattin M200    
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HYPOTHESES 
1) Health status might have a significant impact in the early retirement of the 
Portuguese population. 
2) Rheumatic conditions, particularly prevalent forms, such as osteoarthritis, might 
have a role in this occupational phenomenon. 
3) Substantial indirect costs to society are expected to follow early retirement 
attributable to rheumatic conditions. 
4) Interventions aiming to control early retirement due to RD might be effective in 
reducing this productivity loss. 
 
OBJECTIVES 
The main objectives of this study were the following: 
1) To examine the association between RD and early retirement in the 
Portuguese population.  
2)  To measure the productivity loss associated with early retirement attributable to 
RD in Portugal.  
3)  To review possible effective interventions targeting early retirement due to RD.  
 
The secondary objectives of this research were the following: 
 
1) To characterize early retirees in Portugal, according to sociodemographic 
characteristics, lifestyle factors, health status (e.g. self-reported RD) and other 
possible determinants of early retirement. 
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2) To characterize the Portuguese population with self-reported RD and clinically 
confirmed OA, namely regarding employment status. 
 
3) To identify relevant determinants of early exit from paid employment in Portugal 
and according with different exit pathways (i.e. retirement, unemployment, 
other forms of early exit from work). 
 
4) To assess how the association between RD with early retirement is influenced 
by other relevant factors.   
 
5) To analyse the evolution of this relationship in 2 time periods (2005/2006 
versus 2011/2013), by using distinct databases (INS and EpiReumaPt). 
 
6) To measure the productivity loss attributable to self-reported RD and clinically 
confirmed OA through different retirement routes. 
 
7) To calculate indirect costs attributable to self-reported RD and clinically 
confirmed OA by different subgroups, according to age, gender and region. 
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STRUCTURE 
The research work was divided in 3 main parts according to its main objectives: 
 
PART 1 - CAUSES OF EARLY RETIREMENT 
The Association between Rheumatic Diseases and Early Retirement 
 
PART 2 - CONSEQUENCES OF EARLY RETIREMENT 
The Indirect Costs of Early Retirement Attributable to Rheumatic Diseases 
 
PART 3 – SOLUTIONS FOR EARLY RETIREMENT 
Interventions to Avoid Early Retirement Attributable to Rheumatic Diseases 
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BRIEF METHODOLOGY 
In Section B, each article includes a detailed description of its methodology. 
However, below we summarize some of the most important features regarding data 
source, study population, inclusion and exclusion criteria, case definitions, variables 
of interest and statistical analysis.  
DATA SOURCES 
INS: 
The 4th Portuguese National Health Survey (INS) was conducted in 2005 and 2006 
in all regions of Portugal. The methodology of the INS has been detailed 
elsewhere.201,202 Briefly, the sampling frame was built on census data and included 
all subjects living in individual housing during that period (collective housing such as 
hospitals, prisons, military barracks, or retirement houses was excluded). The 
sample was considered representative of the main regions of mainland Portugal 
(North, Center, Lisbon region, Alentejo, and Algarve) and the autonomous regions of 
the Azores and Madeira. The primary sampling unit (PSU) was the housing unit, 
which were then randomly selected within each geographically defined unit. Subjects 
living in the PSU were then surveyed. Data were collected using face-to-face 
interviews by trained staff and the questionnaire included self-reported information 
about perceived health, chronic diseases, lifestyle, social and demographic 
conditions.  
For the purposes of this study, a subsample of all INS surveyed people approaching 
the statutory pension age, between 50 and 64 years old, was analysed. The sample 
under analysis was composed of 3,762 men and 4,241 women.  
EpiReumaPt: 
EpiReumaPt was the first national, cross-sectional, population-based study on RD in 
all regions of Portugal. The methodology of EpiReumaPt has been detailed 
elsewhere. 203 Briefly, it was performed among a randomized and representative  
sample of the adult Portuguese population, recruited between September 2011 and 
December 2013. Participants were selected through a process of multi-stage random 
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sampling. The sample was stratified according to the Portuguese Nomenclature of 
Territorial Units for Statistics (NUTS II; seven territorial units: North, Center, Lisbon 
region, Alentejo, Algarve, Madeira and Azores) and the size of the population (<2000; 
2000–9999; 10,000–19,999; 20,000–99,999; and ≥100,000 inhabitants). Household 
units were then selected using a random route process. The adults with permanent 
residence in the selected household with the most recently completed birthday were 
recruited (one adult per household).203 
EpiReumaPt had a three-stage approach (Figure 8):  
1st Phase) 10,661 adult participants were randomly selected. Trained interviewers 
undertook structured face-to-face questionnaires that included screening for RD and 
assessments regarding sociodemographic data, socioeconomic profile, lifestyle, 
anthropometric data, quality of life, functional capacity and self-reported chronic non-
communicable diseases, including RD. Additionally, this phase collected data on the 
economic impact of RD, such as healthcare consumption, early retirement, disability 
pensions and unemployment.  
2nd Phase) A rheumatologist visit was performed to all participants that were 
screened positive for at least one RD during the 1st phase, as well as to 20% 
randomly selected individuals with no rheumatic complaints. Procedures included a 
standardized physical examination and appropriate laboratory and imaging tests in 
order to ascertain the RD diagnosis. RD-specific data was also collected in this 
phase, such as the Knee injury and Osteoarthritis Outcome Score (KOOS)204 
3rd Phase) Three rheumatologists revised all the information and confirmed the 
diagnoses according to validated criteria.  
For the purposes of this study, a subsample of all EpiReumaPt surveyed people 
approaching the statutory pension age, between 50 and 64 years old, was analysed. 
The sample under analysis was composed of 1,065 men and 1,727 women.  
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Figure 8- Flowchart of the EpiReumaPt Study.  
 
Adapted from Branco JC et al23 
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STUDY POPULATION & ELIGIBILITY CRITERIA 
In this study we analysed all non-institutionalized INS/EpiReumaPt participants aged 
50 to 64 years old. Details about the inclusion and exclusion criteria used in INS and 
EpiReumaPt can be found elsewhere.201,202,203 Thus, apart the aforementioned age 
restriction, this study did not have any additional eligibility criteria.    
CASE DEFINITIONS 
Exposure Variable:  
The presence of RD was considered for all those participants from the INS or from 
the EpiReumaPt (1st Phase) who answered positively to the following questions: 
INS: “Do you have or did you have any RD (e.g. OA, tendinitis)?” 
 EpiReumaPt: "Has a doctor ever told you that you have a RD?”  
Regarding the case definition of clinically confirmed OA, it was done following the 
initial diagnosis done by a rheumatologist (2nd Phase of EpiReumaPt) following the 
validation performed by 3 experienced rheumatologists (3rd Phase of EpiReumaPt), 
according with the ACR classification criteria, of at least one type of OA: knee OA,205 
hip OA,206 and hand OA.207 
Dependent Variable:  
The primary outcome of interest in this study was early retirement. We adopted a 
lato and stricto sensu definition of early job loss, because there are different 
channels of exit from the labour market and entry into early retirement, including 
unemployment, disability pensions and retirement. These pathways are related to 
the same economic behaviour, which implies an exit from the labour market in the 
later stages of working life and subsequent loss of productivity for society. 
Consequently, since the overall negative social and economic impact of early 
retirement is similar regardless the channels which gave rise to each individual’s 
form of exit from paid work, it was considered also adequate to contemplate a more 
inclusive outcome in the research. Additionally, these forms of early exit from work 
pave the way to definitive premature retirement. Thus, exit from paid employment 
was assumed for all those who didn’t report any kind of paid work (part- or full-time). 
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As opposed, all those reporting any form of paid work were considered employed. 
This definition was used elsewhere in previous research101,126 and could be obtained 
in both datasets (i.e. INS and EpiReumaPt) in a straightforward manner, since 
details about the employment status were directly asked to all participants of these 
surveys. 
However, we also considered relevant to separately analyse more specific types of 
exit from work, including early retirement (stricto sensu).i 
In addition, we analysed the important outcome of early retirement due to RD, which 
was directly assessed in the EpiReumaPt questionnaire with the following questions: 
“What is your current employment situation?” (dropdown list of different options: Full-
time employee; Part-time employee; Housekeeper; Unemployed; work disability; 
Student; and Retired)  (if retired) “Are you retired due to illness?”  (if yes) “Was it 
due to a RD?” 
VARIABLES OF INTEREST 
Table 2 lists all variables that were retrieved from INS and EpiReumaPt databases in 
order to achieve the proposed study objectives.  
STATISTICAL ANALYSIS  
Each article presented in Section B describes the respective statistical analysis, 
namely regarding the descriptive analysis, ii the multivariable regressions and the 
calculation of PAF and indirect costs. Of note, some interactions were studied (e.g. 
RD/OA and age), but did not reach significance in the final models.  
The logistic regression models were tested using Linktest (Appendix 1). The 
assumptions of homoscedasticity, normality, and independence (e.g. no auto-
                                            
i  According to the Portuguese Law, the transition from unemployment to early retirement can occur under pre-specified 
conditions. This study didn’t discriminate between short- and long-term unemployment, given the cross-sectional nature of the 
surveys (i.e. right censorship) and because short-term unemployment (<12 months) represented just a small share of all 
registered unemployment within the studied age-group (e.g. in EpiReumaPt less than 1%).  
In Portugal, disability pensions are calculated on the basis of a disability percentage, determined by the difference between 
what an individual can theoretically earn with his or her maintained functional abilities and what he or she earned prior to the 
disability or what a comparable person without any disability earns.  
ii Significance of the study variables was tested using Student’s t-test or the Chi-square test, where appropriate. A two-tailed p 
value of <0.05 was considered to be statistically significant. 
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correlation) are not needed for the survey mode used in all the analyses, which 
bases its inference on the sample design (stratification and variation between PSU) 
and is robust to violations of those assumptions. In other words, there is no need to 
test for those violations. The basic test of fit is the linktestiii. The idea behind the 
linktest is that if the model is properly specified, one should not be able to find any 
additional predictors that are statistically significant except by chance. After the 
logistic regression command, linktest uses the linear predicted value (_hat) and 
linear predicted value squared (_hatsq) as the predictors to rebuild the model. The 
variable _hat should be a statistically significant predictor, since it is the predicted 
value from the model. This will be the case unless the model is completely 
misspecified. On the other hand, if the model is properly specified, 
variable _hatsq shouldn't have much predictive power except by chance. Therefore, 
if _hatsq is significant, then the linktest is significant. This usually means that either 
we have omitted relevant variable(s) or our link function is not correctly specified 
(Appendix 1).   
INS and EpiReumaPt were designed to obtain representative samples of the 
Portuguese population. In order to guarantee representativeness, the design effect 
of both surveys needed to be taken into account in all statistical analysis. This can 
be achieved by using weighted proportions that have, for this matter, been computed. 
Specifically for the EpiReumaPt main sample, the initial extrapolation weights were 
calculated as the inverse of the inclusion probabilities, taking into account the 
sampling design (i.e. a stratified two-stage cluster sampling design). The 
stratification was based on the seven NUTS II regions and on five classes of the 
number of inhabitants per locality (<2,000; 2,000-9,999; 10,000-19,999; 20,000-
99,999; >99,999). In each stratum, the first sampling stage consisted in the selection 
of localities with a probability proportional to its size (number inhabitants aged 18 
years old or more), except for localities where the number of inhabitants was larger 
than 20,000, where all the localities were selected. In the second stage, households 
were selected using a pseudo-random selection procedure equivalent to the equal 
probability selection. These weights were submitted to a calibration process by 
crossing region (seven classes), size of locality (five classes), gender (two classes) 
and seven age categories (18-25, 26-35, 36-45, 46-55, 56-65, 66-75 and ≥76 years 
                                            
iii This test is specific from the Stata Statistical Software. 
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old). This procedure was used to reproduce the known population totals for the 
crossing margins of these four variables. More details about these weighted 
proportions may be found elsewhere.208,203 
All analyses were performed using Stata IC version 12.0 (StataCorp. 2011. Stata 
Statistical Software: Release 12. College Station, TX: StataCorp LP).  
Table 2 – Variables of interest retrieved from INS and EpiReumaPt 
 
 Variables of Interest INS EpiReumaPt 
Sociodemographic 
Age x x 
Gender x x 
Area of Residence (Regions) x x 
Marital Status x x 
Socioeconomic 
Educational level x x 
Household Income x x 
Lifestyle 
BMI x x 
Smoking Status x x 
Alcohol Consumption x x 
Ill-Health 
Self-reported Health Status x - 
Self-reported chronic  diseases x x 
Comorbidity Score x x 
RD 
Self-Reported RD x x 
Clinically Confirmed OA - x 
Quality of Life 
EQ-5D - x 
SF-36 - x 
Pain 
& 
Functional Capacity 
Chronic Pain x x 
Bodily Pain Index from SF-36 - x 
Longstanding MSK pain - x 
Pain Interference - x 
HAQ - x 
KOOS - x 
Occupational 
Employment Status x x 
Early Retirement due to RD - x 
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Early Retirement x x 
Unemployment x x 
Disability Pensions x x 
Exit from Paid Employment x x 
Type of Work x - 
SECTION B 
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RESULTSiv 
All results presented in this Section were published or submitted in international, 
peer-reviewed journals indexed in PubMed. 
   
PART 1: CAUSES OF EARLY RETIREMENT 
The Association between Rheumatic Diseases and Early Retirement 
 
Article A: 
Association of rheumatic diseases with early exit from paid employment in 
Portugal 
Pedro A. Laires, Miguel Gouveia 
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Introduction
Europe has observed an outstanding increase in life expec-
tancy, while at the same time rates of labor force participa-
tion among older people have been decreasing [1]. Older 
workers are leaving the labor market in great numbers [2], 
and early exit from employment provides a major chal-
lenge to social and health policies. Portugal is already 
among the oldest countries in the world, with one of the 
highest old-age dependency ratio, and is currently facing a 
shrinking number of economically active people support-
ing a growing economically dependent elderly population 
[3]. Thus, this trend is hardly feasible and early exit from 
paid employment in Portugal generates a serious problem 
for social and economic sustainability. In fact, it might just 
be at the very forefront of a general European concern with 
premature exit from work of its potential labor force. Iden-
tification of relevant determinants of early exit from paid 
employment is clearly a prerequisite to delineate strategies 
and interventions aiming to shift from early exit to the vir-
tuous cycle of active aging [2].
There is a large literature on this issue and it is possible 
to identify some variables that might explain the retirement 
decision. First, the financial incentives, such as disability 
pensions or household income [4–6]; second, the type of 
work [7–9]; third, the sociodemographic factors, such as 
sex, education and marital status [10], and lifestyle factors, 
Abstract To examine the association between rheumatic 
diseases (RD) and other chronic morbidity with early exit 
from paid employment in the Portuguese population. The 
study population consisted of all people between 50 and 
64 years of age (3,762 men and 4,241 women) who par-
ticipated in the Portuguese National Health Survey, con-
ducted in 2005/2006. Data were collected on demograph-
ics, ill-health, lifestyle, and socioeconomic factors. Logistic 
regression was used to estimate the isolated effect of rheu-
matic diseases and other chronic diseases on the likelihood 
of exit from paid employment. At the time of the survey, 
45.1 % of the Portuguese population with ages between 50 
and 64 years old were not employed. In the nonemployed 
population, 31.6 % self-reported “poor” to “very poor” 
health, whereas 16.4 % did so in the employed popula-
tion. A larger average number of major chronic diseases 
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such as alcohol consumption [11], smoking [12], and obe-
sity [13–15]; and lastly, health-related determinants, such 
as comorbid conditions [2, 10, 11, 16–24]. These main 
types of determinants may interact. For instance, health 
shocks may have a smaller impact on the hazard of retire-
ment in countries that have the strongest financial incen-
tives to retire early [25]. On the other hand, countries with 
relatively more generous pension schemes due to disability, 
such as the case of Portugal and other southern European 
countries [26, 27], are expected to suffer more impact from 
ill-health on the hazard into early retirement [26]. Further-
more, although the effect of health status on early retire-
ment has long been recognized, that effect is not always 
straightforward due to this interdependence with other 
types of determinants. For instance, chronic diseases such 
as rheumatic diseases (RD) may play a key role on early 
retirement because usually they are both highly prevalent 
and disabling, affecting daily functioning [28, 29], which 
is particularly relevant for occupations where working 
conditions cannot be modified or adjusted to a reduced 
work ability of employees [7, 30, 31]. In fact, studies have 
already shown that the presence of chronic disorders is 
indeed associated with a premature departure from labor 
market [10, 32, 33]. However, some other studies have sug-
gested that employees with chronic disorders tend to retire 
later because they likely have accumulated fewer assets 
during their working life [20]. Hence, the role and the mag-
nitude of the effect of ill-health in early retirement is far 
from being the same across all contexts.
A lot remains to be understood about the relationship 
between ill-health and early retirement and the possible 
influence of the social context and other factors on this 
relationship. Moreover, since health status encompasses a 
broad array of underlying clinical conditions, it is also of 
interest to assess how specific symptoms and chronic con-
ditions are affecting workers’ withdrawal from the work-
force. Previous research has suggested associations of exit 
from work with diseases like cancer [34], heart disease 
[35], depression [36], disorders of the nervous system [37, 
38], and others [10, 11, 39]. The association with RD is 
particularly interesting. These diseases are highly preva-
lent in the western world, and their clinical and functional 
impacts may be profound, representing major causes of 
disability among workers, particularly on manual workers, 
who are exposed on average to harsher working conditions. 
Some studies have analyzed the RD effect on early retire-
ment [10, 40, 41], but again its isolated role is inconclu-
sive, reflecting differences on the type of study performed, 
the population under study, and the explanatory variables 
included in the analysis. Final conclusions about this rela-
tionship are therefore still beyond our grasp. Besides, most 
studies of early retirement and health status have been 
carried out in the United States and Northern European 
countries, but little is known about Southern European 
countries, where disability due to RD and other chronic 
diseases may represent a quantitatively relevant reason for 
exit from the labor market.
Main aims of this study are as follows: (a) To examine 
the association between RD and other major chronic dis-
eases with exit from paid employment in the Portuguese 
population approaching the statutory retirement age and (b) 
To assess how this association is affected by other factors 
(including personal, financial, socioeconomic, and working 
conditions).
Methods
Sample
The source of data for this study was the 4th Portuguese 
National Health Survey (INS), which was conducted in 
2005 and 2006 in all regions of Portugal. The methodology 
of the INS has been detailed elsewhere [42, 43]. Briefly, 
the sampling frame was built on census data and included 
all subjects living in individual housing during that period 
(collective housing such as hospitals, prisons, military bar-
racks, or retirement houses was excluded). The sample 
was considered representative of the main regions of main-
land Portugal (North, Center, Lisbon region, Alentejo, and 
Algarve) and the autonomous regions of the Azores and 
Madeira. The primary sampling unit (PSU) was the hous-
ing unit and sampling built on the population and housing 
census. Within each main region, two strata were defined: 
the freguesias (corresponding to townships) and, within 
the freguesias, geographically defined units of 240 lodg-
ings. The PSUs were then randomly selected within each 
geographically defined unit. Subjects living in the sampling 
unit were then surveyed. The participation rate (defined as 
the percentage of households who responded) as reported 
by the National Institute of Statistics was 76 % [42, 43]. 
Data were collected using face-to-face interviews by 
trained staff and the questionnaire included self-reported 
information about perceived health, chronic diseases, life-
style, social, and demographic conditions.
For the purposes of this study, a subsample of all INS 
surveyed people approaching the statutory pension age, 
between 50 and 64 years old, was analyzed. The sample 
under analysis was composed of 3,762 men and 4,241 
women.
Measures
Early retirement was considered as being out of paid work 
before age 65, which is the statutory retirement age in Por-
tugal. Thus, a broader definition of early retirement (i.e., 
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exit from paid employment) was adopted. There are differ-
ent channels of exit from the labor market and entry into 
early retirement, including unemployment, disability, and 
pure early retirement [5, 44–47]. A caveat of this approach 
is that it doesn’t differentiate temporary (e.g., transitory 
unemployment) from definitive exit from labor market 
(e.g., official retirement); however, adopting a broader 
definition of early retirement enabled this research to take 
into account the existence of different pathways to retire-
ment. These pathways are related to the same economic 
behavior, which implies an exit from the labor market in 
the later stages of working life and subsequent loss of pro-
ductivity for society. Consequently, since the overall nega-
tive social and economic impact of early retirement is simi-
lar without regard of the channels which gave rise to each 
individual’s form of exit from paid work, it was considered 
more adequate to consider this more inclusive outcome in 
the research. Additionally, temporary forms of early exit 
from work pave the way to definitive premature retire-
ment, which highlights the need for the identification of 
determinants and possible interventions that might adjourn 
definitive decision of early retirement. Thus, exit from paid 
employment was considered for all those who didn’t report 
any kind of paid work. As opposed, all those reporting any 
form of paid work were considered employed. This defini-
tion was used elsewhere in previous research [11, 48].
Health measurement
The presence of major comorbidities was assessed through 
self-reporting of the following clinical disorders: RD, chronic 
pain, diabetes, hypertension, asthma, cancer, renal impair-
ment, respiratory diseases (chronic obstructive pulmonary 
disease and chronic bronchitis), previous stroke, previous 
myocardial infarction (MI), anxiety, and depression. A proxy 
measure of general morbidity was built as the sum score of all 
aforementioned chronic illnesses (comorbidity score).
The European version of self-perceived health, a 5-point 
scale questionnaire with answers ranging from “very 
good” to “very poor”, was used to define perceived health 
status. This questionnaire is a broad indicator of health-
related well-being [49, 50] and has been shown to be a 
good indicator of general physical and mental health [16, 
51, 52]. Thus, respondents were asked to describe their 
general health as “very good,” “good,” “fair,” “poor,” or 
“very poor.” For this analysis, the variable was transformed 
into 3 major categories (“very good”/“good”, “fair”, and 
“poor”/“very poor”).
Lifestyle factors
Smoking status was classified into 3 categories (Not a 
smoker/occasional smoker; Ex-smoker; current smoker), 
alcohol consumption was transformed in a dichotomous 
variable (no/yes) for daily alcohol consumption, and obe-
sity measured according to the body mass index (less than 
25 m2/kg; between 25 and 30 m2/kg; and 30 m2/kg or more).
Sociodemographic variables and working type
Area of residence was defined according to the regional 
location of each household (North; Center; Lisbon region; 
Alentejo; Algarve; Azores; and Madeira). Age was grouped 
into 3 age ranges with 5-year intervals (50–54; 55–59; 60–
64 years old). Marital status variable was grouped into 4 
categories (single; married; divorced; widowed). Regarding 
socioeconomic characteristics, educational level was clas-
sified into 3 major levels according to the highest quali-
fication completed: low (no education/primary school), 
medium (basic school between primary and secondary lev-
els), high (secondary education/university degree), monthly 
income of each household was distributed in 4 categories 
(€500 or less; €500–€900; €900–€2000; €2000 or more), 
and occupational social class, which refers to the respond-
ent’s current occupation or last occupation, was assigned 
according to a simplified version of the UK Registrar Gen-
eral’s Classification of occupations, already used in previ-
ous similar research [49]. The six original social classes 
were collapsed into two broad categories: nonmanual 
workers and manual workers.
Statistical analysis
Descriptive analysis was performed to compare exit from 
paid employment against a population with paid employ-
ment. Prevalence of retirement and other characteristics 
were computed as weighted proportions, in order to take 
into account the sampling design of the survey. The associ-
ation of early exit from paid employment with health varia-
bles was assessed through logistic regression analysis. The 
first step in the analysis was to establish cross-sectional 
univariate associations between exit from paid employ-
ment and health measures, sociodemographic factors, life-
style factors and work type. In the second step, multivari-
ate logistic regression was used to evaluate the association 
between exit from paid employment (dependent variable) 
and measures of ill-health (i.e., RD, other comorbidities 
and self-perceived health status) as independent variables, 
when adjusted to the other variables of interest (including 
age, sex, and region). In the final multivariable models, 
only variables statistically significantly associated with the 
dependent variable (p < 0.05) were considered. The models 
were built by means of a manual stepwise technique (back-
ward elimination).
A better measure of the importance of a risk factor may 
be the population attributable fractions (PAF), which takes 
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into account both the strength of the association between 
risk factor and outcome and the prevalence of that risk fac-
tor in the population. PAF were calculated as the resulting 
proportional change in the probability of exit from paid 
employment after a counterfactual exercise where the pres-
ence of a risk factor is artificially eliminated from the sam-
ple. All statistical analyses were carried out using Stata 10 
for Windows.
Results
At the time of the survey, 45.1 % of the Portuguese pop-
ulation with ages between 50 and 64 years old were not 
employed. Their baseline characteristics are presented in 
Table 1 where they are compared against those who were 
still with paid work. Among all regions of Portugal, the 
North region presented the highest prevalence of early 
exit from paid employment. Being older, lower educa-
tion, manual type of work, lower household income, and 
female gender characteristics were more frequent within 
this group. However, this higher frequency in women (a 
group with more homemakers) may be partly explained by 
the unbalance on the different types of exit from employ-
ment between genders. There were no remarkable differ-
ences concerning marital status and lifestyle factors (i.e., 
obesity, alcohol, and smoking consumption) between 
groups (these variables were not included in the models 
shown in Table 2). On the other hand, concerning health 
substantial differences were observed, either measured 
through self-perceived health or through the presence of 
chronic diseases. Early retirees were remarkably worse 
in terms of their health conditions. More than a third 
(31.6 %) of nonemployed individuals reported “poor” to 
“very poor” health, whereas about half of that proportion 
(16.4 %) was found among those still employed (Table 1). 
Higher prevalence of all assessed comorbidities was found 
in the group of individuals with early exit from paid work. 
Additionally, higher average number of comorbidities per 
capita was found in this group (comorbidity score = 1.9 
vs. 1.4, p < 0.001). Particularly, RD were more frequently 
self-reported among those not currently at paid work than 
in the remaining population (43.4 vs. 32.1 %). Among all 
those self-reporting RD, more than half (52.6 %) were 
not employed. Mental health disorders (i.e., anxiety and 
depression) were also more frequent on those out of work.
In Table 2, it is possible to verify the results obtained 
from the uni- and multivariate logistic regressions. In line 
with the descriptive results presented in Table 1, North 
region, higher age, female, lower education, manual type 
of work, lower household income, and worse health status 
were associated with early exit from paid employment. Age 
adjustment didn’t cause many differences in the odds ratios 
of each variable (Table 2—Model 2). However, unsurpris-
ingly, we found high correlation (multicolinearity) among 
covariates and only some predictors remained in the final 
multivariate models (Table 2—Model 3, 4 and 5).
A higher number of comorbidities is a significant pre-
dictor of early exit from paid employment after adjustment 
to other covariates (OR 1.08; CI 1.02–1.15, p = 0.011). 
Table 2—Model 4), but when specific comorbidities were 
included in the multivariate analysis (Table 2—Model 
3), most of the chronic diseases were no longer statisti-
cally significant, with the exception of renal impairment 
(OR 1.74; CI 1.05–2.87, p = 0.031) and previous stroke 
(OR 2.09; CI 1.25–3.52, p = 0.005). In both models and 
regardless the proxy used for comorbidity, region, age, gen-
der, education, and self-perceived health status showed the 
strongest association with early exit from work.
The high association between ill-health and early exit 
from paid employment, when measured by less than “good” 
self-perceived health, translates in ORs varying between 
1.25 and 1.69 for “fair” and between 1.96 and 3.31 for “bad/
very bad”, depending on the type of analysis considered 
(i.e., uni- or multivariate regression models. See Table 2).
As expected, high correlation was observed between RD 
and other important factors, such as the presence of other ill-
nesses (coexistence of RD with other chronic conditions is 
well-known in the literature) [53, 54]. Therefore, in the RD-
specific model (Table 2—Model 5), after adjustment and 
considering cofactors with low variance inflation factor (i.e., 
VIF <5 in order to avoid multicolinearity), only region, age, 
education, and household income remained statistically sig-
nificant. In this model, adjusted OR for RD was 1.31 (1.12–
1.52, p = 0.001). The PAF of RD calculated with adjusted 
and unadjusted ORs were 5 and 9.8 %, respectively.
Of note, we tested for interactions between RD and gen-
der; RD and age; and RD and type of work, but none of the 
interaction variables remained significant in the final multi-
variable models (data not shown).
We have also tested the association of RD with a more 
restrictive definition of early exit work, using only formal 
retirement as the outcome variable in the regressions. In 
spite of the fact that our sample had a considerable num-
ber of other forms of exit from labor market, in particular 
female homemakers (Table 3), we still observed a sig-
nificant association between RD and this more restrictive 
definition of pure early retirement (Table 4). This suggests 
that RD remains associated with early departure from paid 
employment regardless the definition used. 
Discussion
The current study, which was based on a large and repre-
sentative sample of the Portuguese population approaching 
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Table 1  General description of the sample by employment status: Portuguese National Health Survey (n = 8,003) ages 50–64
Exit from paid employment % (N) Paid employment % (N) p value
Employment status 45.1 (838,358) 54.9 (1,021,403) NA
Area of residence
 North 38.5 (322,787) 29.5 (301,592) p < 0.001
 Center 13.0 (108,632) 20.5 (209,142)
 Lisbon region 36.5 (39,089) 36.8 (375,693)
 Alentejo 4.7 (29,791) 5.1 (51,678)
 Algarve 3.6 (17,330) 4.5 (45,808)
 Azores 2.1 (17,330) 1.7 (17,137)
 Madeira 1.8 (14,745) 2.0 (20,349)
Age
 50–54 22.8 (191,519) 47.8 (487,716) p < 0.001
 55–59 34.2 (286,708) 33.5 (342,403)
 60–64 43.0 (360,130) 18.7 (191,284)
Gender (female) 62.6 (524,892) 44.1 (450,204) p < 0.001
Educational level
 Primary school or less 77.9 (651,726) 65.2 (664,201) p < 0.001
 Medium 13.7 (114,658) 18.1 (184,345)
 High 8.5 (70,817) 16.7 (170,372)
Marital status
 Single 5.1 (42,917) 5.4 (54,987) NS p = 0.06
 Married 82.8 (694,411) 83.0 (847,548)
 Divorced 5.0 (42,005) 6.7 (68,874)
 Widowed 7.0 (59,023) 4.9 (49,992)
Occupational class
 Nonmanual worker 36.2 (197,566) 44.8 (456,533) p < 0.001
 Manual worker 63.9 (348,977) 55.2 (563,088)
Self-perceived health status
 Very good/good 20.6 (140,144) 35.3 (244,408) p < 0.001
 Fair 47.7 (322,316) 48.3 (477,134)
 Poor/very poor 31.6 (219,424) 16.4 (162,074)
Body mass index
 <25 kg/m2 32.8 (266,239) 33.3 (336,650) NS p = 0.486
 25–30 kg/m2 42.7 (355,191) 43.6 (440,165)
 ≥0 kg/m2 25.2 (209,742) 23.1 (233,172)
Alcohol (daily consumption) 43.6 (365,570) 46.1 (470,694) NS p = 0.237
Smoking status
 Not a smoker/occasional smoker 72.3 (606,127) 62.4 (637,117) p < 0.001
 Ex-smoker 16.8 (141,214) 21.3 (217,103)
 Current smoker 10.9 (91,015) 16.4 (167,181)
Chronic diseases
 Rheumatic diseases 43.4 (363,587) 32.1 (328,198) p < 0.001
 Diabetes 16.0 (133,783) 11.1 (113,191) p < 0.001
 Asthma 7.7 (64,693) 4.7 (47,864) p = 0.004
 Hypertension 43.5 (364,704) 34.2 (349,487) p < 0.001
 Chronic pain 32.2 (269,877) 22.7 (232,053) p < 0.001
 Cancer 4.3 (36,298) 3.0 (30,275) NS p = 0.09
 Renal impairment 3.9 (32,661) 1.4 (14,223) p < 0.001
 Respiratory diseases 5.7 (47,634) 3.1 (31,603) p = 0.002
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the statutory age of retirement (65 years old), suggests a 
strong association between ill-health and early exit from 
paid employment. This holds true for chronic rheumatic 
disorders, which seem to play a key role in early pathways 
of retirement. Thus, significantly higher ORs for ill-health 
variables were captured in this research, showing its impact 
in the Portuguese labor force participation. Of particular 
note, less than good self-reported health status is highly 
associated with early exit from paid work. This relationship 
is quite independent from other variables, including depres-
sion and anxiety, in almost all multivariate adjustment pre-
sented in this paper. As in previous research from other 
countries, the presence of specific chronic conditions was 
also highly associated with overall exit from paid employ-
ment, in particular, rheumatic conditions, renal impairment, 
and a history of stroke. Not surprisingly, these comor-
bidities, which cause considerable functional disability, 
may represent important sources of inactivity in Portugal. 
The specific focus of RD in this research allowed an esti-
mation of a PAF from 5 to 9.8 %. This means that upon 
an alternative ideal exposure scenario, with no RD in the 
Portuguese population, there could be a reduction of up 
to almost a tenth of the overall risk of early exit from paid 
work, thereby potentially generating significant productiv-
ity gains.
Furthermore, the presence of other comorbidities seems 
to also contribute to the same sort of risk. For each addi-
tional chronic disorder (including chronic pain), there is 
an estimated increase in risk of approximately 8 %, after 
adjustment to other cofactors.
Interestingly, mental-related comorbidities (i.e., depres-
sion and anxiety) seem to have less association with exit 
from work compared with physical-related ones, mostly 
when adjusted to other cofactors. Although these results 
contrast with previous research done in northern Europe, 
especially for depression [10, 11, 36], they appear to be 
in line with some other evidence coming from southern 
Europe [23]. Our findings could be due to several reasons. 
Namely, the lack of societal valorization of mental diseases 
in Portugal may discourage patients to use it as a primary 
reason for retirement. In addition, physical impairment is 
much more likely to qualify for disability pensions than 
most forms of mental illnesses. Another possible reason 
may be based on the underlying strong association between 
physically disabling conditions and depression/anxiety, so 
that the former’s stronger effect may actually mask separate 
effects of the latter. Moreover, one can also speculate that 
our inability to distinguish between mild-to-severe depres-
sion may have driven the results. Portugal’s high preva-
lence of mild-to-moderate depression may “dilute” the pos-
sible higher effect of severe depression in early withdrawal 
from paid work.
Lifestyle factors such as obesity, smoking status, and 
alcohol consumption have already been shown to have an 
effect on some countries’ retirement outcomes [11–15]. 
However, in this study, we found no significant relation-
ship of these factors to exit from paid employment. In 
the case of smoking and alcohol, we cannot rule out that 
differences in exposure definition (quantity and duration) 
may, at least partially, explain this difference relative to 
other research.
Our final multivariate models revealed that higher edu-
cation, higher household income, and having a nonmanual 
type of work are less associated with early exit from the 
labor force. Previous work has shown contradictory results 
on this regard. On the one hand, higher education and 
income, which are characteristics related to better working 
conditions, assure accumulation of more assets during life-
time allowing employees to leave their paid work earlier. 
However, on the other hand, a poor working condition is 
known to be a significant determinant of premature depar-
ture from working life. This has been observed in employ-
ees with physically demanding work or with monotonous 
and repetitive work [7, 9]. Additionally, exposure to manual 
Prevalences of exit from paid work and other subjects’ characteristics were computed as weighted proportions, in order to keep into account the 
sampling design of the survey (N = 1,859,761)
Table 1  continued
Exit from paid employment % (N) Paid employment % (N) p value
 Stroke 3.6 (30,392) 1.6 (16,029) p = 0.002
 Myocardial infarction 2.0 (16,824) 1.5 (15,112) NS p = 0.291
 Anxiety 10.6 (89,006) 7.1 (72,333) p = 0.003
 Depression 16.2 (135,830) 12.6 (128,898) p = 0.014
Household income (per month)
 ≤€500 30.1 (246,406) 19.9 (196,433) p < 0.001
 >€500 and ≤€900 29.3 (239,261) 28.5 (280,996)
 >€900 and ≤€2000 31.0 (253,381) 35.4 (348,990)
 >€2000 9.6 (78,660) 16.2 (159,492)
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Table 2  Logistic regression analysis of the influence of individual characteristics and ill-health on the likelihood of exit from paid employment
OR odds ratio, CI confidence interval
*
 Cofactor not included in the model
§
 Cofactor excluded in the stepwise method (backward elimination with p > 0.05)
a
 All variables separately (unadjusted model)
b
 Adjusted for age
c
 Adjusted for chronic diseases, demographic variables, self-perceived health, and socioeconomic indicators
d
 Adjusted for comorbidity score, demographic variables, self-perceived health, and socioeconomic indicators
e
 RD-specific model adjusted for all remaining cofactors with low variance inflation factor (i.e., VIF < 5)
Model 1a univariate Model 2b multivariate Model 3c multivariate Model 4d multivariate Model 5e multivariate
OR (95 % CI) OR (95 % CI) OR (95 % CI) OR (95 % CI) OR (95 % CI)
Area of residence
 North 1 1 1 1 1
 Center 0.49 (0.39–0.61) 0.43 (0.34–0.54) 0.51 (0.41–0.62) 0.51 (0.42–0.63) 0.53 (0.43–0.64)
 Lisbon region 0.76 (0.61–0.95) 0.70 (0.56–0.88) 0.75 (0.62–0.92) 0.76 (0.62–0.93) 0.77 (0.63–0.94)
 Alentejo 0.71 (0.56–0.89) 0.65 (0.51–0.83) 0.72 (0.59–0.89) 0.73 (0.60–0.90) 0.72 (0.59–0.88)
 Algarve 0.61 (0.49–0.76) 0.55 (0.44–0.70) 0.65 (0.53–0.80) 0.67 (0.55–0.82) 0.62 (0.51–0.76)
 Azores 0.94 (0.75–1.19) NS 0.95 (0.74–1.21) NS 1.08 (0.88–1.31) NS 1.09 (0.89–1.32) NS 1.04 (0.86–1.27) NS
 Madeira 0.68 (0.53–0.86) 0.65 (0.50–0.85) 0.80 (0.63–1.09) NS 0.83 (0.66–1.05) NS 0.85 (0.68–1.07) NS
Age
 50–54 1 * 1 1 1
 55–59 2.13 (1.73–2.62) * 1.88 (1.57–2.25) 1.84 (1.53–2.20) 1.86 (1.55–2.22)
 60–64 4.79 (3.87–5.94) * 4.48 (3.70–5.41) 4.37 (3.61–5.29) 4.32 (3.58–5.22)
Gender (Female) 2.12 (1.80–2.51) 2.25 (1.89–2.68) 1.99 (1.70–2.32) 1.88 (1.60–2.19) *
Educational level
 Primary school or less 1 1 1 1 1
 Medium 0.64 (0.50–0.82) 0.70 (0.55–0.89) 1.04 (0.84–1.28) NS 1.04 (0.84–1.29) NS 0.97 (0.78–1.20) NS
 High 0.42 (0.33–0.55) 0.46 (0.36–0.59) 0.70 (0.56–0.89) 0.70 (0.56–0.89) 0.68 (0.52–0.89)
Occupational class
 Nonmanual worker 1 1 § § *
 Manual worker 1.43 (1.18–1.73) 1.38 (1.13–1.67) § § *
Self-perceived health status
 Very good/good 1 1 1 1 *
 Fair 1.69 (1.43–2.01) 1.52 (1.20–1.91) 1.33 (1.11–1.61) 1.26 (1.04–1.53) *
 Poor/very poor 3.31 (2.71–4.04) 2.87 (2.19–3.75) 2.07 (1.64–2.60) 1.91 (1.49–2.47) *
Chronic diseases
 Rheumatic diseases 1.62 (1.36–1.92) 1.38 (1.15–1.64) § * 1.31 (1.12–1.52)
 Diabetes 1.52 (1.19–1.95) 1.30 (1.01–1.68) § * *
 Asthma 1.70 (1.18–2.45) 1.66 (1.14–2.41) § * §
 Hypertension 1.48 (1.25–1.75) 1.26 (1.06–1.50) § * *
 Chronic pain 1.62 (1.34–1.94) 1.53 (1.26–1.85) § * §
 Cancer 1.48 (0.94–2.33) NS 1.38 (0.88–2.18) NS § * §
 Renal impairment 2.87 (1.56–5.27) 2.71 (1.49–4.93) 1.74 (1.05–2.87) * §
 Respiratory diseases 1.89 (1.25–2.85) 1.59 (1.04–2.44) § * §
 Stroke 2.36 (1.34–4.16) 1.96 (1.06–3.62) 2.09 (1.25–3.52) * §
 Myocardial infarction 1.36 (0.77–2.43) NS 1.02 (0.54–1.91) NS § * §
 Anxiety 1.56 (1.16–2.09) 1.46 (1.09–1.96) § * *
 Depression 1.34 (1.06–1.69) 1.41 (1.10–1.81) § * *
 Comorbidity score 1.94 (1.68–2.24) 1.72 (1.48–1.99) * 1.08 (1.02–1.15) *
Household income (per month)
 ≤€500 1 1 § § 1
 >€500 and ≤€900 0.68 (0.54–0.85) 0.73 (0.58–0.93) § § 0.84 (0.69–1.04) NS
 >€900 and ≤€2000 0.58 (0.46–0.72) 0.65 (0.52–0.83) § § 0.78 (0.64–0.96)
 >€2000 0.39 (0.29–0.53) 0.45 (0.33–0.60) § § 0.66 (0.48–0.89)
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and poor working conditions was also shown to increase 
intentions to leave earlier employment trajectories [7–9, 
55–57]. Therefore, previous data showed that these finan-
cial and working conditions variables can have opposite 
effects on the risk of early retirement. Nevertheless, our 
results demonstrate now that, at least in Portugal, these fac-
tors are more associated with early exit from work than the 
opposite.
Remarkably, marital status didn’t seem to have much of 
an effect on the likelihood of early withdrawal from paid 
employment. Some studies have shown an effect of marital 
status on the risk of early retirement, but the employment 
status of the partner seems to play a more important role in 
this regard. In addition, the family context may also play an 
important role. Couples may coordinate their decisions and 
the partner may influence the choice of leaving the labor 
market [44, 58, 59]. However, this sort of information was 
not captured in the INS database.
We do not expect our results to be influenced by justifi-
cation bias, a common limitation in this type of research. 
Some people may want to justify their early retirement 
through health problems and/or general self-reported lower 
health status. Since this research didn’t use its own ques-
tionnaire and all the analysis was done based on the INS, 
which is not focused on retirement, we don’t expect this 
limitation to have a significant impact on the overall results. 
Surveyed population couldn’t realize any specific inten-
tion to relate their health with their corresponding working 
situation and shouldn’t feel any pressure or need to justify 
their retirement condition. We also don’t anticipate that 
self-reporting may be a significant limitation in this work, 
because most important tested risk factors, such as RD and 
other chronic disorders, are expected to inflict significant 
disability and/or impact on quality of life. Self-reporting is 
then considered to be a reliable marker of the actual pres-
ence of these comorbidities. We also don’t assume answers 
to be subject to recall bias, since no information from the 
past, requiring any particular memory challenge, was used.
However, some limitations must be taken into account 
in interpreting the results of this study. First of all, this 
study may be limited by its cross-sectional design, which 
does not allow evaluation of the temporal relationship 
between onset of risk factors and time of exit from paid 
employment, which would be essential for establishing 
a cause–effect relationship. Nevertheless, onset of most 
forms of RD and main chronic disorders is likely to start 
before premature exit from paid employment. This limi-
tation is expected to be more relevant for self-perception 
of health, late-onset diseases (i.e., cancer, stroke and MI), 
and mental disorders (i.e., depression and anxiety). Some 
researchers have also suggested retirement as a risk fac-
tor for poor health outcomes [25, 60, 61]. Thus, although 
our results are generally consistent with prospective data 
collected elsewhere, we cannot entirely rule out reverse 
causation bias for some cases. Lack of available national 
longitudinal data made this limitation impossible to 
turnaround. Secondly, the INS sampling methodology 
excluded people based on hospitals and retirement homes, 
so this study doesn’t take into account this minority. 
Still, due to obvious reasons, this possible sampling bias 
is expected to weaken the association found between ill-
health and exit from work. Thirdly, early exit from paid 
work is reportedly influenced by many other factors not 
included in these regression models, therefore maybe not 
all possible confounding was addressed in this research. 
However, adjustment was done with all available cofac-
tors in the INS dataset, which according to the literature 
could influence retiring decisions, covering main areas of 
interest, including personal, health, financial, and work-
ing-related conditions. In fact, to our knowledge, this 
might be among one of the studies with higher number of 
addressed cofactors.
To our knowledge, this is the first study that was 
focused on the association of health and early exit from 
paid work in Portugal and one of the few in southern 
Europe. As described before, Portugal is at the forefront 
of this worldwide sustainability issue for social protec-
tion mechanisms concerning the increased incidence of 
early work exit not being compensated with the flow of 
new workers into employment. Therefore, all analyses 
performed in Portugal and subsequent potential inter-
ventions to discourage early out of paid employment can 
Table 3  Description of the sample by type of employment status for ages 50–64: Portuguese National Health Survey (n = 8,003)
Prevalences of different forms of exit from paid work were computed as weighted proportions, in order to keep into account the sampling design 
of the survey (N = 1,859,761)
a
 For instance, people working for a relative without receiving any payment
Employed Exit from paid employment
Officially retired Unemployed Permanently disabled Homemaker Othera
Male 64.6 % (571,198) 23.8 % (209,854) 9.1 % (80,047) 1.6 % (13,912) 0.05 % (428) 0.8 % (7,949)
Female 46.2 % (450,205) 15.7 % (152,783) 6.2 % (60,441) 1.5 % (14,905) 28.8 % (279,688) 1.6 % (13,843)
Total 54.9 % (1,021,403) 19.5 % (362,636) 7.6 % (140,487) 1.6 % (28,816) 15.1 % (280,115) 1.3 % (21,792)
Author's personal copy
499
Rheum
atol Int (2014) 34:491–502
 
1 3
Table 4  Logistic regression analysis by type of early exit from paid employment
OR Odds Ratio;  CI confidence interval
* Cofactor not included in the model (VIF > 5)
§ Cofactor excluded in the stepwise method (backward elimination with p > 0.05)
a
 Exit from paid employment includes: early retirees, unemployed, permanently disabled, homemakers, and others
Early retirement Early retirement + unemployment Exit from paid employmenta
Univariate logistic regres-
sion OR (95 % CI)
Multivariate logistic regres-
sion OR (95 % CI)
Univariate logistic regres-
sion OR (95 % CI)
Multivariate logistic regres-
sion OR (95 % CI)
Univariate logistic regres-
sion OR (95 % CI)
Multivariate logistic 
regression OR (95 % CI)
Rheumatic diseases 1.36 (1.15–1.62) 1.24 (1.01–1.52) 1.22 (1.04–1.42) 1.20 (1.01–1.43) 1.62 (1.36–1.92) 1.31 (1.11–1.52)
Age
 50–54 1 1 1 1 1 1
 55–59 3.19 (2.44–4.18) 3.27 (2.46–4.33) 2.06 (1.67–2.54) 2.11 (1.70–2.61) 2.13 (1.73–2.62) 1.86 (1.55–2.22)
 60–64 8.79 (6.79–11.37) 9.97 (7.56–13.2) 4.20 (3.43–5.15) 4.44 (3.59–5.51) 4.79 (3.87–5.94) 4.32 (3.58–5.22)
Gender (female) 0.61 (0.52–0.73) 0.54 (0.44–0.66) 0.61 (0.52–0.71) 0.56 (0.48–0.67) 2.12 (1.80–2.51) *
Area of residence
 North 1 1 1 1 1 1
 Center 0.74 (0.59–0.94) 0.68 (0.53–0.88) 0.59 (0.48–0.73) 0.55 (0.44–0.68) 0.49 (0.39–0.61) 0.53 (0.43–0.64)
 Lisbon 1.00 (0.81–1.25) NS 0.85 (0.67–1.09) NS 0.86 (0.71–1.05) NS 0.77 (0.62–0.95) 0.76 (0.61–0.95) 0.77 (0.63–0.94)
 Alentejo 1.07 (0.86–1.34) NS 1.08 (0.85–1.38) NS 0.94 (0.77–1.16) NS 0.92 (0.74–1.14) NS 0.71 (0.56–0.89) 0.72 (0.58–0.88)
 Algarve 0.73 (0.58–0.92) 0.67 (0.52–0.86) 0.62 (0.51–0.76) 0.57 (0.46–0.70) 0.61 (0.49–0.76) 0.62 (0.51–0.76)
 Azores 0.85 (0.68–1.06) NS 0.83 (0.65–1.07) NS 0.56 (0.46–0.69) 0.54 (0.44–0.68) 0.94 (0.75–1.19) NS 1.04 (0.86–1.27) NS
 Madeira 0.59 (0.44–0.78) 0.60 (0.44–0.82) 0.42 (0.33–0.55) 0.42 (0.32–0.56) 0.68 (0.53–0.86) 0.85 (0.68–1.07) NS
Educational level
 Primary school or less 1 1 1 1 1 1
 Medium 1.32 (1.05–1.65) 1.59 (1.22–2.08) 1.26 (1.02–1.55) 1.48 (1.18–1.85) 0.64 (0.50–0.82) 0.97 (0.78–1.20) NS
 High 1.13 (0.89–1.44) NS 1.26 (0.91–1.75) NS 0.90 (0.72–1.14) NS 1.14 (0.89–1.45) NS 0.42 (0.33–0.55) 0.68 (0.52–0.89)
Household income
 ≤€500 1 § 1 § 1 1
 >€500 and ≤€900 0.99 (0.79–1.26) NS § 1.03 (0.83–1.27) NS § 0.68 (0.54–0.85) 0.84 (0.69–1.04) NS
 >€900 and ≤€2000 1.18 (0.94–1.48) NS § 1.06 (0.86–1.30) NS § 0.58 (0.46–0.72) 0.78 (0.64–0.96)
 >€2000 1.35 (1.01–1.78) § 0.87 (0.66–1.13) NS § 0.39 (0.29–0.53) 0.66 (0.48–0.89)
Other comorbidities
 Asthma 1.57 (1.13–2.18) 1.61 (1.10–2.35) 1.37 (1.00–1.87) § 1.70 (1.18–2.45) §
 Chronic pain 1.36 (1.14–1.63) 1.38 (1.12–1.70) 1.32 (1.11–1.56) § 1.62 (1.34–1.94) §
 Cancer 1.94 (1.29–2.89) 2.00 (1.26–3.16) 1.69 (1.15–2.48) § 1.48 (0.94–2.33) NS §
 Renal impairment 3.36 (2.15–5.25) 2.96 (1.74–5.05) 2.95 (1.89–4.59) 2.60 (1.62–4.16) 2.87 (1.56–5.27) §
 Stroke 3.56 (2.24–5.66) 2.94 (1.72–5.03) 3.47 (2.18–5.51) 3.02 (1.85–4.95) 2.36 (1.34–4.16) §
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be a useful reference for policies to be undertaken else-
where, especially in countries more similar from a socio-
economic and epidemiologic perspective, such as other 
southern European countries. Our results concerning the 
impact of ill-health on premature exit from paid work 
seem to be in line with at least some of the evidence pre-
viously published in Italy and Spain [23, 49]. However, 
as already mentioned, there is still scarce data on this 
subject in the context of southern European countries. 
These nations are currently facing an aging population, 
high rates of unemployment, and huge economic pres-
sures, which contribute to a common need to generate and 
share evidence to support policies for increasing produc-
tivity and postponing retirement, including interventions 
on those individuals with disability. In addition to this, 
there are peculiarities in the national social systems that 
are generally common among Portugal and other south-
ern European countries. For example, these countries 
behave similarly in the two main disability policy indica-
tors originally constructed by OECD [62]: the first indi-
cator covers compensation measures or benefit programs, 
which summarizes subjective indicators of disability and 
sickness benefit values and availability, where Portugal 
and Spain score above the OECD average (higher score 
means greater system generosity) and the second covers 
the employment and integration schemes, including the 
availability of special employment programs, vocational 
rehabilitation, and in work benefits, where Portugal shares 
with Italy lowest scores in Europe [26]. These similarities 
also justify a shared model based on collective knowledge 
about the conditions and determinants of early exit work 
in southern Europe.
By using a national population-based survey (high exter-
nal validity), this research may aid building that model and 
may support appropriate policies, while at the same time 
can also help to customize policies for subsets of the popu-
lation (i.e., different risk groups). For instance, all activi-
ties aiming to decrease the risk of early exit from paid work 
should take into account the gender and the type of work 
of each particular subpopulation under analysis. On this 
regard, more attention should be brought to female manual 
workers, in particular in the northern region, a subgroup 
expected to be more vulnerable to RD (for the age group 
considered, there is a RD prevalence of 55 % in female 
manual workers from north of Portugal). In Spain, other 
published work attained similar results regarding this vul-
nerable subgroup [49].
By specifically addressing RD, which affects almost 
half of the Portuguese population with age close to retire-
ment, it was possible to isolate the association of such 
disorders as a whole group of diseases to the likelihood 
of early withdrawal from work. Nonetheless, future 
research should discriminate those forms of RD, which 
are more disabling and consequently more likely to be 
associated with anticipated exit from work. This will 
allow society and labor market policies to be geared 
toward helping employees with highly disabling RD to 
remain in work or reintegrate into the workforce. This 
sort of policies will be essential for all those unemployed 
who are unsuitable to work due to disability. According 
to latest official statistics, unemployment rates in the age 
group of 55–64 years old have doubled since 2005 [63]. 
Measures aiming to shift from compensation-oriented 
policies toward integration-oriented policies will have a 
positive effect on this trend. Some intervention programs 
specifically addressing rheumatic patients have been 
already tested with proven success. In Spain, rheumatolo-
gists following detailed proceedings in a specialist-run 
early intervention program had a clear effect on tempo-
rary work disability [64]. Certainly, this sort of interven-
tions targeting specifically these conditions will provide 
long-term productivity gains to society. These produc-
tivity gains may in fact counterbalance the costs of such 
interventions.
Conclusion
This research foresees great potential concerning the risk 
reduction of early exit from paid work by eliminating or 
controlling chronic diseases in the population, in particular 
those causing high disability such as RD. Thus, health and 
social protection policies should identify high-risk popu-
lations when it comes to define policies to dissuade early 
retirement.
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Background: Rheumatic diseases (RD) cause physical disability that may lead to early exit from work, generating
indirect costs to society. We aimed to measure these costs in a population approaching the statutory retirement
age. Methods: The analysis was based on the prevalence of self-reported RD using a bottom-up approach. Health
and sociodemographic data were retrieved from the fourth National Health Survey (INS), for all people between
50 and 64 years of age (3762 men and 4241 women), whereas an official national database was used to estimate
productivity values by gender, age group and region, using the human capital approach. The effects of RD on the
likelihood of early exit from paid employment and the attributable fractions estimates were obtained at the
individual level by logistic regression. Results: At the time of the survey, 37.2% of the population aged 50–64
years self-reported at least one RD. Among these, 52.6% were not employed, compared with 40.7% of those
without RD (P<0.001). The annual indirect costs following premature exit from work attributable to RD were
E650 million (E892 per RD patient). Early retirement amounted to E367 million, whereas early retirement and
unemployment totalized E385 million (E504 and E528 per RD patient, respectively). Females are responsible for
about 60% of these costs; however, males contribute with higher individual productivity losses. Conclusion: Early
exit from work attributable to RD amounts to approximately 0.4% of the national GDP. The public health concern
and the economic impact highlight the need to prioritize investments in health and social protection policies
targeting patients with rheumatic conditions.
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Introduction
Rheumatic diseases (RD) are characterized by pain and physicaldisability that may lead not only to a substantial consumption of
health resources but also to productivity losses and early
retirement.1–3 Knowledge about the economic burden of this
group of disorders has progressed in recent years confirming that
the total economic burden of RD is often more substantial than
other chronic conditions, including cardiovascular diseases and
cancer; and that the impact of the disability caused by these
conditions is significant on both direct and indirect costs, such as
early exit from work.4 Foregone productivity due to premature
withdrawal from work decreases the wealth of society and thus
should be considered in the estimation of the economic impact of
these illnesses.5
Available evidence suggest that RD play a key role on overall early
exit from work because usually they are both highly prevalent and
disabling, in particular for occupations where working conditions
are difficult to modify or adjust to the impaired work abilities of
employees.6,7 Nevertheless, most published works on indirect costs
address specific rheumatic conditions (e.g. rheumatoid arthritis8–10
and ankylosing spondylitis11) and there is a general lack of research
about the costs associated with RD as a whole. Considering all RD,
instead of dealing with specific RD forms, puts the focus on common
characteristics of all forms of rheumatic conditions (for instance,
highly prevalent in lower social classes, progressive physical disability).
Considerable changes in labour force rates have been observed in
the last decadeswith a shrinking number of economically active people
supporting a growing economically dependent elderly population.12
This has led to heavy financial demands and to Social Protection
systems sustainability problems for countries with high
unemployment, early retirement and disability pensions, likely
influenced by progressively prevalent chronic diseases, such as RD.
Nowadays, in developed countries, over a third of the population ap-
proaching the statutory retirement age suffers some type of RD.13–16
This situation will deteriorate in the coming future and therefore RD
are expected to have a growing impact in indirect costs, in particular
those caused by premature departure from the labour market. This
makes RD good candidates to be the target of specific public health
policies, which in turn should be preceded by research supporting
informed decision making. Calculating this specific type of indirect
costs attributable to RD may help to prioritize not only this group of
illnesses as a whole but also aid to identify particular subgroups at
higher risk, thereby justifying higher investments on activities to
reduce their risk of early withdrawal from work.
The main aim of this study is to measure the indirect costs
associated with early exit from work attributable to all RD in a
population approaching the statutory retirement age.
Methods
Sample
The source of data for this study was the Fourth Portuguese National
Health Survey (INS), which was conducted in 2005 and 2006 in all
regions of Portugal. The methodology of the INS has been detailed
elsewhere.17,18 Briefly, the primary sampling unit was the housing
unit, which were randomly selected within each geographically
defined unit. Subjects living in the sampling unit were then
surveyed by trained staff. The sample was considered representative
of the main regions of Portugal.18,19
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In this study, the subsample of all INS surveyed people approach-
ing the statutory pension age, between 50 and 64 years, was analysed.
The sample under analysis composed of 3762 men and 4241 women.
Cases of RD were defined according the participant’s self-reported
history of any RD (‘Do you or did you have any rheumatic disease
(e.g. osteoarthritis, tendinitis)?’
Indirect costs
Early retirement was considered as being out of paid work before age
65 years, which is the most common statutory retirement age,
including Portugal. There are different channels of exiting from
the labour market, including unemployment, disability and pure
early retirement.19–21 These pathways are related to the same
economic behaviour, which implies an exit from the labour
market in the later stages of working life and subsequent loss of
productivity for society. However, it was still considered relevant
and more informative to separately analyse and report results for
three main types of early exit from work: Type 1, pure retirement;
Type 2, pure retirement and unemployment and Type 3, all forms of
exit from paid employment.
We adopted the society’s perspective and used the human capital
approach to estimate productivity costs by valuing healthy time lost
due to the disease using market wage rates, which can be viewed as
the loss of an investment in a person’s human capital.22 The friction
cost approach has been proposed as an alternative to calculate
indirect costs; however, it is considered less appropriate to
estimate the productivity losses for retirees and other forms of
early exit from paid employment, which was the focus of our
research.23–25
The value of lost production was assessed by obtaining the market
wage rates from national public sources concerning year 2005.26
These figures needed to be adjusted for social security contributions,
since the economic cost of lost production is calculated on gross
incomes and includes employers’ contributions to social security.
We obtained an annual average value of E19 455 for men and a
E12 899 for women, for ages between 50 and 64 years. All unit
values of lost production were stratified by age range, gender and
geographic region (Supplementary Appendix S1).
Estimation of the sole impact of RD on the probability of early
exit from paid employment was assessed using logistic regression
models for the three types of outcome explained earlier
(Supplementary Appendix S2). The following relevant covariates
were included in the initial models: age, gender, region, other
comorbidities, self-perceived health status, lifestyle factors, marital
status, socioeconomic characteristics and occupational social class.
In the final logistic models, only covariates with a statistically sig-
nificant association to the dependent variable (P<0.05) were
considered.
A good measure of the impact of RD in the early exit from paid
employment may be the population attributable fractions (PAF),
which take into account both the strength of the association
between RD and early exit from work, as measured in the logistic
models, and the prevalence of RD in the surveyed population. PAF
were calculated as the resulting proportional change in the probabil-
ity of exit from paid employment after a counterfactual exercise
where the presence of RD is artificially eliminated from the
sample. This recalculated probability of early work exit was used
to estimate the indirect costs attributable to RD. Thus, annual
indirect costs associated with early exit from work and attributable
to RD were obtained after multiplying each observation’s probability
change with the corresponding unit value of production (previously
assigned in the INS sample according to age group, gender and
geographic region).
Descriptive analysis was also performed comparing the RD
population against the non-RD population. All variables were
tested at the bivariate level using the chi-square test. Prevalence of
exit from work and other characteristics were computed as weighted
proportions, to take into account the sampling design of the survey.
Results
At the time of the survey, 37.2% of the population with ages between
50 and 64 years self-reported at least one RD. The baseline charac-
teristics of RD and non-RD sub-populations are presented in more
detail in table 1. As expected, RD were more prevalent among older
people and women. The same applies for those with lower
education, lower household income and manual type of work. RD
are highly associated with other comorbidities, such has chronic
pain, hypertension, depression and anxiety. Almost all disorders
surveyed were more often self-reported among those with RD
(table 1), and higher average number of comorbidities per capita
was found in the RD group (comorbidity score = 2.7 vs. 0.9,
P< 0.001). Additionally, more than a third (37%) of RD individuals
reported ‘poor’ to ‘very poor’ health, whereas less than half of that
proportion (14.9%) was found among those without RD, meaning a
clear worse self-perceived health associated with RD.
Table 1 General description of the sample by presence or absence
of RD for ages 50–64 years: National Health Survey (n=8003)
RD % (N) Non-RD % (N) P value
Prevalence 37.2 (691 786) 62.8 (1 167 975)
Age
50–54 27.6 (191 188) 41.8 (488.047) P<0.001
55–59 35.4 (244 632) 32.9 (384.479)
60–64 37.0 (255 965) 25.3 (295.448)
Gender (female) 70.1 (485 180) 42.0 (489 917) P<0.001
Educational level
Primary school or less 78.6 (543 636) 66.3 (772 291) P<0.001
Medium 12.9 (89 389) 18.0 (209 614)
High 8.5 (58 760) 15.7 (182 429)
Marital status
Single 4.4 (30 659) 5.8 (67 245) P<0.001
Married 83.1 (574 573) 82.8 (967 387)
Divorced 5.5 (37 931) 6.3 (72 949)
Widower 7.0 (48 622) 5.2 (60 393)
Occupational class
Non-manual worker 34.8 (190 079) 45.5 (464 020) P<0.001
Manual worker 65.2 (356 435) 54.5 (555 630)
Self-perceived health status
Very good/good 12.7 (92 463) 38.6 (436 611) P<0.001
Fair 50.3 (366 495) 46.6 (526 506)
Poor/very poor 37.0 (269 752) 14.9 (167 931)
Other chronic diseases
Diabetes 15.9 (109 865) 11.7 (137 108) P<0.001
Asthma 9.4 (65 174) 4.1 (47 383) P<0.001
Hypertension 47.1 (325 960) 33.2 (388 231) P<0.001
Chronic pain 39.2 (270 838) 19.8 (231 092) P<0.001
Cancer 4.5 (31 286) 3.0 (35 287) P=0.001
Renal impairment 4.1 (28 073) 1.6 (18 811) P<0.001
Respiratory diseases 7.1 (48 796) 2.6 (30 440) P<0.001
Stroke 2.0 (13 938) 2.8 (32 482) P=0.094
Myocardial infarction 1.3 (9298) 1.9 (22 637) P=0.906
Anxiety 15.7 (108 721) 4.5 (52 618) P<0.001
Depression 21.8 (150 709) 9.8 (114 018) P<0.001
Household income (per month)
!E500 25.9 (175 884) 23.7 (59 070) P<0.001
>E500 and!E900 31.0 (209 957) 27.6 (310 299)
>E900 and!E2000 34.4 (233 566) 32.8 (368 805)
>E2000 8.7 (59 070) 15.9 (179 083)
All results are based on weighted data. Prevalence of RD and
subjects’ characteristics were computed as weighted proportions,
to keep into account the sampling design of the survey
(N=1859761).
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Exit from work
Almost half of the surveyed population with ages between 50 and 64
years were out of paid work (45.1%, table 2). Among those who self-
reported RD, 52.6% were not employed, compared with 40.7% of
those without RD (P< 0.001, table 2—Type 3). In particular, 22.7%
of RD participants declared to be officially retired (i.e. Type 1)
compared with only 17.9% of those without RD. When considering
all forms of exit from paid employment, women are more present
than men, most likely due to higher proportion of female
housewives; however, men are more likely to be out of work when
narrow definitions of exit of work are used (Type 1: 23.7% vs.
15.7%; Type 2: 32.8% vs. 21.9%; Type 3: 35.4% vs. 53.8%, respect-
ively, for men and women). This observation stills holds true if the
population with RD is analysed separately from the non-RD sub-
population (table 2).
Logistic models and attributable fractions
In this nation-wide representative sample, a high association was
obtained between RD and early exit from work, regardless of the
definition used. For example, when using the Type 3 definition, the
univariate odds ratio (OR) for RD was 1.62 (CI: 1.36–1.92,
P< 0.001, Supplementary Appendix S2). This OR became 1.31 (CI:
1.12–1.52, P<0.001) when adjusted. Also regarding Type 3, the PAF
of RD calculated with adjusted and unadjusted ORs were 5% and
9.8%, respectively (table 3). The observed average probability of the
sample to be out of paid work (Type 3) according to the model
developed was 46.9%, whereas after transforming all observations
into non-RD status, the model delivered a reduced average prob-
ability of 44.6%. After summing the products of each observation’s
probability change with the corresponding unit value of production
(Supplementary Appendix S1), an overall estimate of E650 million
per year of indirect costs caused by premature exit from work at-
tributable to RD was obtained. This represents an annual indirect
cost per person with RD of E892. When using other definitions of
early exit from work, estimates of annual indirect costs of E367
million for pure reforms (Type 1) and E385 million for pure
reforms and unemployment (Type 2, figure 1) were found; with
annual indirect costs per person with RD of E504 and E528, re-
spectively (table 3). Figure 1 depicts the evolution of estimated
indirect costs attributable to RD by early out of work type.
Females have higher indirect costs than males, particularly when
using the Type 3 definition (E403 million vs. E247 million,
respectively).
Figure 2 shows the gender and age group contributions for the
overall productivity losses according to each type of exit from work
definition. Not surprisingly, both advanced age and female gender
are associated with higher indirect costs. However, costs per person
with RD are higher for men (E788 vs. E390 for Type 1; E784 vs.
E426 for Type 2 and E1185 vs. E775 for Type 3), regardless of the
age group considered (Supplementary Appendix S3).
Table 2 Description of the sample by type of exit from work for ages 50–64 years: National Health Survey (n=8003)
Type 1, % (N) Type 2, % (N) Type 3, % (N)
RD Males 33.9 (69 983) 42.0 (86 707) 44.9 (92 770)
Females 17.9 (87 041) 24.3 (117 932) 55.8 (117 932)
All gender 22.7 (157 024) 29.6 (204 639) 52.6 (363 587)
Non-RD Males 20.6 (139 871) 30.0 (203 193) 32.6 (220 695)
Females 13.4 (65 742) 19.5 (95 291) 51.9 (254 075)
All gender 17.6 (205 613) 25.6 (298 485) 40.7 (474 770)
Global (RD+non-RD) Males 23.7 (209.854) 32.8 (289.900) 35.4 (313.465)
Females 15.7 (152.783) 21.9 (213.223) 53.8 (524.892)
All gender 19.5 (362 636) 27.1 (503 124) 45.1 (838 358)
All results are based on weighted data. Type 1, pure retirement; Type 2, pure retirement +unemployment; Type 3, all
forms of exit from paid employment.
Table 3 Summary of OR, population attributable fractions and indirect costs associated with RD (by definition of exit
from work)
Type 1
(early retirement)
Type 2
(early retirement +unemployment)
Type 3
(exit from paid employment)a
RD 22.7% 29.6% 52.6%
OR adjusted (unadjusted) 1.24 (1.36) 1.20 (1.22) 1.31 (1.65)
PAF adjusted (unadjusted) 5.9% (9.7%) 4.6% (5.5%) 5.0% (9.8%)
Overall indirect costs 367ME 385ME 650ME
Indirect costs per RD patient 504E 528E 892E
ME, millions of euros.
a: Exit from paid employment includes early retirees, unemployed, permanently disabled, homemakers and others.
Figure 1 Indirect costs due to early exit from work attributable to
RD (by gender). ME, millions of euros; Type 1, pure retirement;
Type 2, pure retirement +unemployment; Type 3: all forms of exit
from paid employment
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Discussion
This study estimated that RD-related productivity losses due to early
exit from paid employment are potentially associated with an annual
cost between E367 million and E650 million (depending on the type
of early exit from work considered). More than half of the sample
with RD was not employed at the time of the survey and that
translates into substantial costs for society. This research is based
on a large and representative sample of the country’s population
approaching the statutory age of retirement, and thus, it is likely
to reflect accurately the economic impact on Portuguese society.
Considering the timeframe of the survey (2005/2006), this sort of
costs is about 0.4% of the national GDP.
As RD are more prevalent in women, overall indirect costs split by
gender were unbalanced with greater overall economic burden on
females. The trend to even wages between genders and the worsening
of the epidemiology of RD particularly in women lead to the ex-
pectation that these costs will grow faster in the coming future if
nothing is done to the contrary, namely by controlling RD burden.
The evidence around the gender decomposition of indirect costs per
capita may be useful to raise awareness concerning the case of male
RD patients, whose higher mean individual contribution of RD to
indirect costs deserves concern. However, more importantly, along
with the abovementioned reduction of gender inequalities in wages,
female gender is more vulnerable to RD, meaning that public health
policies on this regard should aim predominantly at women.
Of note, when housewives are not included in the analysis, men
are more likely to be out of paid employment earlier than women. Ill
health seems to play a particular role in early decisions of retirement
among males. Men reporting more comorbidities and/or lower self-
perceived health status are significantly more likely to be out of work
earlier in their careers (data not shown). This topic in itself deserves
further research as there may be great potential for targeted policies
to achieve productivity gains.
Although age groups closer to retirement age have lower unit
values of production, they are contributing more for overall
indirect costs, because there is substantial higher prevalence or
early retirees in these ages. Meaning that not only it is relevant to
act in earlier ages but also it is still worthwhile to do so for older
ones.
The reduced average probability of exit from work following the
artificial removal of RD from the sample (counterfactual simulation)
suggests that upon an alternative ideal exposure scenario, with no
rheumatic disorders in the population, there could be a reduction of
up to almost a tenth of the overall likelihood of early exit from paid
work. We must highlight the fact that RD are not only highly
associated with other comorbidities but that they are also established
risk factors for some of these comorbidities. For example, RD are
associated with an increased risk of chronic pain, cardiovascular risk,
depression and anxiety.27–32 In its turn, these comorbidities are also
associated with early exit from work.33 This means that RD may
contribute further to the increased risk of early work exit through
these alternative ill-health routes and that the herein presented
indirect costs could have risen if these other secondary effects of
RD had been considered. For instance, the univariate OR for
chronic pain is between 1.36 and 1.62, for Type 1 and Type 3
outcomes, respectively. This means that RD underlying chronic
pain are also expected to be affecting labour force participation
through this disability route.
Studies have shown that the total economic burden of RD is often
more substantial than other chronic conditions due to both direct
and indirect costs.4 In fact, depending on the specific condition, the
indirect costs of RD may equal or even exceed the direct costs.34
However, most cost-of-illness studies on RD are restricted to specific
rheumatic forms and the literature still suffers from a general lack of
research on the indirect costs associated with RD as a whole. To our
knowledge, the current research is among the few studies of the
indirect costs of RD specifically analysing early exit from work.
Nonetheless, some authors have addressed the impact of RD in
similar forms of indirect costs and they all came up with high
estimates. For example, in 1998, a major share of the total cost of
musculoskeletal disorders in Canada came from indirect costs
(roughly 2.4% of the Canadian gross domestic product at that
time).35 This large share of indirect costs is in line with results
from seminal studies in the United States done by Rice36,37 and
Yelin et al.38,39 and it was even more pronounced in Sweden,
where indirect costs (specially from early retirement) were
accounted as 90% of all costs caused by RD.40 More recently, in
Australia, arthritis caused an annual loss of approximately 0.7% of
GDP due to early retirement, which is in line with our results and
much higher than the same type of costs caused by other disabling
diseases,41 such as cardiovascular disease ("0.06% of GDP),42
diabetes ("0.08%)43 and mental conditions ("0.1%).44 Anyway,
one as to bear in mind that comparing results of cost-of-illness
studies is hampered by discrepancies between study designs,
definition of RD, methodological choices and sources of data used.5
Our results were mostly based on self-reported data. We do not
expect to have a significant bias due to low reliability of the partici-
pants’ reported data, because RD are expected to inflict significant
disability and/or impact in quality of life and therefore should be
associated with high predictive values. On the other hand, we do not
expect our results to be influenced by justification bias (i.e. some
people may want to justify their early retirement through health
problems, which is a common limitation in this type of research),
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as this study was based on the INS, which was not focused on
retirement and did not generate any pressure for responders to
justify their retirement condition. However, some limitations must
be taken into account in interpreting the results of this study. First,
this study may be limited by its cross-sectional design, which does
not allow evaluation of the temporal relationship between the onset
of RD and the timing of labour force departure, meaning that some
cases may have had RD onset after exit from work. Lack of available
national longitudinal data made this limitation impossible to
overcome. Nevertheless, onset of most forms of RD is likely to
start before the statutory age of retirement. Second, early exit
from paid work is reportedly influenced by many other factors not
included in the regression models used, therefore maybe not all
possible confounders were addressed in this research. However,
adjustment was done with a considerable number of available
cofactors in the INS dataset. In fact, to our knowledge, this might
be among one of the studies with higher number of addressed
cofactors. Third, the human capital method has been criticized for
its overestimation of indirect costs,24 since the real paid production
loss to society is likely to be lower (for instance, for long-term
absence, the work can be done by someone drawn from the un-
employment pool or by reallocating existing employees).
Nevertheless, as explained before, to address the objectives of this
study, we considered this approach as the most appropriate and
widely used method.45 Gender wage differences impact the
estimates in particular when studying RD, a disease more likely
affecting women with lower average wages. Because there is no
definitive method to solve this methodological dispute, we opted
for a more conservative approach by allowing gender differences
on unit production values. Finally, unit values of production were
estimated through official statistics based on gender, region and age
group. Necessarily, this methodology is a rough estimate of
individual unit values of production. Still, from all available
options, to our knowledge, this approach is the most appropriate.
This comprehensive population-based research underlines the
high economic burden of RD concerning early retirement,
justifying more attention when discussing policies facing the most
relevant sustainability challenges of ageing western countries.
Demographic trends and the epidemiological shift to an enduring
chronic diseases paradigm will worsen this scenario if nothing is
done.
Rheumatic disorders are still undervalued in health policies.
However, we cannot afford to be inactive regarding this topic any
longer and should address possible interventions intended to stop
early exit from work due to RD. A prolongation of working life in
these patients must be accomplished without threatening their well-
being. Some intervention programs specifically addressing
rheumatic patients have already been put in place and tested.46
For example, vocational rehabilitation delivered to RD patients at
risk for job loss, but while they were still employed, delayed job
loss.47 Working conditions are potentially important modifiable
risk factors. On this regard, Chorus et al.48,49 found that individuals
with rheumatoid arthritis who had received at least one form of
workstation accommodation (included shortening work hours,
slowing pace of work, changing tasks and being allowed to
manage work) were 2.5 times less likely to be work disabled; but
these interventions require further investigation and should be
addressed to other prevalent and/or disabling rheumatic
conditions as well. Also, Aba´solo et al.50 reported a successful case
in which rheumatologists following detailed proceedings in a
specialist-run early intervention program had an effect on work
disability, at least for some forms of RD.
Although, there is already some amount of evidence on the effect
of certain interventions on the likelihood of early departure from
work attributable to RD, it is unquestionable the need to research
further this topic. From a societal perspective, some of these inter-
ventions are likely to be cost-effective by providing long-term prod-
uctivity gains, which should offset the investment costs in this
crucial area. Our results underlines the high economic burden of
RD coming from early retirement and offer useful background in-
formation to help prioritize investments in health and social
protection policies targeting patients with rheumatic conditions.
Supplementary data
Supplementary data are available at EURPUB online.
Conflicts of interest: None declared.
Key points
# Data suggest a strong association between rheumatic
diseases (RD) and likelihood of early exit from paid
employment.
# There is a great potential concerning the risk reduction of
early exit from work by eliminating or controlling rheumatic
disorders in the population.
# Estimated indirect costs of early exit from work attributable
to RD amounts to approximately 0.4% of the national GDP.
# Early retirement attributable to RD is therefore an important
public health issue and its economic impact highlights the
need for sustainable health policies.
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APPENDICES 
Appendix 1 – Summary of average unit values of production by gender, age-group and geographic 
region 
 
MEN  
Age-group National North Center Lisbo
n 
Alentejo Algarv
e 
Azores Madeir
a 
50-54 €20 204 €16 712 €17 270 €27 673 €17 619 €17 085 €17 161 €22 562 
55-59 €19 897 €16 491 €16 565 €27 697 €16 891 €17 714 €17 706 €21 002 
60-64 €18 135 €16 499 €16 017 €25 282 €14 729 €17 460 €15 607 €17 045 
Average  
(50-64) 
€19 455 €16 568 €16 632 €26 935 €16 506 €17 424 €16 877 €20 472 
 
WOMEN  
Age-group National North Center Lisbon Alentejo Algarve Azores Madeira 
50-54 €13 579 €11 136 €10 528 €18 360 €11 872 €12 735 €12 344 €14 782 
55-59 €13 137 €12 315 €10 766 €17 004 €11 446 €12 243 €12 350 €13 815 
60-64 €11 863 €10 951 €13 145 €13 356 €9 263 €11 572 €11 157 €12 586 
Average  
(50-64) 
€12 899 €11 500 €11 571 €16 513 €10 975 €12 203 €11 980 €13 789 
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Appendix 2 - Logistic regression analysis by type of early exit from paid employment. [OR=Odds 
Ratio; 95% CI=95% confidence interval] 
 
 TYPE 1  
(EARLY RETIREMENT) 
TYPE 2  
(EARLY RETIREMENT + 
UNEMPLOYMENT) 
TYPE 3  
(EXIT FROM PAID 
EMPLOYMENT)* 
Univariate 
Regression  
OR (95% CI) 
Multivariate 
Regression  
OR (95% CI) 
Univariate 
Regression  
OR (95% CI) 
Multivariate 
Regression  
OR (95% CI) 
Univariate 
Regression  OR 
(95% CI) 
Multivariate 
Regression  
OR (95% CI) 
Rheumatic 
Diseases 
1.36 (1.15-
1.62) 
1.24 (1.01-
1.52) 
1.22 (1.04-
1.42) 
1.20 (1.01-
1.43) 
1.62 (1.36-
1.92) 
1.31 (1.12-
1.52) 
Age        
 50-54 1 1 1 1 1 1 
 55-59 3.19 (2.44-4.18) 3.27 (2.46-4.33) 2.06 (1.67-2.54) 2.11 (1.70-
2.61) 
2.13 (1.73-2.62) 1.86 (1.55-
2.22) 
 60-64 8.79 (6.79-
11.37) 
9.97 (7.56-13.2) 4.20 (3.43-5.15) 4.44 (3.59-
5.51) 
4.79 (3.87-5.94) 4.32 (3.58-
5.22) 
 Gender 
(Female) 
0.61 (0.52-0.73) 0.54 (0.44-0.66) 0.61 (0.52-0.71) 0.56 (0.48-
0.67) 
2.12 (1.80-2.51) * 
Education       
  Low 1 1 1 1 1 1 
  Medium  1.32 (1.05-1.65) 1.59 (1.22-2.08) 1.26 (1.02-1.55) 1.48 (1.18-
1.85) 
0.64 (0.50-0.82) 0.97 (0.78-
1.20) NS 
   High  1.13 (0.89-
1.44) NS 
1.26 (0.91-
1.75) NS 
0.90 (0.72-1.14) 
NS 
1.14 (0.89-
1.45) NS 
0.42 (0.33-0.55) 0.68 (0.52-
0.89) 
Household 
income  
      
 ≤€500  1 § 1 § 1 1 
 >€500 &    
      ≤€900  
0.99 (0.79-
1.26) NS 
§ 1.03 (0.83-
1.27) NS 
§ 0.68 (0.54-
0.85) 
0.84 (0.69-
1.04) NS 
 >€900 &  
     ≤€2000 
1.18 (0.94-
1.48) NS 
§ 1.06 (0.86-
1.30) NS 
§ 0.58 (0.46-
0.72) 
0.78 (0.64-
0.96) 
  >€2000 1.35 (1.01-
1.78) 
§ 0.87 (0.66-
1.13) NS 
§ 0.39 (0.29-
0.53) 
0.66 (0.48-
0.89) 
Comorbidities       
 Asthma 1.57 (1.13-
2.18) 
1.61 (1.10-
2.35) 
1.37 (1.00-
1.87) 
§ 1.70 (1.18-
2.45) 
§ 
 Chronic pain 1.36 (1.14-
1.63) 
1.38 (1.12-
1.70) 
1.32 (1.11-
1.56) 
§ 1.62 (1.34-
1.94) 
§ 
 Cancer 1.94 (1.29-
2.89) 
2.00 (1.26-
3.16) 
1.69 (1.15-
2.48) 
§ 1.48 (0.94-
2.33) NS 
§ 
 Renal   
 Impairment 
3.36 (2.15-
5.25) 
2.96 (1.74-
5.05) 
2.95 (1.89-
4.59) 
2.60 (1.62-
4.16) 
2.87 (1.56-
5.27) 
§ 
 Stroke 3.56 (2.24-
5.66) 
2.94 (1.72-
5.03) 
3.47 (2.18-
5.51) 
3.02 (1.85-
4.95) 
2.36 (1.34-
4.16) 
§ 
Area of 
residence 
      
  North  1 1 1 1 1 1 
  Center 0.74 (0.59-
0.94) 
0.68 (0.53-
0.88) 
0.59 (0.48-
0.73) 
0.55 (0.44-
0.68) 
0.49 (0.39-
0.61) 
0.53 (0.43-
0.64) 
  Lisbon 1.00 (0.81-
1.25) NS 
0.85 (0.67-
1.09) NS 
0.86 (0.71-
1.05) NS 
0.77 (0.62-
0.95) 
0.76 (0.61-
0.95) 
0.77 (0.63-
0.94) 
  Alentejo 1.07 (0.86-
1.34) NS 
1.08 (0.85-
1.38) NS 
0.94 (0.77-
1.16) NS 
0.92 (0.74-
1.14) NS 
0.71 (0.56-
0.89) 
0.72 (0.58-
0.88) 
  Algarve 0.73 (0.58-
0.92) 
0.67 (0.52-
0.86) 
0.62 (0.51-
0.76) 
0.57 (0.46-
0.70) 
0.61 (0.49-
0.76) 
0.62 (0.51-
0.76) 
  Azores 0.85 (0.68-
1.06) NS 
0.83 (0.65-
1.07) NS 
0.56 (0.46 – 
0.69) 
0.54 (0.44-
0.68) 
0.94 (0.75-
1.19) NS 
1.04 (0.86-
1.27) NS 
  Madeira 0.59 (0.44-
0.78) 
0.60 (0.44-
0.82) 
0.42 (0.33-
0.55) 
0.42 (0.32-
0.56) 
0.68 (0.53-
0.86) 
0.85 (0.68-
1.07) NS 
* Exit from paid employment includes: early retirees, unemployed, permanently disabled, homemakers, others. 
*Cofactor not included in the model (VIF>5). 
§ Cofactor excluded in the stepwise method (backward elimination with p>0.05). 
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Appendix 3 – Indirect Costs attributable to RD for different age-groups (by type of early exit from work 
and gender) per inhabitant with RD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type 1: pure retirement.  
Type 2: pure retirement + unemployment.  
Type 3: all forms of exit from paid employment 
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a b s t r a c t
Objectives: To measure early retirement due to self-reported rheumatic diseases (RDs) and
to estimate the respective indirect costs and years of working life lost (YWLL).
Methods: We used individual level data from the national, cross-sectional, population-
based EpiReumaPt study (September 2011eDecember 2013) where 10,661 inhabitants were
randomly surveyed in order to capture and characterize all cases of RD within a repre-
sentative sample of the Portuguese population. In this analysis, we used all participants
aged between 50 and 64 years, near the official retirement age. A national database was
used to calculate productivity values by gender, age and region, using the human capital
approach. YWLL were estimated as the difference between each participant's current age
and the respective retirement age, while the potential years of working life lost (PYWLL)
were given by the difference between official and actual retirement ages. We also calcu-
lated the percentage of time in inactivity (inactivity ratio ¼ YWLL/Active age-range [15e64
years old]).
Results: 29.9% of the Portuguese population with ages between 50 and 64 years were retired
with 13.1% self-reporting retirement due to RD. The estimated annual indirect cost
following premature retirement attributed to RD was V910 million (V555 per capita; V1625
per self-reported RD patient and V13,592 per early retiree due to RD). Females contributed
with 84% for these costs (V766 million; V882 per capita vs V187 frommales). We observed a
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total number of 389,939 accumulated YWLL (228 per 1000 inhabitants) and 684,960 PYWLL
(401 per 1000 inhabitants). The mean YWLL and PYWLL inactivity ratios were 12% and 21%,
respectively. RD patients with higher values of disability have the highest risk of early
retirement.
Conclusions: Early retirement attributed to self-reported RD amounts to approximately 0.5%
of the national gross domestic product (GDP) in 2013, due to large YWLL. Both the public
health concern and the economic impact highlight the need to prioritize investments in
health and social protection policies targeting patients with rheumatic conditions.
© 2016 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
Introduction
Early retirement generates a serious problem for social
and economic sustainability in developed countries where,
in recent decades, there has been a substantial rise in the
percentage of the labour force out of work because of
sickness or disability and in the related social protection
benefits.1,2 The combination of an ageing population and
widespread early retirement puts severe strains on our
social security systems' capacity to maintain today's
standard of living for future generations of older people. In
particular, Portugal is already among the oldest countries
in the world, with one of the highest old-age dependency
ratios, and it is in the forefront of this general concern
regarding premature work withdrawal.2 Early retirement is
influenced by several factors, including progressively
prevalent chronic pathologies, such as rheumatic diseases
(RD).3e15,40 RD are among the most common chronic non-
communicable diseases. They are the leading cause of
work disability in developed countries and consume a
large amount of health and social resources,16e18 where
over a third of the population approaching the statutory
retirement age suffers from some type of RD.19e21 This
situation is expected to deteriorate in the coming future,
and therefore, RD is expected to cause growing produc-
tivity losses (indirect costs), in particular by premature
departures from the labour market. Thus, better knowl-
edge about the relationship between RD, its functional
limitations and the ability to work is fundamental to
prevent early retirement. Moreover, measurement of cur-
rent indirect costs of RD may raise awareness on public
opinion and decision makers, ultimately triggering needed
action.
Previous research has measured this sort of indirect
costs, but mostly addressed specific rheumatic conditions or
used data from broad non-specific surveys.4,5,12,22e27 Given
the importance and the aforementioned impact of this
topic, it is also relevant to explore it with RD-specific in-
formation, namely disability data and direct subjects' re-
ports on the occupational impact caused by these diseases
as a whole.
Thus, the main aim of this study is to measure early
retirement attributed to self-reported RD, the respective in-
direct costs and years of working life lost, based on a nation-
wide RD-specific survey, which directly addressed the
occupational impact due to these health conditions.
Methods
Sample
This study uses the first national, cross-sectional, population-
based study on RD in all regions of Portugal e EpiReumaPt
study. The methodology of EpiReumaPt has been detailed
elsewhere.28 Briefly, EpiReumaPt (September 2011eDecember
2013) randomly selected 10,661 adult subjects through a
stratified multistage sampling by Portuguese regions (Euro-
pean NUTS II level) and by size of location. Participant
households were selected by the random route methodology.
Face-to-face interviews inquired participants about socio-
demographic data, socio-economic profile (measures of
wealth, household income, current professional status), life
style (e.g. alcohol and coffee intake), anthropometric data
(weight and height), quality of life (European Quality of Life
questionnaire with five dimensions and three levels validated
for Portugal, EQ-5D index29,30) functional capacity (Health
Assessment Questionnaire, HAQ31), and self-reported chronic
non-communicable diseases, including RD. Additionally, Epi-
ReumaPt has data on the economic impact of RD, such as
healthcare consumption (number and type of medical ap-
pointments, hospitalizations, homecare assistance and other
healthcare service's needs, in the previous 12 months), early
retirement, disability pensions and other forms of premature
withdrawal from work.
For thepurposesof this analysis,weuseddata fromthefirst
phase of EpiReumaPt for all participants from Portugal main-
land aged between 50 and 64 years old near the official retire-
ment age of 65 years (1065men and 1727 women). The sample
was considered representative of the Portuguese
population.28,32
Measurements
For this analysis, we considered the presence of RD through
self-reporting. The same applies for the following major
chronic diseases: diabetes, cardiovascular disease (including
risk factors such as hypertension and high cholesterol), al-
lergy, pulmonary disease, gastrointestinal disease, neurolog-
ical disease, mental disease and cancer. A proxy measure of
general morbidity was built as the sum score of all afore-
mentioned chronic illnesses (comorbidity score). Obesity was
measured according to the body mass index (underweight:
<18.5m2/kg, normal: 18.5e25m2/kg, overweight: 25e30m2/kg,
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obese: "30 m2/kg). Area of residence was defined according to
the regional location of each household (North, Center, Lis-
bon, Alentejo and Algarve). Marital status variable was clas-
sified by five categories (single, married, consensual union,
divorced and widowed). Educational level was grouped into
three major levels according to the highest degree completed:
low (primary school or less), medium (basic education be-
tween primary and secondary levels) and high (secondary
education or more, including university degrees).
Years of working life lost (YWLL) and inactivity ratio
YWLL were determined for cases with premature retirement
attributed to RD estimated as the difference between each
participant's age at the time of the survey and the respective
retirement age, while the potential YWLL (PYWLL) is the dif-
ference between official and actual retirement ages. PYWLL
assumes there is no return to work. We also calculated the
percentage of time in inactivity by dividing each early retiree
YWLL and PYWLL by the active age range of 15e64 years old
(inactivity ratio ¼ YWLL and PYWLL/active age range). We
reported the mean inactivity ratios for the whole population
of early retirees due to RD.
Indirect costs
Early retirement due to RD was primarily assessed through
participants' self-reporting (‘Did you retire due to RD?’). In
order to calculate the corresponding indirect costs of such
economic impact, we adopted society's perspective and used
the human capital approach to estimate productivity costs by
valuing healthy time lost due to the disease using market
wage rates, which can be viewed as the loss of an investment
in a person's human capital.33
The value of lost production was assessed by obtaining
the mean market wages (fixed and variable portions of
compensation) from national public sources for 2013.34 These
figures needed to be adjusted for social security contributions
since the economic cost of lost production is based on total
costs to employers. This approach yielded an annual average
value of V24,891 for men and V16,079 for women, for ages
between 50 and 64 years. All unit values of lost production
were stratified by age, gender and geographic region
(Appendix 1).
Annual indirect costs associated with early retirement due
to RD were obtained by summing all annual average values of
production (assigned in the EpiReumaPt sample according to
age, gender and region) for those who self-reported early
retirement due to RD.
The methodology described above may overestimate in-
direct costs by not considering additional retirement risks
imposed by other factors. To correct for that possibility, we
also deployed population attributable fractions (PAF). PAF
were calculated as the resulting proportional change in the
probability of early retirement due to RD (using logistic
multivariable models explaining retirement) after a counter-
factual exercise where the presence of RD is artificially elim-
inated from the sample. This recalculated probability of early
retirement was then used to estimate the indirect costs
attributable to RD bymultiplying each observation's change in
the probability of retirement with the corresponding unit
value of production.
Statistical analysis
Descriptive analysis was mainly performed comparing
retired against non-retired individuals. Prevalence of
retirement and other characteristics were computed
weighting the data, in order to take into account the sam-
pling design of the survey. Missing values were not
replaced, and all statistics were calculated based on non-
missing values. In this survey, respondents were directly
asked if their early retirement was due to a RD. However,
since these disorders may underlie and contribute for early
retirement even when RD is not self-reported to be its
cause, we also measured the association between RD and
overall early retirement through multivariable logistic
regressions.
The logistic multivariable models were built by means of a
manual stepwise technique (backward elimination), and only
cofactors statistically significantly associated with the
dependent variable (P < 0.05) were considered. All statistical
analyses were carried out using Stata 12.0.
Results
Based on the inference from the sample to the total main-
land Portuguese population at the time of this survey, 29.9%
of the Portuguese population with ages between 50 and 64
years were retired and 52% were out of the labour force
(including unemployment, disability pensions and any other
form of exit from work). Among the early retirements, 43.2%
were on grounds of ill health (12.9% of the overall sample),
of which in turn about a third (30.4%) was specifically due to
RD (Table 1). Thus, 13.1% of all retirees and 3.9% of the
Portuguese population within the studied age-range self-
reported RD as the main reason for early retirement. Of the
population under study, 48% was employed. This subpopu-
lation had higher levels of education, was less frequently
married, less obese and had a lower number of chronic
diseases compared with participants out of work, in
particular those early retired due to RD (Table 1). Employed
people also have less RD than the overall population and
than the early retirees (30.0% vs 34.2% and 40.2%, P < 0.001
and P ¼ 0.017, respectively). They had higher household
income, with a lower presence in bottom salary ranges (i.e.
<750V/month) while the opposite in the upper ones (i.e.
>2000V/month). The majority of the early retirement
attributed to RD was observed in females (81.6% vs 41.5% of
females in the early retirement group not due to RD). As
expected, the cumulative probability of this sort of early exit
from work increases with age, in particular above the age of
50 years (Fig. 1).
Healthcare resource consumption
Those who self-reported RD also notified more healthcare
consumption. The proportion of users and the mean number
of medical hospital specialty appointments per user was
higher (62.1% and 5.2 vs 51.4% and 3.4 for non-RD population,
Appendix 2) as was the proportion of hospitalizations and
home care assistance in the previous 12 months, although
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non-statistically significant (12.8% and 1.5% vs 8.8% and 1.2%
for non-RD population, Appendix 2). Among those self-
reporting RD, 2.5% were hospitalized specifically due to RD
in the same time period. On the other hand, 14.4% of early
retirees were hospitalized vs 8.4% of non-retirees (P ¼ 0.03).
RD and early retirement are associated with a higher
number of medical appointments, and early retirement is
associated with a higher likelihood of hospitalization (odds
ratio [OR]: 1.84; confidence interval [CI]: 1.04e3.25;
P ¼ 0.035).
Association between RD and early retirement
More than a third (34.2%; females: 46.3%) of the studied
population self-reported RD, being also more likely to self-
report other main chronic disease (OR: 3.4; CI: 2.53e4.65;
P < 0.001). Self-reported RD is independently associated with
Table 1e General description of the sample by employment status: EpiReumaPt ages 50e64 years (n¼ 2792/N¼ 1,706,749).
No early
retirement
Early
retirementa
Early retirement
due to
diseaseb
Early retirement
due to RDc
Paid
employment
Early exit
from paid
employmentd
Employment status 70.1%/1,195,906 29.9%/510,843 12.9%/220,489 3.9%/66,953 48.0%/819,137 52.0%/887,612
Age (years) 55.5 60.0 (P < 0.0001) 58.7 (P < 0.0001) 60.5 (P < 0.0001) 55.1 58.4 (P < 0.0001)
Gender (female) 55.7% 46.8% (P ¼ 0.02) 52.4% (P ¼ 0.90 NS) 81.6% (P < 0.0001) 51.4% 54.6% (P ¼ 0.32 NS)
Educational level
Primary or less 50.9% 61.6% 71.0% 83.3% 43.7% 63.6%
Medium 22.9% 19.7% 21.2% 10.2% 24.3% 19.8%
High 26.3% 18.7% (P ¼ 0.01) 7.8% (P ¼ 0.0004) 6.6% (P < 0.0001) 32.0% 16.6% (P < 0.0001)
Marital status
Single 9.9% 6.3% 9.7% 4.5% 10.7% 7.1%
Married 68.8% 73.2% 64.4% 82.9% 68.6% 71.5%
Divorced 13.2% 11.0% 14.5% 3.9% 12.9% 12.2%
Widowed 6.4% 7.9% 9.2% 7.9% 6.3% 7.3%
Consensual union 1.7% 1.4% (P ¼ 0.21 NS) 2.3% (P ¼ 0.62 NS) 0.9% (P ¼ 0.08 NS) 1.5% 1.7% (P ¼ 0.37 NS)
Body mass index
Underweight 0.6% 0.9% 1.0% d 0.3% 1.0%
Normal 31.5% 27.5% 27.1% 21.5% 33.0% 27.7%
Overweight 43.6% 39.8% 34.2% 23.0% 46.0% 39.1%
Obese 24.4% 31.9% (P ¼ 0.10 NS) 37.6% (P ¼ 0.05) 55.5% (P ¼ 0.001) 20.7% 32.2% (P < 0.0001)
Functional
capacitydHAQ (0e3)
0.29 0.44 (P ¼ 0.0001) 0.69 (P < 0.0001) 0.94 (P < 0.0001) 0.22 0.44 (P < 0.0001)
Quality of lifedEQ-5D
index
0.80 0.75 (P ¼ 0.004) 0.66 (P < 0.0001) 0.59 (P < 0.0001) 0.84 0.75 (P < 0.0001)
Chronic diseases (self-reported)
RD 31.7% 40.2% (P ¼ 0.03) 49.7% (P ¼ 0.0007) 84.9% (P < 0.0001) 30.0% (P ¼ 0.02) 38.2%
Cardiovascular 58.2% 67.8% (P ¼ 0.007) 75.8% (P < 0.0001) 77.2% (P ¼ 0.02) 56.0% 65.9% (P ¼ 0.001)
Diabetes 9.8% 17.6% (P ¼ 0.0001) 22.3% (P ¼ 0.0002) 23.5% (P ¼ 0.13 NS) 7.9% 16.1% (P < 0.0001)
Pulmonary 4.9% 8.4% (P ¼ 0.04) 10.6% (P ¼ 0.003) 6.8% (P ¼ 0.75 NS) 4.3% 7.5% (P ¼ 0.01)
Allergy 20.9% 21.9% (P ¼ 0.75 NS) 24.1% (P ¼ 0.45 NS) 39.8% (P ¼ 0.04) 20.9% 21.5% (P ¼ 0.77 NS)
Gastrointestinal 18.8% 28.5% (P ¼ 0.003) 32.6% (P ¼ 0.002) 28.8% (P ¼ 0.26 NS) 17.4% 25.7% (P ¼ 0.004)
Neoplastic 3.8% 5.4% (P ¼ 0.15 NS) 7.6% (P ¼ 0.02) 3.0% (P ¼ 0.51 NS) 3.5% 5.0% (P ¼ 0.12 NS)
Mental 17.3% 24.9% (P ¼ 0.02) 42.7% (P < 0.0001) 49.7% (P ¼ 0.0002) 15.5% 23.4% (P ¼ 0.0009)
Neurologic 2.3% 6.2% (P < 0.0001) 11.1% (P < 0.0001) 4.4% (P ¼ 0.62 NS) 1.9% 5.0% (P ¼ 0.0001)
Comorbidity score 1.68 2.21 (P < 0.0001) 2.77 (P < 0.0001) 3.2 (P < 0.0001) 1.57 2.08 (P < 0.0001)
RD, rheumatic diseases; HAQ, Health Assessment Questionnaire; EQ-5D, European Quality of Life questionnaire with five dimensions and three
levels; NS, non-significant.
a P-values vs no early retirement.
b P-values vs no early retirement due to disease.
c P-values vs no early retirement due to RD.
d P-values vs employed.
Fig. 1 e Probability of early retirement due to RD, by age.
The confidence interval consists of the space between the
two dashed lines. RD, rheumatic diseases.
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early retirement (unadjusted OR: 1.45; CI: 1.05e2.01; P¼ 0.025.
Adjusted OR: 1.37; CI: 1.01e1.84; P ¼ 0.042. Appendix 3). Some
other characteristics are also associated with early retire-
ment, in particular being older, being male and having other
chronic diseases, specifically gastrointestinal and neurolog-
ical diseases (Appendix 3). Additionally, higher levels of
disability measured by the HAQ score increase the likelihood
of early retirement (OR: 1.58; CI: 1.27e1.97; P < 0.001). On the
other hand, the self-reported RD population has more
disability with higher mean scores of HAQ (0.57 vs 0.21 for
non-RD population, P < 0.001) and early retirees with RD have
significantly worst score vs those with RD but not retired (0.69
vs 0.51, respectively; P ¼ 0.023). The individuals with RD and
higher levels of disability (i.e. HAQ scores "2) are at the
utmost risk of early retirement (55.3% vs 35.1% for all RD
population and 31.9% for those with HAQ scores "2 but
without RD). Likewise, the highest association was measured
between RD plus high disability and early retirement
(adjusted OR: 3.87; CI: 1.63e9.16; P ¼ 0.002. By contrast, non-
significant adjusted ORs of 1.13 and 1.22 were obtained
when testing the association of RD with early retirement in
individuals with low disability measured by HAQ scores of <1
and <2, respectively). We estimated an almost linear rela-
tionship between levels of disability and the probability of
early retirement, with its y-intercept and slope being
increased by RD (Fig. 2).
Mean age of early retirement, YWLL and inactivity ratio
The observed mean age of early retirement attributed to RD
was 54.8 years old. Despite the considerable variation
throughout the years, there was an overall positive trend in
the recent past (Fig. 3). Considering only those who retired
prematurely in the last five years, the mean age of retirement
due to RD is 58.2 years old and, projecting this trend over time,
by year 2050, this figure could reach 65 years.
Fig. 2 e Relationship between disability levels and probability of early retirement (by presence of self-reported RD). Y-axis:
probability of early retirement; X-axis: disability level measured by the HAQ Score. (A) Without self-reported RD; (B) With
self-reported RD. The confidence interval consists of the space between the two dashed lines. RD, rheumatic diseases; HAQ,
Health Assessment Questionnaire.
Fig. 3 e Evolution of mean age of retirement due to self-
reported RD. RD, rheumatic diseases.
Fig. 4 e Years of working life lost due to self-reported RD.
RD, rheumatic diseases; YWLL: years of working life lost;
PYWLL: potential years of working life lost.
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Urban regions seem to be associated with higher mean age
of early retirement attributable to RD.
This sort of early retirement has led to a total of 389,939
YWLL (228 per 1000 inhabitants).Women accounted for 85% of
these YWLL. A total number of 684,960 PYWLLwere estimated
(401 per 1000 inhabitants) (Fig. 4). Themean YWLL and PYWLL
inactivity ratios were 12% and 21%, respectively.
Indirect costs
The estimated annual indirect cost following premature
retirement attributed to RDwasV910million (V555 per capita;
V1625 per self-reported RD patient and V13,592 per early
retiree due to RD). Females contribute with 84% of these costs
(V766 million; V882 per capita vs V187 for malesdFigs. 5 and
6). Moreover, we estimated a mean global cost of V117,502
(95% CI: V78,171eV156,832) per early retiree due to RD from
each one's actual age of retirement until the 65 years official
age of retirement (assuming a constant annual productivity
values for past years and applying an annual 5% discounting
rate for future years as recommended by our national health
economics guidelines).35 The global mean past cost per early
retiree due to RD was V67,569 (95% CI: V43,467eV91,670),
while the mean global future discounted costs if no return to
work occurs is expected to be V48,304 (95% CI:
V29,025eV67,582).
Finally, after using the PAF methodology, due to the rea-
sons already explained, the overall indirect costs reduced by
approximately 16% (i.e. V761 million, V464 per capita and
V1359 per self-reported RD patient).
Discussion
In this research, after implementing the first large-scale
epidemiological population-based study that evaluated RD
in Portugal, we estimated that early retirement self-
reportedly to be due to RD is potentially associated with
an annual cost of up to V910 million in Portugal. These
pathologies are highly frequent in the population, especially
among the oldest. In our sample, we observed a proportion
of over a third of self-reported RD, and among these, a third
was retired and more than half were non-employed. There
is a noticeable network of factors influencing retirement
decisions, and many factors are both related with RD and
early retirement, including age, comorbidities, income and
educational level. However, we found the association with
self-reported RD to be robust and independent from other
influencing factors, and this is consistent with previous
published data.3,13,36 In fact, we observed a high number of
accumulated YWLL and substantial inactivity ratios attrib-
uted to RD, which translates into the abovementioned costs
for societydapproximately 0.5% of the national gross do-
mestic product (GDP) in 2013. This considerable economic
burden has been observed in other countries.37e41 For
instance, in Australia, arthritis caused an annual estimated
loss of approximately 0.7% of GDP due to early retirement.42
The EpiReumaPt study collected a considerable amount of
data, including occupational and socio-economic variables.
The specific sample used in this survey had ages in the vi-
cinity of the statutory retirement age, and more than half
were out of paid work meaning that substantial productivity
losses were occurring, in particular due to ill health. These
results are in line with previous research using data from the
Portuguese Health National Survey 2005/2006 (INS),15 mean-
ing that no improvements have been made since then at the
epidemiological level (i.e. similar prevalence of self-reported
RDdINS: 37.2% vs EpiReumaPt: 34.2% and similar associa-
tion with early retirementdadjusted ORs were: 1.24 in the
INS vs 1.37 in EpiReumaPt). In fact, from a strictly economic
perspective, this situation may have worsened. At the time of
INS 2005/2006, we estimated a productivity loss due to RD of
up to V650 millions, amounting up to 0.4% of GDP. This dif-
ference may result from several reasons, including higher
productivity unit values (INS 2005/2006, men: V19,455
women: V12,899 vs EpiReumaPt 2011/2013: men: V24,891
women: V16,079) and methodological differences (e.g. in the
EpiReumaPt study participants were for the first time directly
Fig. 5 e Annual indirect costs of early retirement due to
self-reported RD. *Line inside bars refers to the lowest
estimate. RD, rheumatic diseases.
Fig. 6 e Annual indirect costs of early retirement due to
self-reported RD (per capita). *Line inside bars refers to the
lowest estimate. RD, rheumatic diseases.
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asked whether they had had retired early because of RD).
From the epidemiological and clinical standpoints, there's no
reason to expect the aforementioned difference. In fact, as
discussed, we measured similar self-reported prevalences
and there's no reason to expect any recent increase in the
frequency of more disabling types or worst stages of RD.
Finally, we also do not anticipate any sort of survivorship
bias (survival of the fittest) effect because there is no signif-
icant RD-specific mortality, in particular within the studied
age range, meaning that no imbalance is expected between
both analysis concerning the most vulnerable RD subjects.
Obviously, many other reasons may play important roles,
including occupational and organizational ones. Changes in
the retirement policies are expected to have an impact as
well. Recently, early retirement was subjected to more
restrictive rules (e.g. more rigorous screening of applicants to
disability pensions lead to younger applicants having lower
probabilities of success), but on the other hand, many ap-
plicants anticipated their decisions of early withdrawal from
work in order to avoid expected future penalties and worse
eligibility criteria for retirement. It is difficult to understand
exactly the magnitude of these opposing structural effects, in
particular for the RD population, but definitely the recent
sovereign debt crisis and subsequent social reforms must
have had considerable influence. It is also arduous to predict
its evolution; however, despite the already discussed
changes, we observed a positive trend on the mean age of
early retirement attributed to RD. A lot remains to compre-
hend about the undermining reasons of this trend. For
instance, if early retirement caused by RD is artificially
postponed (e.g. excessive penalties unaffordable for those
with lower income) or instead if structural policies are taking
place to avoid RD disability and promote job adaptation.
Obviously, any measure that obligates the labour force to
employ the same effort under the same conditions regardless
its physical and functional circumstances may adjourn in-
direct costs in the short run, but would not work on the
longer one and even may exacerbate medical conditions
leading to higher direct costs.
In this study, we observed higher healthcare consumption
in the RD population, which in turn translates into higher
direct costs. The hospitalization and medical appointments
rates were higher compared to the non-RD population.
Interestingly, early retirement was also associated with these
costs. This might be due to a general worsening of health
prior to retirement or instead triggered/worsened by it. If the
last case is true, permissive criteria concerning disability
pensions and early retirement per se does not guarantee any
cost offset from less healthcare consumption.
At a global level, occupational policies have focused on job
retention rather than on the return to work.43 Although we
recognize that return-to-work policies are less likely to be
successful, we also need to highlight that our data suggest
that they would provide significant productivity gains to so-
ciety. In this sample, we measured 389,939 YWLL and expect
a similar number of YWLL from the same individuals until
the official retirement age. Therefore, if nothing is done,
otherwise, the amount of working years still to be lost from
the current early retirees due to RD will almost equal those
already gone, meaning that health policies probably should
target return to work as well, in particularly for younger re-
tirees. It is true that RD are degenerative and progressively
disabling, but is also true that there is a growing number of
interventions available to reduce and control physical
impairment, which allied with vocational rehabilitation and
job accommodation (e.g. ergonomic adaptations) might allow
some RD patients to return to work.
In general, the data show that women are less prone to
early retirement. However, the opposite occurs when the
cause is RD. Currently, females contribute with about 85% of
YWLL and indirect costs attributed to RD. Since RD is more
prevalent in women, it is not surprising that YWLL and in-
direct costs split by gender are unbalanced with greater
burden on females. In addition, we also observed more
disability in females among those self-reporting RD (data not
shown), which might contribute to this gender difference in
our results, given the straightforward relationship between
disability and early retirement due to RD. Sadly, in the last
decade, we did not observe any trend to reduce wage dis-
parities between genders in the age-range studied (com-
pound annual growth rate for men is 3.1% while it is 2.8% for
women). If gender wage disparities had been reduced, the
estimated indirect costs would have been even higher. In
fact, if we were to assume productivity values similar to
those of men for the whole sample, the indirect costs esti-
mate would rise by about 30%. Future research is necessary
to understand how these costs will evolve in the coming
years as a function of the expected evolution of gender
disparities.
We also observed a strong association between high scores
of HAQ and early retirement. Within the model of the aeti-
ology of work disability (PathologydImpairmentdFunctional
LimitationsdWork DisabilitydEarly Retirement),44,45 HAQ
might be a good proxy to detect risk of health-related pre-
mature retirement. In this context, early retirees with RD have
significantly worst HAQ values compared to individuals still at
work under the same clinical conditions, and there is a cu-
mulative risk of early retirement when the RD patient already
has high levels of HAQ. This means that it might be worth-
while to segment RD patients according with disability levels
because that is a straightforward method to set distinct levels
of work withdrawal risk. Targeting RD as a whole regardless
of any other factor might be an approach too broad to be
effective. Since HAQ assessment is simple and inexpensive,
employers could periodically survey employees regarding ill-
health conditions, including RD, and their disability level.
This could be a fruitful proactive investment particularly for
manual workers.
This analysis is based on self-reported data, meaning
that from a rigorous epidemiological angle, this research
might be subject to misclassification bias (i.e. main inde-
pendent variable not clinically confirmed). In fact, we
grouped all participants who did not self-reported RD in the
non-RD population, but many might suffer from a rheu-
matic condition. However, these results should also be used
from a pragmatic angle to encourage fast and easy
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identification of vulnerable employees according with their
level of retirement risk. Certainly, all cases of self-reported
RD must be clinically confirmed (in order to avoid false
claims and misperception about self-conditions), but this
proxy might not only be easier to obtain but also more
useful compared with a broader RD clinical diagnosis since
the strong correlation between disease self-awareness and
worst/advanced disease stages (i.e. higher disability and
therefore early retirement risk). In addition, given the
recognizable low access to specialist appointments
that some population segments still have, self-reported
information about RD should be considered prior
to further and more complex measures (including
upfront diagnosis assessment and possible customized
interventions).
We do not expect our results to be influenced by justifi-
cation bias (i.e. some people may want to justify their early
retirement through health problems, which is a common
limitation in this type of research).46 The EpiReumaPt
questionnaire is not exclusively dedicated to occupational
data, and the survey did not generate any sort of pressure
for responders to justify their retirement condition. Never-
theless, some limitations must be taken into account when
interpreting the results of this study. First, it may be limited
by its cross-sectional design, which does not allow for an
evaluation of the temporal relationship between some co-
factors and the studied outcomes. However, in order to
calculate the indirect costs, we used data mainly from the
direct question about early retirement due to RD. The same
was done regarding date and age of early retirement
attributed to RD. Thus, for the main objectives of this work,
we do not expect any temporal bias (also known as reverse
causality) from this study design. However, the reported age
of early retirement is still subject to memory bias. Second,
the human capital method has been criticized for its over-
estimation of indirect costs47 since the real paid production
loss to society is likely to be lower (for instance, the work
can be done by someone drawn from the unemployment
pool). The friction cost approach has been proposed as an
alternative to calculate indirect costs; however, it is
considered less appropriate to estimate the productivity
losses for early retirees, which was the focus of our
research.47e49 On the other hand, unit values of production
were estimated through official statistics based on gender,
region and age. Necessarily, this methodology is a rough
estimate of individual unit values of production. In partic-
ular, RD patients are associated with lower incomes. Still,
given the information available, it is the most suitable
method. Third, RD may underlie early retirement even when
it is not perceived by the patient, and our indirect costs
calculation might have been undervalued because it did not
consider other forms of RD contribution to premature
withdrawal from work (e.g. by triggering or worsening
another cause of early retirement, such as associated co-
morbidity, lifestyle and sociodemographic conditions).
Finally, due to the cross-sectional design, our results are
right-censored, leading to likely underestimation of the re-
sults (i.e. early retirement more probable to occur than re-
turn to work within the sample until all participants reach
the official retirement age).
This study has several strengths too. It is the first
population-based study on RD in our country, allowing
direct information between RD and its occupational impact.
To our knowledge, this must be among the few studies
focusing on indirect costs based on a representative sample
specifically dedicated to RD. Moreover, this database will
allow prospective follow-up to better understand the various
paths of early retirement and its connection with RD and
other factors in more detail.50 It will also allow future
research on the effectiveness of interventions targeting early
retirement.
To conclude, this comprehensive population-based
research underlines the high economic burden of RD con-
cerning early retirement, justifying more attention when
discussing policies facing one of the most relevant sustain-
ability issues of ageing western countries. Rheumatic disor-
ders are still undervalued in health policies. However, we
cannot afford to be inactive regarding this topic any longer
and should address possible interventions intended to miti-
gate early retirement attributed to RD (e.g. early diagnosis,
effective treatment and vocational rehabilitation).51 The
depreciation in the stock of human capital due to self-
reported RD through early retirement already amounts to
approximately 0.5% of the national GDP, and given the de-
mographic and epidemiologic trends, it might get even higher
if nothing is done otherwise. Therefore, public health policies
must indeed directly address this sort of foregone productivity
with effective strategies, which ultimately aim to improve
patients' quality of life and the wealth of our society. This
research provides a strong case to move fast on this direction
with relevant evidence for decision makers to prioritize in-
vestments in health and social protection policies targeting
patients with rheumatic conditions, in particular those highly
disabled.
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Appendix 1. Summary of average unit values of production by gender, age and geographic region (2013).
Age National North Centre Lisbon Alentejo Algarve
Men
50 V22,868 V21,271 V21,091 V32,376 V21,147 V19,808
51 V23,875 V21,066 V20,753 V32,081 V21,659 V18,518
52 V24,609 V21,357 V20,290 V31,991 V22,772 V19,523
53 V24,688 V21,497 V20,834 V32,895 V22,182 V18,722
54 V25,831 V21,942 V20,475 V31,422 V24,079 V19,314
55 V25,624 V22,005 V21,086 V32,877 V23,712 V20,063
56 V25,185 V22,005 V21,065 V33,006 V24,686 V18,943
57 V25,813 V22,665 V20,187 V33,248 V23,917 V20,398
58 V23,696 V22,757 V20,719 V34,349 V24,228 V18,808
59 V25,881 V23,593 V21,222 V34,765 V25,096 V20,406
60 V23,843 V21,586 V20,037 V32,585 V24,078 V19,509
61 V26,350 V22,616 V21,393 V36,334 V22,330 V19,943
62 V25,966 V24,180 V20,432 V34,934 V25,275 V18,210
63 V24,645 V23,053 V19,851 V33,056 V25,360 V17,408
64 V24,490 V24,474 V20,181 V34,764 V28,163 V17,266
Average (50e64) V24,891 V22,404 V20,641 V33,379 V23,912 V19,123
Women
50 V16,290 V14,524 V13,384 V20,811 V13,740 V15,466
51 V15,880 V14,864 V13,451 V20,522 V13,811 V15,637
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Appendix 2
Hospitalizations Medical
appointments
(all)
Medical
appointments
(all hospital
specialtiesx)
Medical
appointments
(general
practitioners)
Medical
appointments
(rheumatology)
Home
care
assistance
Self- reported
RD
Early
retirement
a) 18.0%;
b) 2.5%
c) 95.7%;
d) 7.8 (6.4e9.2)
c) 74.9%;
d) 5.3 (3.7e6.8)
c) 89.8%;
d) 3.9 (3.3e4.6)
c) 8.8%;
d) 2.7 (1.9e3.4)
c) 2.5%
No early
retirement
a) 10.0%
(P ¼ 0.10)*;
b) 2.5%
(P ¼ 0.99)
c) 87.1%
(P ¼ 0.06)*;
d) 6.9 (5.9e7.9)
c) 55.2%
(P ¼ 0.0007);
d) 5.2 (4.3e6.0)
c) 78.1%
(P ¼ 0.02)*;
d) 4.0
(3.4e4.7)
c) 10.8%
(P ¼ 0.42)*;
d) 2.4
(1.9e2.9)
c) 1.0%
(P ¼ 0.06)
All
self-reported
RD
a) 12.8%;
b) 2.5%
c) 90.1%;
d) 7.2 (6.4e8.1)
c) 62.1%;
d) 5.2 (4.4e6.0)
c) 82.2%;
d) 4.0 (3.5e4.5)
c) 10.1%;
d) 2.5 (2.1e2.9)
c) 1.5%
Non-RD
(unknown
RD)x
Early
retirement
a) 11.9%;
b) 0.3%
c) 91.3%;
d) 5.5 (4.4e6.6)
c) 56.5%;
d) 4.1 (2.9e5.4)
c) 83.5%;
d) 3.2 (2.8e3.6)
c) 2.8%;
d) 2.1 (1.3e2.9)
c) 0.7%
No early
retirement
a) 7.6%
(P ¼ 0.21)*;
b) 0.6%
(P ¼ 0.32)
c) 82.4
(P ¼ 0.0002)*;
d) 4.2
(3.9e4.6)
c) 49.4%
(P ¼ 0.12);
d) 3.2
(2.8e3.5)
c) 70.3
(P < 0.0001)*;
d) 2.7
(2.5e3.0)
c) 1.1%
(P ¼ 0.06)*;
d) 1.4
(1.2e1.7)
c) 1.3%
(P ¼ 0.33)
All non-RDx a) 8.8%
(P ¼ 0.11)**;
b) 0.5%
(P < 0.0001)**
c) 84.8%
(P ¼ 0.25);
d) 4.6
(4.2e5.0)
c) 51.4%
(P ¼ 0.008);
d) 3.4
(3.0e3.9)
c) 73.9%
(P ¼ 0.05);
d) 2.9
(2.7e3.1)
c) 1.6%
(P < 0.0001);
d) 1.7
(1.3e2.2)
c) 1.2%
(P ¼ 0.46)
All a) 10.1%;
b) 1.2%
c) 86.6%;
d) 5.5 (5.2e5.9)
c) 55,0%;
d) 2.3 (2.0e2.5)
c) 76.8%;
d) 3.3 (3.1e3.5)
c) 4.5%;
d) 2.3 (2.0e2.7)
c) 1.3%
RD, rheumatic diseases.
a) Proportion of hospitalized patients in the previous 12 months/ b) proportion of hospitalized patients in the previous 12 months directly
caused by RD. c) Proportion of users in the previous 12 months/ d) mean number of consumption per user.
xAll participants who did not self-reported RD were classified has non-RD. *P-values: early retirement vs no early retirement. **P-values: RD vs
non-RD. xAll medical appointments except general practitioners.
e (continued )
Age National North Centre Lisbon Alentejo Algarve
52 V16,709 V15,202 V13,291 V20,965 V14,281 V15,595
53 V16,165 V15,006 V13,067 V21,020 V14,068 V14,931
54 V17,526 V15,250 V13,158 V21,075 V13,612 V14,653
55 V16,504 V15,379 V13,459 V20,312 V13,731 V15,434
56 V15,437 V15,251 V13,343 V21,297 V14,298 V15,507
57 V15,557 V15,313 V12,612 V20,181 V14,629 V15,402
58 V15,359 V15,205 V13,018 V19,968 V13,632 V14,444
59 V16,881 V16,023 V14,525 V19,495 V13,140 V15,262
60 V15,727 V15,726 V13,192 V19,362 V13,180 V15,151
61 V16,103 V15,792 V12,819 V19,901 V13,359 V13,546
62 V15,954 V15,860 V13,088 V20,745 V13,340 V14,257
63 V15,629 V15,452 V13,850 V18,797 V13,298 V16,413
64 V15,460 V15,489 V13,070 V17,956 V13,426 V14,059
Average (50e64) V16,079 V15,356 V13,288 V20,160 V13,703 V15,050
National V20,255
Note: National values are weighted averages according with each age, sex and region population size.
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Appendix 3. Logistic regression results.
Outcome: general early retirement Outcome: early retirement due to RD
Univariable OR
(95% CI)
Multivariable OR
(95% CI)
Univariable OR
(95% CI)
Multivariable OR
(95% CI)
Rheumatic diseases (self-reported) 1.5 (1.1e2.0) 1.4 (1.0e1.8) 11.9 (5.8e24.4) 6.8 (3.7e12.4)
Age 1.0 (1.0e1.0) 1.0 (1.0e1.0) 1.0 (1.0e1.0) 1.0 (1.0e1.0)
Gender (female) 0.7 (0.5e0.9) 0.5 (0.4e0.7) 4.1 (2.0e8.3) 1.9 (1.0e3.4)
Area of residence
North 1 1 1 1
Centre 1 (0.7e1.4) NS 0.9 (0.7e1.4) 1.3 (0.5e3.5) NS 1.5 (0.7e3.3) NS
Lisbon 0.9 (0.6e1.4) NS 1.1 (0.7e1.7) NS 1.4 (0.3e5.4) NS 1.7 (0.6e4.9) NS
Alentejo 1.0 (0.7e1.6) NS 1.1 (0.7e1.8) NS 1.8 (0.6e5.1) NS 2.3 (0.9e5.9) NS
Algarve 0.7 (0.4e1.3) NS 0.6 (0.3e1.2) NS 0.5 (0.1e2.7) NS 0.9 (0.2e4.9) NS
Azores 0.9 (0.6e1.4) NS 0.9 (0.6e1.6) NS 2.4 (0.9e6.5) NS 2.9 (1.2e6.9)
Madeira 0.6 (0.4e0.9) 0.6 (0.4e0.9) 0.7 (0.2e2.0) NS 0.6 (0.2e1.7) NS
Educational level
Low 1 e 1 1
Medium 0.7 (0.5e1.1) NS e 0.3 (0.1e0.7) 0.5 (0.3e1.1) NS
High 0.6 (0.4e0.8) e 0.2 (0.1e0.4) 0.3 (0.1e0.8)
Chronic diseases (self-reported)
Cardiovascularx 1.8 (1.3e2.4) e 2.2 (1.1e4.3) e
Diabetes 1.9 (1.4e2.8) e 2.3 (0.8e6.9) NS e
Pulmonary 1.8 (1.0e3.1) e 1.2 (0.5e2.9) NS e
Allergy 1.1 (0.6e1.5) NS e 2.6 (1.0e6.5) e
Gastrointestinal 1.7 (1.2e2.5) 1.7 (1.2e2.4) 1.5 (0.8e2.9) NS e
Neoplasic 1.5 (0.9e2.4) NS e 0.7 (0.2e2.2) NS e
Mental 1.6 (1.1e2.3) e 4.4 (1.9e10.3) 2.4 (1.3e4.5)
Neurologic 2.8 (1.7e4.4) 2.9 (1.6e5.2) 1.3 (0.5e3.5) NS e
OR odds ratio, CI confidence interval*.
All initial multivariable models were adjusted for age, gender, area of residence (NUTSII), education level (primary school or less, medium and
high), household income and other chronic diseases. Cofactors were excluded in the stepwise method if P > 0.05. Cofactor age was transformed
(mean centring) due to high multicollinearity (variance inflation factor >10). Other covariates of potential interest (e.g. smoking status, physical
exercise and marital status) were also tested, but no significant association was found.
xCardiovascular includes risk factors hypertension and hypercholesterolaemia.
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EARLY EXIT FROM WORK ATTRIBUTABLE TO OSTEOARTHRITIS AND ITS 
ECONOMIC BURDEN 
 
ABSTRACT 
OBJECTIVES: To describe the association of clinically confirmed osteoarthritis (OA), 
including its most frequent location (i.e. knee), with early exit from work and to 
calculate its economic burden (productivity loss).  
METHODS: We analysed data from the population-based EpiReumaPt study 
(Sep2011-Dec2013). 10,661 inhabitants were surveyed to capture all cases of 
rheumatic and musculoskeletal diseases within a representative sample of the 
population. We analysed all participants aged 50-64 years, near the official 
retirement age and all OA cases were clinically validated, according to the ACR 
classification criteria. For retired participants, years of working life lost (YWLL) were 
determined as the difference between each OA participant’s age and the respective 
retirement age when self-reported retirement was caused by a rheumatic condition, 
while the potential YWLL (PYWLL) was the difference between official and actual 
retirement ages. An official wage database was used to estimate productivity by 
gender, age and region using the human capital approach. The effects of OA on the 
likelihood of early exit from paid employment and the attributable fractions estimates 
were obtained at the individual level by multivariable logistic regression.  
RESULTS: In the survey, more than half of the population aged between 50 and 64 
years were out of paid work (51.8%) and had an OA prevalence of about 30% 
(29.7%; men: 16.2% and women: 43.5%. Knee OA: 18.6%; hand: 12.6%; hip: 3.6%). 
OA is associated with early exit from paid employment, specifically knee OA (OR: 
2.25; CI: 1.42-3.59; p=0.001). Other OA locations do not have a statistically 
significant effect on work loss. Early exit from paid employment due to OA led to a 
total of 143,262 YWLL and 338,822 PYWLL (84 and 198, respectively, per 1000 
inhabitants in the age group 50-64). The estimated annual indirect cost attributable 
to OA was €656 million (€384 per capita; €1294 per OA patient and €2095 per OA 
patient out of work). Females contributed with 61.6% of these costs (€404 million).  
CONCLUSIONS: A considerable amount of working life loss and indirect costs are 
associated with OA. Premature withdrawal from employment attributable to OA 
amounts to approximately 0.39% of the national GDP. The high prevalence and the 
impact of this disabling chronic disease highlight the need to prioritize policies 
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targeting early exit from work in OA and research on the cost-effectiveness of 
interventions aiming to reduce such economic burden.  
INTRODUCTION 
In many western countries the population is ageing due to increasing longevity and 
falling birth rates.1 However, a high rate of exit from the workforce persists as a 
consequence of numerous factors, including health-related problems.2-6 Several 
studies show that ill-health is a risk factor for transitions between paid employment 
and various forms of non-employment, including retirement and unemployment.3,7,8   
Osteoarthritis (OA) is the most common joint condition in adults and globally it is the 
fastest increasing major health condition.  It is recognized as one of the leading and 
rapidly growing causes of disability. Its most disabling manifestation (joint pain) is 
strongly associated with common forms of disability, including work restriction.   
The increasing prevalence of chronic health conditions, especially OA, in people 
near the retirement age raises questions about the viability of attempts to extend 
working life. However, research about the effect of OA on work participation and its 
economic burden is still scarce.12,13   
Thus, the main aim of this study is to describe the association of clinically confirmed 
OA, including its most frequent location (i.e. knee), with early exit from work and to 
calculate the respective productivity loss (i.e. indirect costs and YWLL). 
METHODS 
Sample   
This study uses the first national, cross-sectional, population-based study on 
rheumatic diseases in Portugal – the EpiReumaPt study.14 The methodology of 
EpiReumaPt has been detailed elsewhere.15 Briefly, EpiReumaPt (September 2011 - 
December 2013) randomly selected a representative sample of 10,661 adult 
subjects who self-reported several data following a questionnaire applied by trained 
staff. Additionally, rheumatologists performed a standardized physical examination 
and appropriate labouratory/imaging evaluation on those participants with rheumatic 
complaints/symptoms.  
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For the purposes of this analysis we used data from all EpiReumaPt participants 
aged between 50 and 64 years, near the official retirement age (1,065 men and 
1,727 women).  
Measures 
The following self-reported measures were used: major chronic diseases (yes/no: 
diabetes, cardiovascular diseases including risk factors such as hypertension and 
high cholesterol, allergy, pulmonary disease, gastrointestinal disease, neurological 
disease, mental disease and cancer); comorbidity score (built as the sum of all 
aforementioned chronic illnesses); body mass index (BMI); quality of life (using the 
final 0-100 score from the SF-36 Health Survey16,17 and its eight items separately, 
including the bodily pain index; and the European Quality of Life questionnaire with 
five dimensions and three levels validated for Portugal, EQ-5D index18,19); 
longstanding musculoskeletal pain (≥3 months); pain interference with work activities 
(i.e. pain affecting labour and domestic activities based on the SF-36 question: 
“During the past 4 weeks, how much did pain interfere with your normal work, 
including both work outside the home and housework?”); functional capacity (0-3 
score from the Health Assessment Questionnaire, HAQ20); marital status; and 
educational level (classified into 3 major levels according to the highest degree 
completed: primary school or less, basic education between primary and secondary 
levels, and secondary education or more, including university degrees). 
In this analysis we considered the presence of OA through clinical confirmation 
initially done by a rheumatologist and then validated by a team of 3 experienced 
rheumatologists, according with the ACR classification criteria, of at least one type of 
OA: knee OA,21 hip OA22 and hand OA.23 All those without any of these OA types 
were considered to be non-OA (non-OA may include cases with spondylarthritis). We 
also used OA-specific variables collected by the rheumatologists during their 
evaluation, such as the Knee injury and Osteoarthritis Outcome Score (KOOS)24, a 
commonly used patient-reported outcomes tool for patients with knee OA, including 
OA pain characterization. Regarding the case definition for the main outcome, 
individuals were directly asked about their employment status and all those who did 
not report any kind of paid work (part- or full-time), including housekeepers without a 
regular salary, and those in official early retirement or disability pensions, were 
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included in the early exit from paid employment group. All those reporting any form 
of regularly paid work were considered employed. This definition was used 
elsewhere in previous research.8,25 A broader definition of early withdrawal from 
work enables to take into account the existence of different pathways to early 
retirement. However, we also considered relevant to separately analyse more 
specific types of exit from work, including pure early retirement and unemployment. 
Years of Working Life Lost (YWLL) and Inactivity Ratio 
YWLL were determined for OA cases with premature retirement due to rheumatic 
disease estimated as the difference between each participant’s age at the time of the 
survey and the respective retirement age, while the potential YWLL (PYWLL) is the 
difference between official and actual retirement ages. PYWLL assumes there is no 
return to work. We also calculated the percentage of time in inactivity (Inactivity Ratio 
= YWLL/Active age-range [15-64 years old]). We excluded all OA participants with 
concomitant inflammatory rheumatic diseases with very likely impact on retirement, 
such as rheumatoid arthritis and spondylarthritis. All cases with known retirement 
data were also excluded if prior to onset of OA symptoms.  
Indirect Costs 
In order to calculate indirect costs of premature work loss associated with OA in 
Portugal´s mainland we adopted society’s perspective and used the human capital 
approach. This method estimates productivity by valuing healthy time lost due to OA 
using market wage rates, which can be viewed as the loss of an investment in a 
person’s human capital. Early exit from paid employment associated with OA was 
assessed through logistic regression models. A good measure of the impact of OA in 
the early exit from paid employment may be the population attributable fractions 
(PAF), which take into account both the strength of the association between OA and 
early exit from work, as measured in the logistic models, and the prevalence of OA in 
the surveyed population. PAF were calculated as the resulting proportional change in 
the probability of premature work withdrawal following a counterfactual exercise 
where the presence of OA is artificially eliminated from the sample. This recalculated 
probability of exit from work was then used to estimate the indirect costs attributable 
to OA by multiplying each observation’s probability change with the corresponding 
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unit value of production. The unit values of production were assessed by obtaining 
the market wage rates from national public sources for 2013.26 These figures needed 
to be grossed up by social security contributions. This approach yielded an annual 
average value of €24,891 for men and €16,079 for women, for ages between 50 and 
64 years. All unit values of production were stratified by age, gender and geographic 
region (Appendix 1).  
Statistical Analysis 
Descriptive analysis was mainly performed comparing early withdrawals from work 
(including early retirees) versus the employed participants of the analysed sample. 
Prevalence of early exit from work and other characteristics were computed as 
weighted data, in order to take into account the stratified sampling design of the 
survey. Missing values were not replaced and all statistics were calculated based on 
non-missing values. To explore the association between OA and early exit from work 
we built multivariable logistic regression models by means of a manual stepwise 
technique (backward elimination) using the following potential confounders: age, 
gender, region, marital status, education, household income, BMI and chronic 
diseases. Pain and disability were not included in the multivariable models since they 
are considered intermediate factors of OA within the studied etiologic model, as 
further explained bellow.27,28 Their association with the outcome was instead 
analysed separately adjusted for age, gender and region. All statistical analyses 
were carried out using Stata IC V.12 (StataCorp, 2011. Stata Statistical Software: 
Release 12. College Station, Texas, USA: StataCorp LP). 
RESULTS 
In the survey, more than half of the population aged between 50 and 64 years were 
out of paid work (51.8%. Table 1) and had an OA prevalence of about 30% (29.7%; 
men: 16.2% and women: 43.5%. Knee OA: 18.6%; hand: 12.6%; hip: 3.6%). Lower 
education and monthly household income were more frequent in the premature 
withdrawals, while the marital status single was more likely found in the people 
employed. The out of work group had a worse health status, with higher comorbidity 
scores, lower quality of life and lower functional capacity. Higher prevalence of 
diabetes and neurologic disorders were also found in this group. Particularly, in 
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comparison to the paid employment group, OA prevalence was significantly higher in 
all other groups (Table 1).  
Table 1 - General description of the sample by employment status: EpiReumaPt ages 50–65  
 
 UNEMPLOYMENT EARLY RETIREMENT 
EXIT FROM 
WORK 
PAID 
EMPLOYMENT 
Employment Status 12.2%  30.2%  51,8%  48.2%  
Age (years) 55.2 (p=0.192)* 59.9 (p<0.001)* 58.2 (p<0.001)* 54.6 
Gender (female) 55.3% (p=0.187) 44.2% (p=0.757) 52.2% (p=0.305) 46.3% 
Educational Level 
Primary or less 55.0% 64.0% 63.4% 37.3% 
Medium 23.3% 17.6% 19.6% 28.5% 
High 21.7% (p=0.024) 18.4% (p<0.001) 17.0% (p<0.001) 34.2% 
Marital Status 
Single  11.7% 3.4% 5.7% 14.9% 
Married / Consensual 
union 70.6% 77.3% 76.2% 64.5% 
Divorced  14.3% 10.4% 10.3% 15.3% 
Widowed  3.4% (p=0.673) 8,9% (p=0.002) 7.8%(p=0.007) 5.2% 
Body Mass Index 
Underweight 
(<18.5m2/kg) 0% 0.5% 0.5% 0.4% 
Normal  
(18.5-25m2/kg) 28.5% 25.7% 27.0% 30.5% 
Overweight 
(25-30m2/kg) 44.6% 50.3% 46.3% 46.7% 
Obese 
(≥30m2/kg) 
27.7% 
(p=0.788) 
23.5% 
(p=0.801) 
26.2% 
(p=0.762) 22.4% 
Clinically Confirmed OA 42.8% (p<0.001) 32.1% (p=0.08) 35.4% (p=0.003) 23.5% 
Knee OA 29.0% (p<0.001) 22.0% (p=0.005) 24.2% (p<0.001) 12.6% 
Hand OA 14.3% (p=0.413) 12.3% (p=0.797) 13.6% (p=0.405) 11.6% 
Hip OA 3.1% (p=0.795) 4.2% (p=0.809) 3.6% (p=0.998) 3.6% 
Chronic Diseases (self-reported) 
Cardiovascular  60.6% (p=0.740) 62.8% (p=0.991) 63.7% (p=0.874) 62.8% 
Diabetes 10.1% (p=0.180) 17.5% (p=0.003) 15.9% (p<0.001) 6.4% 
Pulmonary  11.5% (p=0.147) 7.5% (p=0.407) 9.9% (p=0.110) 5.0% 
Allergy 22.4% (p=0.411) 20.5% (p=0.242) 22.4% (p=0.356) 27.5% 
Gastrointestinal  22.6% (p=0.460) 26.6% (p=0.114) 25.5% (p=0.102) 19.1% 
Neoplasic  5.9% (p=0.458) 6.5% (p=0.282) 5.7% (p=0.338) 3.9% 
Mental  15.8% (p=0.493) 13.6% (p=0.942) 17.2% (p=0.130) 13.4% 
Neurologic  1.6% (p=0.644) 6.7% (p=0.005) 4.8% (p=0.004) 1.2% 
Comorbidity Score 1,87 (p=0.471) 2.03 (p=0.10) 2.04 (p=0.03) 1.74 
Longstanding 
Musculoskeletal Pain 47.0% (p=0.049) 39.7% (p=0.399) 43.9% (p=0.073) 34.8% 
Functional Capacity - HAQ  0.48 (p=0.012) 0.43 (p=0.033) 0.47 (p=0.002) 0.28 
Quality of Life – EQ-5D  0.72 (p<0.001) 0.79 (p=0.152) 0.75 (p=0.002) 0.83 
* all p values versus paid employment. OA, Osteoarthritis; HAQ, Health Assessment Questionnaire; EQ-5D, European Quality 
of Life index. 
 
The participants with OA had more comorbidities (Comorbidity score: 2.3 vs 1.7; 
p<0.001), in particular diabetes, gastrointestinal and mental disorders, and were 
more likely to self-report other main chronic diseases (age, sex and region adjusted 
OR: 1.70; CI: 1.07-2.69; p=0.023). OA participants had worse quality of life 
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measured by all SF-36 items (Appendix 2), especially the bodily pain index (54.9 vs. 
72.6, p<0.001), and by the EQ-5D score (0.68 vs. 0.83; p<0.001). OA patients 
reported more frequently longstanding musculoskeletal pain than non-OA (52.5% vs. 
34.1%; p<0.001). The OA population also score worse in functional capacity 
measured by the HAQ scale (0.64 vs. 0.28; p<0.001). Within the OA group, 61.8% 
were not working versus 47.6% for those without OA (p=0.004). Most were females 
(71.0% versus 41.9% for those non-OA in the out of work group; p<0.001). A non-
significant difference was observed when analysing specifically early retirement 
(32.6% vs. 29.1%, respectively; p=0.437). Unemployment is a major early route of 
work loss in the OA population (17.7% vs. 9.9% for non-OA; p=0.002). The vast 
majority of registered unemployment lasted more than 12 months (95.8%).  
Figure 1 – Prevalence of Early Exit from Work, Early Retirement and Unemployment according to 
ages 50-64 
 
 
 
 
 
 
 
 
 
 
 
OA, Osteoarthritis 
 
Figure 1 shows how unemployment rates were high among the youngest of the OA 
population (i.e. 50-56) whilst being surpassed by official early retirement after 
approximately the age of 56. A distinct dynamic is observed in the non-OA 
population where unemployment rates are in line with early retirement bellow age 55.  
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Table 2 - Logistic regression analysis by type of early exit from paid employment.  
 
 Unemployment Early Retirement Early Exit From Paid 
Employment 
 Univariable 
OR (95% CI) 
Multivariable 
OR 
(95% CI)a 
Univariable OR  
(95% CI) 
Multivariable 
OR 
(95% CI)a 
Univariable 
OR (95% CI) 
Multivariable 
OR 
(95% CI)a 
Knee Osteoarthritis  1.97* (1.25-
3.10) 
2.68* (1.58-
4.53) 
1.37 (0.90-
2.08)  
- 2.22* (1.49-
3.29) 
2.25* (1.42-
3.59) 
Age  0.99* (0.97-
1.00) 
0.98* 
(0.97-1.00) 
1.03* (1.01-
1.04) 
1.03* (1.01-
1.04)  
1.01 (1.00-
1.03)  
1.01* (1.00-
1.03)  
Gender (Female) 1.31 (0.83-
2.09)  
1.06 (0.61-
1.84)  
0.75 (0.47-
1.18)  
0.64 (0.41-
1.00) 
1.27 (0.80-
2.00)  
1.23 (0.79-
1.93)  
Educational level (Ref: Primary or less) 
     Medium 0.89 (0.51-
1.56)  
- 0.47* (0.26-
0.84) 
0.46* (0.23-
0.92) 
0.41* (0.22-
0.74) 
0.31* (0.18-
0.55) 
     High 0.77 (0.44-
1.34)  
- 0.46* (0.26-
0.80) 
0.62 (0.36-
1.06)  
0.29* (0.17-
0.49) 
0.49* (0.27-
0.89)  
Marital Status (Ref: Single) 
    Married / 
Consensual union 
0.85 (0.36-
1.99)  
- 4.38* (1.81-
10.57) 
4.21* (1.62-
10.92) 
3.11* (1.30-
7.43) 
5.28* (2.24-
12.45) 
Divorced  0.97 (0.36-
2.57)  
- 2.89 (0.97-
8.63)  
2.99 (0.97-
9.22)  
1.77 (0.64-
4.87)  
1.78 (0.69-
4.58)  
Widowed  0.41 (0.13-
1.29)  
- 6.14* (2.23-
16.93) 
6.08* (2.00-
18.48) 
3.93* (1.50-
10.29) 
4.04* (1.34-
12.17) 
Chronic Diseases  
Cardiovascular  0.88 (0.55-
1.42) 
- 0.97 (0.58-
1.62)  
- 1.04 (0.64-
1.68)  
- 
Diabetes 0.87 (0.47-
1.61) 
 2.25* (1.30-
3.89) 
1.92* 
(1.09-3.41) 
2.78* 
(1.67-4.65) 
- 
Pulmonary  0.98 (0.43-
2.24) 
- 2.08 (0.83-
5.21)  
- 2.08 (0.84-
5.15)  
- 
Allergy 0.86 (0.51-
1.44) 
- 0.70 (0.41-
1.20)  
- 0.76 (0.43-
1.33)  
- 
Gastrointestinal  1.02 (0.63-
1.66)  
- 1.40 (0.89-
2.23)  
- 1.45 (0.91-
2.31)  
- 
Neoplasic  1.27 (0.50-
3.26)  
- 1.61 (0.70-
3.70)  
- 1.51* 
(0.62-3.65) 
 
Mental  1.04 (0.64-
1.70)  
- 0.82 (0.54-
1.23)  
-  1.34 (0.91-
1.99)  
- 
Neurologic  0.50 (0.15-
1.59)  
- 4.83* (2.19-
10.66) 
5.00* 
(1.95-
12.83) 
4.17* 
(1.83-9.50) 
4.58* 
(1.40-
15.00) 
Household Income (Ref: ≤€500) 
>€500 and ≤€1000 0.31* (0.18-
0.55) 
0.36* (0.20-
0.64) 
0.84 (0.43-
1.62)  
- 0.43* (0.23-
0.80) 
0.40* (0.23-
0.69) 
>€1000 and ≤€2000 0.10* (0.04-
0.24) 
0.12* (0.05-
0.28) 
0.98 (0.45-
2.12)  
- 0.26* (0.12-
0.54) 
0.25* (0.12-
0.53) 
>€2000 0.15* (0.06-
0.43) 
0.18* (0.06-
0.50) 
0.79 (0.34-
1.81)  
- 0.22* (0.10-
0.49) 
0.25* (0.10-
0.65) 
Regional Controls  YES  YES  YES 
OR odds ratio, CI confidence interval, *p<0.05. 
 a - All multivariable models were adjusted for age, gender, geographic region (7 main regions: North, Center, Lisbon region, 
Alentejo, Algarve, Azores and Madeira), marital status, education level, household income, body mass index and chronic 
diseases. Cofactors were excluded in the stepwise method if p>0.05 (except for age and gender).  
Association between OA and Early Exit from Work 
OA is associated with early exit from paid employment (OR: 1.85; CI: 1.27-2.69; 
p=0.001), but not with official early retirement (OR: 1.43; CI: 0.96-2.12; p=0.08). 
Knee location of OA is particularly associated with early exit from work (OR: 2.25; CI: 
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1.42-3.59; p=0.001. Table 2), while no significant association was observed for hand 
OA (OR: 1.17; CI: 0.76-1.80; p=0.477) or hip OA (OR: 1.04; CI: 0.36-2.99; p=0.938). 
As mentioned before, unemployment seems to be a major channel of exit from work 
for patients with OA (OR: 1.97; CI: 1.27-3.06; p=0.002), in particular for knee OA 
(OR: 2.68; CI: 1.58-4.53; p<0.001. Table 2), and for the youngest (50-57) from the 
sample (OR: 3.47; CI: 1.88-6.41; p<0.001).  
Pain and Disability 
Pain plays a key role in the risk of workforce withdrawal. A strong association was 
seen between pain interference and premature work loss, especially within the knee 
OA population (OR: 1.52; CI: 1.16-1.99; p=0.002). Those who scored worse in pain 
interference were more frequently out of work (Figure 2). In fact, not only the OA 
population was more likely to score worse (p=0.02) in this parameter, but also the 
aforementioned association between knee OA and exit from work becomes non-
significant if only the subset of population with low pain interference is analysed (i.e. 
none to moderate pain interference. OR: 1.55; CI: 0.97-2.48).  
Figure 2 – Pain Affecting Work and Domestic Activities & Early Exit from Work 
 
 
Lines indicate Early Exit from Work (all p-values of Knee OA versus No Knee OA groups are non-significant)  
Bars indicate Pain Interference distribution by intensity levels (p=0.02) with corresponding 95% confidence intervals (vertical 
lines). OA, Osteoarthritis 
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Furthermore, looking specifically at the knee location, more impactful forms of OA 
are strongly related with premature work loss. Using the KOOS subscale scores it 
was possible to observe that knee OA with worst scores on OA symptoms, pain, 
quality of life, ability to perform activities of daily living and function in sport and 
recreation increased the likelihood of individuals being out of work. This particularly 
applies for pain and OA symptoms (Figure 3).  
Figure 3 – Probability of early exit from work according with KOOS subscales Levels 
 
 
KOOS, Knee injury and Osteoarthritis Outcome Score 
 
In addition, knee OA patients with highest levels of disability, measured by HAQ 
(scores ≥ 2) are at the greatest risk of early exit from work (80.7% vs. 67.4% for all 
knee OA population and 51.2% for those with HAQ scores ≥ 2 but without knee OA). 
We estimated an almost linear relationship between levels of disability and the 
probability of early exit from paid employment, with its y-intercept increasing with the 
presence of knee OA (Appendix 3). Similar to what was observed with pain, the 
association between knee OA and exit from work becomes non-significant if only the 
RESULTS – ARTICLE D 
 85 
subset of population with less disability is analysed (i.e. HAQ scores below the 
average of the population [0.38]. OR: 0.74; CI: 0.28-1.99; p=0.552). 
Years of Working Life Lost  
Given the lack of a significant association of hip and hand OA with employment 
status, only knee OA cases were used to measure the productivity loss (i.e. YWLL 
and indirect costs). Thus, we estimated that early exit from paid employment 
following OA work disability led to a total of 143,262 YWLL (84 per 1000 inhabitants). 
Women accounted for 75.3% of these YWLL. The retirement route contributed the 
most for these YWLL (52.3%; 74,957 YWLL), followed by unemployment (39.9%; 
57,210 YWLL) and being on disability pensions (7.7%; 11,095 YWLL). Additionally, a 
total of 130,602 PYWLL were estimated if early retirement is considered and 
338,822 PYWLL (198 per 1000 inhabitants) for all forms of exit from work. The mean 
YWLL and PYWLL inactivity ratios were 10.0% and 23.7%, respectively.   
Indirect Costs 
The estimated annual indirect cost due to premature exit from work attributable to 
OA was €656 million (€384 per capita; €1294 per OA patient and €2095 per OA 
patient out of work). Females contributed with 61.6% of these costs (€404 million), 
but mean per capita indirect costs were larger for OA males (cost per OA male 
patient: €1795 vs. €1102 for females; cost per OA male patient out of work: €2776 
vs. €1817 for females; Figure 4).            
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Figure 4 – Indirect costs per capita in the 50-64 population, per OA patient and per OA patient out of 
work. 
 
OA, Osteoarthritis. 
 
DISCUSSION 
In this study using the first large-scale epidemiological population-based survey that 
evaluated rheumatic and musculoskeletal diseases in Portugal, we found an 
association between clinically confirmed OA and early exit from paid employment. 
However, this relationship was only found for the knee OA (not for hip and hand). We 
estimated that OA might have led to annual indirect costs amounting to 
approximately 0.39% of the national GDP (2013). Females contributed with 61.6% of 
this productivity loss. Males have higher mean OA indirect costs given the higher 
average wages.    
As expected, OA patients are mostly females and older when compared with the 
non-OA population. They have lower levels of education, lower household income, 
significantly self-reported poorer quality of life and a higher number of comorbidities. 
These characteristics may themselves influence labour force participation. In fact, in 
this study we observed an association between premature work loss and lower 
levels of education, marital status (married or widowed), neurologic diseases and 
lower household income. Nevertheless, the association we found between clinically 
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confirmed OA and premature work withdrawal is robust and independent from other 
influencing factors, which is consistent with previous published data.20-31 
OA generates disabling pain pushing the individuals to leave work prematurely. We 
captured pain through several alternative measures (i.e. pain interference and bodily 
pain item from the SF-36 questionnaire, KOOS pain subscale, and self-reported 
longstanding musculoskeletal pain) and, as expected, OA patients consistently 
reported more pain than others without the condition. In addition, we observed a 
straightforward relationship between pain and withdrawal from employment. This is 
consistent with the literature.29,32,33 We also detected that OA patients with higher 
levels of disability, measured by high scores of HAQ, were at the highest risk of early 
exit from paid work. This also aligns with previous research34,35 and with the 
etiological model behind this research, which assumes that OA generates the pain, 
impairment and disability that ultimately may lead to work withdrawal. Thus, we 
confirmed in our research that pain and disability are key factors for job loss driven 
by OA. 
Interestingly, we did not find a statistical association between OA and official early 
retirement (regardless of anatomic location). OA seems instead to drive the labour 
force out of paid employment mainly through unemployment. This is particularly 
evident in the earlier ages. Afterwards unemployment is overtaken by early 
retirement when patients with OA get closer to the official retirement age. We did not 
find the same interplay between age-specific frequencies of retirement and 
unemployment in the non-OA population. Thus, unemployment appears to be the 
predominant first step to irreversible out-of-work state in OA patients, although likely 
not being fully converted into official retirement (in Portugal, under some 
circumstances, unemployment benefit may be converted into the old-age pension), 
since no significant association was seen with this musculoskeletal disorder. It would 
be relevant to further explore if this occurs because labour market policies are 
restricting early retirement in this sort of patients (e.g. formal rejection of early 
retirement applications to Social Security from employees with OA) or if other 
reasons are taking the lead instead. This finding highlights the need to target 
research and integration-oriented policies towards unemployment generated by OA. 
More knowledge in this area may produce employment gains since premature 
retirement restriction policies by themselves are insufficient to mitigate the job losses 
as alternative routes may take place as seen in the OA case. Although 
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unemployment benefits may be time limited, from the societal perspective these 
pathways of early exit from work embody the same economic burden (i.e. identical 
productivity losses) and therefore strategies that simply push individuals from one 
route to another are truly not socially efficient. 
In this nationwide study we estimated a significant number of YWLL due to OA and 
annual indirect costs of €656 million euros (€2061 per patient). Previous research in 
other countries has measured different indirect costs of OA per patient per annum.36-
43 Comparing results of cost-of-illness studies is hampered by discrepancies across 
study designs, case definition, methodological choices, wage levels and source of 
data used.44 Additionally, these cost results vary with time and geography. However, 
there are some common take-home messages: First, the economic burden of OA is 
considerable and closely related to its high prevalence. Second, indirect costs are 
likely to surpass other per patient costs (e.g. drug and other medical costs).45-47 
Third, these costs are also likely to exceed those from other chronic disabling 
conditions. For example, Schofield et al. measured annual losses of arthritis through 
early retirement (approximately 0.7% of GDP)48 superior to other pathologies, such 
as cardiovascular disease,49 diabetes50 and mental conditions.51  
We estimated an even higher number of potential years of working life still to be lost 
if no return to work happens until the official retirement age in the OA population. In 
fact, on average the estimated PYWLL cut by almost a quarter the whole potential 
working life span (i.e. 23.7% of inactivity ratio). This finding highlights the need to 
promote return to work policies, in particularly for the youngest unemployed. Since 
OA is degenerative return to work may became progressively more difficult as the 
disease advances. However, there are options available to reduce pain and 
functional disability (e.g. anti-inflammatory drugs and knee arthroplasty), which allied 
to vocational rehabilitation might allow some OA patients to return to work.52 Cost-
effectiveness evaluations of this sort of interventions should take into account such 
economic offsets. For instance, a recent study estimated significant societal savings 
from all knee arthroplasties performed in the United States.53 On the other hand, this 
type of evaluations concerning non-medical vocational rehabilitation interventions 
are still scarce in OA.12,13 Thus, data from this study can also be important to pave 
the way for cost-effectiveness analysis of such interventions aiming to reduce 
productivity losses caused by OA. 
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This study has several limitations that must be taken into account when interpreting 
its results. First, it may be limited by the cross-sectional design, which does not allow 
for an evaluation of the temporal relationship between onset of OA and time of exit 
from paid employment, which would help in establishing a cause–effect relationship. 
Lack of available national longitudinal data made this limitation impossible to 
overcome. Nevertheless, onset of OA is likely to start before premature exit from 
paid employment and reverse causality is unlikely (i.e. early exit from work as a risk 
factor to OA onset). Second, wages were estimated through official statistics based 
on gender, region and age. Necessarily, this methodology is a rough estimate of the 
individual unit values of production. In particular OA patients are likely associated 
with lower incomes. Still, given the information available, it is the best feasible 
method. Third, due to the cross-sectional design, our results are right-censored, 
leading to likely underestimation of the results (i.e. further exit from work is more 
probable to occur than return to work within the sample until all participants reach the 
official retirement age). Finally, given the richness of the EpiReumaPt dataset we do 
not consider our analysis to be overly influenced by hidden confounding, since we 
used a considerable number of control variables that according to the literature could 
influence exit from work.  
This study has several strengths too. It is based on a large population-based study 
about rheumatic diseases in Portugal. It uses confirmed diagnosis of OA done by 
rheumatologists. To our knowledge, this must be among the few studies focusing on 
indirect costs of OA based on such a representative sample specifically dedicated to 
rheumatic and musculoskeletal conditions, a sample that is likely to accurately reflect 
this particular type of economic impact on society (high external validity). It will 
certainly facilitate future research on the effectiveness and cost-effectiveness of 
interventions targeting reduced work ability due to OA. Unquestionably, this issue 
deserves further attention. Recently, access to early retirement was restricted in 
some European countries that are still lacking integration policies such as vocational 
rehabilitation programs.  Since OA is highly disabling and prevalent, particularly at 
ages near the statutory retirement age, it might well be an ideal area for public 
policies to steer a better balance between restricting early retirement and integration 
policies. Moreover, OA is a musculoskeletal disease where the etiological model 
(from the onset of symptoms/pain to the work disability/withdrawal) may be further 
understood and subsequently disrupted by effective health interventions.  
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In conclusion, this population-based study unveils the impact of the association 
between OA, in particular the knee location, and early exit from paid employment. It 
describes in detail the high economic burden underlying such association. The 
findings justify giving more attention to OA when discussing policies facing the 
ageing of developed countries. The depreciation in the stock of human capital due to 
OA is already extensive and given the demographic and epidemiological trends it 
may get even worse if nothing is done. This research should provide relevant 
evidence for decision makers to prioritize investments in health and policies targeting 
patients with OA. 
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APPENDICES 
Appendix 1 is the same as Appendix 1 from Article C.  
 
 
Appendix 2 -  Quality of Life Results (SF-36 and EQ-5D)  
 
 
ALL  
OA 
Knee 
OA NON-OA 
SF-36 physical function 
(0-100 from worst to best) 65.2 59.7 80.8 (p<0.001)* 
SF-36 role limitations because of physical health problems 59.8 57.7 77.3 (p<0.001) 
SF-36 bodily pain 54.9 51.2 72.6 (p<0.001) 
SF-36 social functioning 80.3 78.7 87.8 (p<0.001) 
SF-36 general mental health 58.8 59.9 69.7 (p<0.001) 
SF-36 role limitations because of emotional problems 71.2 67.2 85.3 (p<0.001) 
SF-36 vitality 51.4 51.1 61.9 (p<0.001) 
SF-36 general health perceptions 47.8 47.3 56.6 (p<0.001) 
SCORE EQ-5D  
(0-100 from worst to best imaginable health state) 0.68 0.66 0.83 (p<0.001) 
SCORE HAQ  
(0-3 from best to worst) 0.64 0.61 0.28 (p<0.001) 
OA, Osteoarthritis; SF-36, Short-Form Health Survey; EQ-5D, European Quality of life Questionnaire.  
*All p values: OA versus non-OA. 
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Appendix 3 – Relationship between disability levels and probability of early exit from work (by 
presence of knee OA). Y-axis: Probability of early exit from work; X-axis: Disability level measured by 
the HAQ Score.  
 
 
A       B 
 
 
 
 
 
 
 
 
 
 
A: Without knee OA; B: With knee OA. 
OA, osteoarthritis; HAQ, Health Assessment Questionnaire. 
The confidence interval consists of the space between the two dashed lines. 
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PART 3 – INTERVENTIONS TO AVOID EARLY RETIREMENT 
ATTRIBUTABLE TO RHEUMATIC DISEASES 
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INTERVENTIONS AIMING TO REDUCE EARLY RETIREMENT DUE TO 
RHEUMATIC DISEASES 
ABSTRACT 
INTRODUCTION: Aging of the population and early retirement translates into 
productivity losses to society. Persistence of working life is crucial to counteract this 
sustainability issue faced by western countries. Musculoskeletal and rheumatic 
diseases (RD) may cause work disability and early exit from work. The objective of 
this article is to review the current knowledge about interventions aiming to reduce 
early retirement of RD patients.                                         
METHODS: We searched PubMed and The Cochrane Library for studies either in 
English or Portuguese between January 2000 and June 2016 that evaluated the 
impact of interventions targeting early retirement in RD patients still at work. We also 
searched for grey literature from Portuguese institutional repositories.          
RESULTS: We identified several published studies testing pharmacologic and non-
pharmacologic vocational rehabilitation interventions. None was specifically identified 
for Portugal. The general low quality of the literature and its inconsistency makes it 
unfeasible to draw definitive conclusions. However, some broad recommendations 
might be outlined. An effective intervention must: 1) act upon different levels (e.g. RD 
patient, workplace), involving several stakeholders (e.g. rheumatologists, 
occupational physicians, employers); 2) prioritize the right patients (e.g. more 
disabling RD); and 3) consider the patients’ role, for instance by including an element 
of patient education and support. Despite the lack of good quality evidence on this 
field, there seems to be a growing interest in the international scientific community 
with several ongoing studies promoting such interventions. This promising data will 
be very useful to set up effective policies.                                                                   
CONCLUSIONS: This article summarizes the current knowledge about the impact of 
interventions to avoid or mitigate early retirement in RD patients. It highlights the 
demand for further research and it also contributes to aware decision-makers about 
the relevance of this topic, particularly in Portugal. 
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INTRODUCTION 
The world has continued to observe an increase in the life expectancy.1 The old-age 
dependency ratio is rising steadily in most western countries, which are currently 
facing a growing economically dependent elderly population.2 In Portugal, for 
instance, in 1980 there were a total of 1.8 million pensions with a ratio of 4 active 
age people per each Social Security old-age pensioner, but now there are over 3.6 
millions pensions (including both the Social Security System and the Public 
Administration Retirement Fund) and a ratio of 2.6.3 Life expectancy at 65 was 13.5 
in 1980, while now it is 19.1.4 At the same time, the median age of retirement 
continues to be below the official age (defined as the age at which women and men 
are entitled to draw a full retirement pension).5,6 
Despite the recent overall increase in the median retirement age, it has been 
increasing at a much slower pace than life expectancy, which leads to sustainability 
problems that will force all countries to take action sooner or later. In fact, a trend 
with early exit from employment is hardly feasible and provides a major challenge to 
social and health policies. In particular, Portugal is already among the oldest 
countries in the world, with one of the highest old-age dependency ratios and it is at 
the forefront of this general problem regarding premature work withdrawal.2 
There are different routes of entry into early retirement, including long-term 
unemployment, disability and pure early retirement.7-11 These pathways lead to the 
same economic outcome: exit from the labour market in the later stages of working 
life and subsequent loss of productivity for society. Thus, temporary forms of 
premature work loss generally pave the way to definitive early retirement. This must 
be taken into account prior to the planning and implementation of possible 
interventions that might adjourn definitive decision of retirement.  
This article reviews the available evidence regarding interventions aiming to reduce 
early retirement due to musculoskeletal and rheumatic diseases (RD). 
METHODS 
The information source used was PubMed, maintained by the US National Library of 
Medicine, and The Cochrane Library (including The Cochrane Database of 
Systematic Reviews, Cochrane Central Register of Controlled Trials, Database of 
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Abstracts of Reviews of Effects, Health Technology Assessment Database). We 
searched for studies either in English or Portuguese between January 2000 and 
June 2016, combining relevant keywords, such as “retirement”, “job loss”, “job 
retention”, “exit from work”, “work participation”, “employment status”, “sick leave”, 
“work disability”, “rheumatic diseases”, “musculoskeletal diseases” and “arthritis”. We 
also searched for grey literature from Portuguese institutional repositories. The 
objectives of this search were specified by the following PICO framework: Population 
- RD adults still at work who experience, or are likely to experience, disability; 
Intervention - Any vocational rehabilitation intervention (pharmacologic and non-
pharmacologic); Comparison – any or other intervention (including the standard 
practice); Outcomes - early exit from work, including early retirement. 
DETERMINANTS OF EARLY RETIREMENT  
The first step to set up effective interventions or even to start research on their 
effectiveness is to understand the bases of early retirement. The literature already 
has comprehensive evidence about determinants of early retirement and/or risk 
factors that might explain the retirement decision. This long list of possible variables 
might be clustered in 5 main domains: financial, occupational, sociodemographic, 
lifestyle and ill-health conditions (Table 1).v Obviously, the precise effect of each one 
of these possible determinants is different for each context. One the one hand we 
cannot expect that a given determinant of early retirement found to be significant in a 
certain country will also be found significant in another country. On the other hand 
determinants identified to influence a specific type of early retirement may not 
significantly affect other sorts of retirement. Furthermore, determinants of early 
retirement may interact. For instance, ill-health may have a relatively smaller impact 
on the hazard of retirement when policies generate strong financial incentives to 
retire early.12 In contrast, policies that create generous disability pension schemes 
are expected to suffer more impact from ill-health on the hazard into early retirement. 
Thus, it is of paramount importance to frame the research into the exact setting in 
which one wants to intervene. Available literature may be useful to guide the overall 
strategy, but context-specific data is absolutely required to design effective actions 
aiming to put off early retirement.  
                                            
v Table 1 from the General Introduction section. 
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Finally, it is worth noting that some qualitative studies identify other relevant factors 
affecting early retirement related with the individual’s perception and experience 
towards the environment, such as conflicts at work, the wish to do other things 
outside of work, enjoy life, have more flexibility, spend more time with a spouse or 
grandchildren, and care for others.13 This brings an additional layer of complexity to 
this social problem that ideally should not be forgotten when defining effective 
interventions. 
ILL-HEALTH AND RHEUMATIC DISEASES’ IMPACT 
Although the effect of health status on early retirement has long been recognized, 
that effect is not always straightforward due to the interdependence with other types 
of determinants. For instance, chronic diseases, such as RD, may play a key role on 
early retirement because they might be prevalent and disabling, affecting daily 
functioning,14,15 which is particularly relevant for occupations where working 
conditions cannot be modified or adjusted to a reduced work ability of employees.16-
18. In fact, studies have already shown that the presence of certain chronic disorders 
is associated with a premature departure from the labour market.19-21 However, 
some other studies have suggested that employees with chronic disorders tend to 
retire later because they likely have accumulated fewer assets during their working 
life, the so-called wealth effect.22 Once again, the role and the effect of ill-health in 
early retirement is far from being the same across all contexts.  
A lot remains to be understood about the relationship between ill-health and early 
retirement and the possible influence of the social context and other factors on this 
relationship. Moreover, since health status encompasses a broad array of underlying 
clinical conditions, it is also of interest to assess how specific symptoms and chronic 
conditions are affecting withdrawal from the workforce. Previous research has 
suggested associations of exit from paid employment with diseases like cancer,23 
heart disease,24 depression,25 disorders of the nervous system,26,27 and others.20,28,29 
The association with RD is particularly interesting. These diseases are highly 
prevalent in the western world and their clinical and functional impacts may be 
profound, representing major causes of disability among workers, particularly on 
manual-workers, who are exposed on average to harsher working conditions. Thus, 
workforce participation among patients with RD has received considerable attention. 
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Disability and productivity costs are very high, estimated at up to 4 times greater 
than direct RD healthcare costs.30-34 This is of particular concern because RD, such 
as osteoarthritis, are projected to increase in prevalence, in part because of the 
ageing of the population, but also due to lifestyle factors, such as lack of physical 
activity and obesity.35-37 
Some studies have analysed the RD effect on early retirement,20,38,39,40 but 
unsurprisingly its isolated role is also context-dependent and influenced by the 
evidence source itself, reflecting differences on the type of study performed, the 
population under study and the explanatory variables included in the analysis.  
However, regardless the context and the exact magnitude of the effect of RD on 
early retirement there is a theoretical underlying etiological model, which is depicted 
in Figure 7.vi RD usually generates pain and impairment, which in turn may lead to 
disability and ultimately to work withdrawal. In each step of this general model there 
are influencing factors, at least some of which may be changeable to some extent 
(e.g. pain control and disease activity). Thoroughly comprehension of this model is 
crucial to plan effective interventions to reduce RD-related early retirement.  
Earlier studies were targeted to help disabled RD patients return to work (i.e. 
focusing the very end of the etiological model). However, in general, once people are 
unable to work they are unlikely to re-enter the workforce. This irreversibility is likely 
to be particularly true for progressing disabling conditions, such as RD. Therefore, 
emphasis has recently shifted towards employment loss prevention (i.e. acting on 
the earlier steps of the etiological model). It is better and easier to prevent premature 
work withdrawal than to deal with it after it occurs.42 Our article focuses on studies 
that tested specific interventions following this principle. Nevertheless, it is worth 
noting that interventions targeting return to work may also be effective. This can be 
particularly true for those recently on sick leave, since there is a strong association 
between increased length of sickness absence and increased risk of taking a 
disability pension.43 In fact, a recent review has found that some workplace 
interventions reduced time to (first and lasting) return to work among workers with 
RD on sick leave more than usual care.44  
 
                                            
vi Figure 7 from the General Introduction section. 
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INTERVENTIONS AIMING TO REDUCE EARLY RETIREMENT 
Vocational rehabilitation (also called occupational rehabilitation or work rehabilitation) 
is directed to employment outcomes and it can be defined as ‘a process to overcome 
the barriers an individual faces when accessing, remaining, or returning to work 
following injury, illness, or impairment’.45,46 Vocational rehabilitation may include 
medical and non-pharmacological management of the condition, assessment of 
needs, work adjustment and control measures, disability awareness training, 
retraining and capacity building, and support for the individual, employer, or 
others.45,46 In fewer but more pragmatic words, vocational rehabilitation is whatever 
aids someone with a health condition to return and/or remain at work. Therefore, it 
encompasses all interventions that have these outcomes as their primary aim.  
This is in fact the main distinction from the traditional ‘treatment’ intervention, which 
has the primary goal of treating pathology and/or relieving symptoms. This may be 
sufficient to enable the person to continue or return to work, but that is an indirect or 
secondary outcome. Vocational rehabilitation instead is directed to improving 
capability for work and secondarily may lead to improvement of symptoms and 
disease control. 
Despite the fact that vocational rehabilitation should be individualized in order to 
meet the needs of the person it is not a matter for healthcare alone. It commonly 
requires a combination of healthcare and workplace assessments, to address the 
health problem and work issues and therefore such interventions can be targeted at 
a range of levels: individual (e.g. pharmacologic therapy, job coaching and training, 
vocational counselling; empowerment for work, self-management), environmental or 
organizational (e.g. work adaptations, ergonomic measures, job accommodations; 
interventions targeted directly at the employer).47,48 The basic assumption is that 
productivity will be improved when individuals are well matched to the inherent 
requirements, often referred to as person-environment fit.49 Therefore, it should 
require a multistakeholder approach - the individual, the employers and the 
healthcare professionals - working together with a common goal. 
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PHARMACOLOGIC INTERVENTIONS 
Pharmacological interventions for RD aiming to decrease pain and inflammation may 
have an impact on work participation and, in the long run, in the early withdrawal 
from employment. This may be through their effect on disease activity, pain or 
physical function, which are all known predictors of work disability.50,51 
Pharmacologic interventions are disease-specific, mainly rheumatoid arthritis (RA), 
and can encompass drugs (e.g. anti-TNF therapy) or treatment approaches (e.g. 
intensive treatment regimen). Below are some of the studies that tested the impact of 
pharmacologic interventions on early exit from work, including early retirement: 
• In 2003, Yellin E et al. interviewed 497 American RA patients of working age (18–
64 years) about their employment status in the year of diagnosis and as of the study 
year. Among RA patients who had been employed at the time of diagnosis, those 
from the etanercept clinical trials were more likely to be employed at the time of 
survey. Moreover, the authors found that after adjustment for relevant factors having 
been in the etanercept clinical trials was associated with higher employment rates.52  
• In 2004, Puolakka K et al. analysed the impact of initial aggressive drug treatment 
with DMARDs versus therapy with a single DMARD in the prevention of work 
disability in patients with early RA. 195 patients were randomly assigned to receive 
either combination therapy with DMARDs (sulfasalazine, methotrexate, 
hydroxychloroquine) plus prednisolone or single therapy with a DMARD with or 
without prednisolone. After 2 years, the drug treatment strategy was no longer 
restricted. At baseline, 162 patients (80 in the combination-treatment group and 82 in 
the single- treatment group) were still working or at least available for work. After 5 
years of follow-up the authors found a positive impact with initial aggressive drug 
treatment in terms of lost productivity - including sick leave and employment loss, 
either temporary (unemployment) or permanent (disability pensions and retirement). 
However, this benefit was mainly due to the differences in sick leave. In fact, no 
statistically significant differences were seen in the take-up of disability pensions or 
early retirement.53  
• In the same year, Kobelt G et al. observed a slight increase in the work capacity 
(from 31% to 33%, based on the proportion of patients on full time work) of 160 RA 
patients under 65 treated during the first year with either etanercept or infliximab in 
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four rheumatology units in southern Sweden. However, 2 patients retired during that 
period of time increasing the proportion on retirement from 14.5% to 16.2%.54  
• In 2006, Smolen JS et al. verified that the proportion of patients whose status 
changed from employable at baseline to unemployable at week 54 was smaller in 
722 RA patients receiving methotrexate plus infliximab compared with 282 RA 
patients receiving methotrexate alone (8% versus 14%; p=0.05).55  
• In 2007, Wolfe F et al. examined the effect of anti-TNF therapy on work disability 
using data from the National Data Bank (NDB) for RD. They studied 3886 patients 
with RA who were employed at study entry, of whom 1986 received and 1900 did not 
receive anti-TNF therapy. After adjustment for demographics, RA severity, and 
comorbidity the authors did not find that anti-TNF therapy was associated with the 
reduction of self-reported employment loss. However, these results might be 
hampered by a number of limitations, including the study design (non-randomized) 
and the study population (<61 years old).56   
• In 2008, Allaire S et al. using a nested, matched, case–control approach in a large 
cohort of rheumatoid arthritis patients (NDB) observed no protection of anti-TNF 
therapy against any or disease-attributed employment loss. However, a protective 
effect was found for users with shorter disease duration (<11 years. OR 0.4, 95% CI 
0.2-0.9).57  
• In the same year, Cole JC and colleagues, re-examined data from 2 clinical trials 
[one for RA methotrexate failure patients (n=652) and another for RA severe anti-
TNF failure patients (n=391)] and found a significant reduction in the likelihood for 
early exit from work with abatacept treatment compared with placebo (at 6 months, 1 
year and 2 years).58  
• Also in 2008, Bejarano V et al. published results from a randomized controlled trial 
(RCT) reporting positive results on reduced employment loss for a 56-weeks period 
following treatment with adalimumab plus methotrexate.59  
• Similarly, a year later, Halpern MT et al. have shown in an open label extension 
study that patients with RA who received adalimumab experienced considerably 
longer periods of work and continuous employment. Thus, during a 24-month period, 
158 patients who received adalimumab worked 2 months longer (95% CI 1.3-2.6) 
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and were significantly less likely to stop working than did the 180 patients treated 
with DMARDs (HR 0.36, 95% CI 0.15-0.85).60  
• In 2010, Augustsson J et al. using data from the Stockholm anti-TNF follow-up 
registry concluded that biological therapy is associated with increases in workforce 
participation in patients with RA.61 Similar results have been obtained in another 
Swedish register for ankylosing spondylitis.62   
• In the same year, Verstappen SM et al. using a large British RD registry (BSRBR, 
British Society for Rheumatology Biologics Register) found that compared with the 
use of conventional DMARDs, the use of anti-TNF did not prevent patients with RA 
(n=3291) from not working due to ill-health/disability (adjusted OR 0.80; 95% CI 
0.36-1.81; P=0.596). However, RA patients in the anti-TNF group who were in 
remission 6 months after commencing anti-TNF therapy were less likely to exit work 
3 years after inclusion in the register.63  
• Still in 2010, van Vollenhoven RF et al. showed that the likelihood of gaining/ 
retaining employment over 2 years’ treatment in early RA patients was greater for 
the combination therapy of abatacept plus methotrexate (n=219) than for the 
methotrexate alone (n=214. OR 1.53, 95% CI 1.04–2.26).64  
• In 2013, Eriksson JK et al. in a randomized controlled open-label trial observed 
radiological superiority of biological compared with conventional combination therapy 
which did not translate into better work loss outcomes (i.e. monthly sick leave and 
disability pension days 21 months after randomization) in patients with early RA who 
had experienced an insufficient response to methotrexate.65  
• More recently, in 2016, the same author and colleagues compared the long-term 
employment loss in methotrexate-refractory early RA patients randomized to addition 
of infliximab or conventional combination treatment. Of 210 working age patients, 
109 were randomized to infliximab and 101 to conventional treatment. After over 7 
years of follow-up in real world clinical practice, the authors observed that, compared 
to the year before randomization, exit from employment of these patients improved 
significantly, with the largest improvement during the first 3 years. However, no 
difference was detected between strategies, and the level of work loss days 
remained twice that observed in the general population.66  
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• In the same year, Olofsson T et al. using the Swedish Biologics Register, after 5 
years of follow-up, observed a substantial decrease in work loss (i.e. mean monthly 
days lost and accumulated employment loss) of RA patients with high and moderate 
disease activity treated with anti-TNF.67  
Many other studies explored other work-related outcomes (e.g. surrogate markers) in 
RD following pharmacologic interventions.68-83  
The inconsistencies in the literature regarding the effect of pharmacologic 
approaches upon early retirement and overall early exit from work highlights the 
demand for further research and also the already mentioned need to address this 
topic at different levels, effectively targeting the person-environment fit.  
NON-PHARMACOLOGIC INTERVENTIONS 
The evidence in the currently available literature is insufficient to make definitive 
recommendations for policymakers, health professionals and others concerning non-
pharmacologic interventions. Levels of evidence quality are relatively low and 
findings so far are inconsistent. It is true that this derives, at least partially, from the 
fact that the determinants and the factors, which affect RD-related employment loss 
and early retirement, differ according to the context under study. In addition, the vast 
heterogeneity of the interventions analysed makes it extremely difficult to set a 
common ground for recommendations or standard approaches ready to be applied 
for all environments and disease models. However, this inconsistence also finds its 
own roots in the quality of the studies that originated the current evidence (overall 
very low to moderate GRADE score).84,85 
A recent systematic review by Oakman J et al.48 was undertaken to analyse what are 
the most effective interventions to remain productively employed for those with 
persistent musculoskeletal pain, a unifying characteristic across the vast majority of 
rheumatic conditions. The review concluded that low numbers of participants and 
limited studies resulted in a low grading of the evidence and that further research is 
required to ensure that effective workplace interventions are developed. Previously, 
Palmer KT and colleagues86 reviewed the effectiveness of interventions in 
community and workplace settings to reduce sickness absence and employment 
loss in workers with musculoskeletal disorders and also found studies typically small 
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(median n of 107) and limited in quality. Although they measured a significant 
positive median relative risk of 1.25 for the identified interventions aiming to avoid 
musculoskeletal-related work withdrawal, the effects were smaller in larger and 
better-quality studies, suggesting publication bias. Of note, this review also 
highlighted that no cost benefit analyses identified an intervention with statistically 
significant net economic benefits.86 
A vast amount of studies focused on interventions aiming to facilitate return to work 
after sickness absence of employees with low back pain. However, there is already 
some data for other RD (e.g. chronic arthritis) and with other occupational outcomes 
as well, such as early retirement. Below one can find the list of the most relevant 
studies performed in this area (some studies also have a pharmacologic 
intervention): 
• In 2003, Allaire SH et al. made a RCT with 48 months of follow-up undertaken to 
determine the efficacy of vocational rehabilitation, which consisted of 3 components: 
job accommodation, vocational counselling and guidance, and education and self-
advocacy. The job accommodation component consisted of an assessment of 
possible health-related work place barriers to job performance (e.g. difficulty 
handling objects, working the required number of hours, or doing repetitive tasks) 
and development of solutions to the barriers that participants had identified. In the 
vocational counselling and guidance component, the counsellor and participant 
evaluated the individual’s job in light of his or her RD. If problems were foreseen, 
possible job alternatives, requirements, and relevant resources were identified. In 
addition, the counsellors conveyed positive messages about each participant’s ability 
to work. In the education and self-advocacy component, information about legal 
rights and responsibilities (such as the employee’s responsibility to request 
accommodation when needed), guidance regarding disclosure issues, and skills 
training to increase the participant’s ability to request a job accommodation in an 
appropriate manner were provided. The counsellors also gave the participants in the 
experimental group documentation about how to manage health-related employment 
problems and about other available resources. A total of 242 patients with RD 
residing in Massachusetts, USA at risk for job loss were recruited, 122 for the 
experimental group and 120 for the control one. Employment withdrawal was 
delayed in the experimental group compared with the control group. After adjustment 
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for potential confounders, participation in the experimental group was found to be 
protective against temporary or permanent work loss (OR: 0.58, 95% CI 0.34–
0.99).87  
• In 2005, Abásolo L et al. analysed the effect of a specific program, run by 
rheumatologists in Spain, in which care was delivered during regular visits and 
included 3 main elements: education, protocol-based clinical management, and 
administrative duties. Thus, the visits were structured following specific proceedings 
for the different diagnoses, which included education (e.g. instructions about the 
diagnosed RD and due self-management), pharmacologic (treatment of pain, 
inflammation, anxiety and depression) and non-pharmacologic treatment, and timing 
of diagnostic tests in a stepwise manner. 13,077 patients were included in this RCT, 
7805 in the control group and 5272 in the intervention group. The program was 
highly efficacious in several occupational outcomes. In particular, fewer participants 
in the intervention group were permanently work disabled or took early retirement 
after 4 years.88,89 
• In 2005, de Buck PD et al. conducted a RCT within the region of Leiden, the 
Netherlands to investigate the effectiveness of a multidisciplinary job-retention 
vocational rehabilitation program in RD patients at risk for job loss, consisting of a 
systematic assessment followed by education, vocational counselling, guidance, and 
medical or non-medical treatment. The program was delivered by a multidisciplinary 
team comprising a rheumatologist, a social worker, a physical therapist, an 
occupational therapist and a psychologist. An occupational physician was also 
connected to the team and the organization of the program was in the hands of a 
coordinator. The basic assessment was performed by a rheumatologist (current level 
of disease activity and joint destruction, presence of extra-articular manifestations or 
comorbidity, and extent and severity of activity limitations; prognosis regarding future 
impairments and activity limitations) and the coordinator (education level and 
previous jobs; systematic registration of the problems encountered in the current 
working situation, using a list of potential challenges and psychosocial situations). If 
necessary, additional team members were asked to see the patient to gather more 
information about specific aspects of the work situation. Depending on the specific 
problems of the individual patient, the intervention further consisted of education 
(such as providing written and oral information about the social security system 
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regarding sick leave and work disability), counselling and guidance (such as the 
identification of resources for adapting the work environment or work hours, 
promotion of work self-efficacy), or treatment (such as adaptation of the medical 
treatment in consultation with the referring rheumatologist, exercise therapy, 
occupational therapy, functional training of relevant activities, or mental restoration). 
All patients made at least 2 visits to the hospital in connection with the job-retention 
vocational rehabilitation program and the total duration of the intervention varied, and 
lasted 4 to 12 weeks. A total of 140 patients with a chronic rheumatic condition were 
randomly assigned to either this vocational rehabilitation program or usual outpatient 
care. In contrast with the previous studies and despite the comprehensive 
intervention, the authors observed no difference between the 2 groups regarding the 
proportion of patients having lost their employment at any time point, with 24% and 
23% of the patients in the vocational rehabilitation program and outpatient care 
groups, respectively, having lost their work after 24 months. This could be at least 
partly explained by the studied population being composed by ~40% of patients 
already on sick leave at baseline, many of them longer than 6 weeks. Long-term sick 
leave usually indicates substantial limitations in work capacity and often precedes 
permanent work disability. Of note, this study found significant less fatigue in the 
intervention group, which in turn is expected to lead to more employment 
maintenance in the long run.90 The authors emphasized that there was still plenty 
rationale for the future development and evaluation of vocational rehabilitation 
programs, in particular the need for early identification of RD patients at risk for work 
disability, namely through the broad implementation in the clinical setting of 
rheumatologic care of instruments to measure work disability.91 Later, in 2007, van 
den Hout WB and colleagues aimed to estimate the cost-utility of this vocational 
rehabilitation program and concluded that its costs (€1,426 per patient, of which 20% 
were time and travel costs incurred by the patients) were outweighed by total 
savings on other health care (consultations, hospitalizations, or home nursing care) 
and non-health care costs (aids and appliances, productivity costs, or home help and 
informal care), but not significantly.92   
• In 2011, Varekamp I et al. studied the effect of an employment maintenance 
program for employees with chronic disease (25% with RD). This group-training 
program consisted of six three-hour sessions every two weeks, with a seventh 
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session two months after the sixth. This was combined with three individual 
counseling sessions. It had an empowerment perspective with the aim of enhancing 
the knowledge, self-awareness and skills (especially communication skills) of the 
individuals, in order to help them solve problems at work. Participants were randomly 
assigned to the intervention (N=64) or control group (N=58) and after 24 months of 
follow-up no statistical differences were observed regarding employment 
maintenance, which remained high in the whole group resulting in too low power to 
show any significant changes. Alike de Buck PD et al91 the authors observed less 
fatigue in the intervention group.93  
As mentioned above, the overall quality of these studies is low, namely due to risk of 
bias, inconsistency and imprecision,94 which also highlights the need for further 
research on this important topic. Other studies are currently ongoing to evaluate the 
effectiveness of specific interventions on employment retention of RD patients.95,96    
On the other hand, some studies have already reported the effect of non-
pharmacologic interventions in more temporary occupational outcomes, such as sick 
leave,97 or surrogate markers of early retirement, such as assessments of function 
and work ability.98-104 Some scales have been developed specifically to measure 
work ability in RD patients.105  
DISCUSSION  
Many studies have been conducted about interventions aiming to achieve successful 
outcomes in terms of RTW of workers with RD, however emphasis has shifted 
towards employment maintenance rather than the more likely irreversible exit from 
work. This article focuses on interventions to avoid early retirement while RD 
patients are still at work. There seems to be more consistent data on the positive 
effects of pharmacologic interventions than on the non-pharmacologic ones. Many 
reasons may explain this, namely the very nature of the interventions themselves. 
Non-pharmacologic job vocational activities vary immensely and its effectiveness 
may be difficult to replicate in different settings. Pharmacologic interventions may 
lower RD activity and cease pain and impairment, which in turn interfere with work 
disability and early retirement. It is therefore of the utmost importance that RD 
patients are effectively treated with the most appropriate pharmaceutical approach. 
Obviously, this judgment must always be done by the rheumatologist who needs to 
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decide on a case-by-case basis among the available treatment options. On this 
regard, the current trend to expand the rheumatology referral network in Portugal 
may bring significant productivity gains by allowing the system to effectively address 
the problems systematized in the etiologic model presented in this article and 
thereby avoiding early retirement caused by RD. Unquestionably, in order to ensure 
optimization of this network, effective identification and referral of RD patients at risk 
of job loss requires alignment with the primary care (i.e. general practitioner and 
occupational physicians).   
Despite the overall inconsistence and low quality of information, some studies have 
already shown promising results for the non-pharmacologic interventions. For 
instance, the work done by Lydia Abásolo and colleagues88 is being highlighted by 
the Fit for Work Europe initiative, which produced estimates about the effects of 
repeating this intervention in other European countries. Thus, extrapolating this data 
for all 28 Member States, the total estimated number of additional EU workers who 
would be available for work each day would be one million.106 The ultimate 
occupational outcome from successful interventions might be so large that justifies 
on the one hand further research on the topic and on the other to take the risk to 
intervene even when uncertainty still remains about its effectiveness. The inertia on 
this field is already too costly and certainly the early retirement scenario is not going 
to improve if nothing is done otherwise. Of course, the decision should always 
depend on the budget required to implement a given job vocational program and due 
opportunity costs (i.e. the costs of the alternatives that must be forgone in order to 
afford a given intervention). On this regard, taking advantage of geographically or 
historically closed stakeholders might be a key success factor, by sharing costs and 
leveraging synergies and economies of scale. For instance, job vocational programs 
agreed upon by large employers and the nearest rheumatology department in a 
certain region could be a cost-effective starting point – to build the proof-of-concept 
of a given protocol and to pilot a broader national policy targeting early retirement in 
RD patients. Surely, such programs, if possible, should go along with longitudinal 
prospective studies in order to measure the occupational outcomes and their levels 
of cost-effectiveness.  
In order to increase the likelihood of success of such interventions, some guidance 
can be drawn from the current literature. First, well-planned interventions should aim 
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different levels (e.g. RD patient, workplace) and should foster lean communication 
and alignment of all involved actors (e.g. rheumatologists, occupational physicians, 
employers). A coordinator could integrate all aspects of such multilevel and 
multidisciplinary intervention in order to better guarantee the person-environmental fit 
by orchestrating distinct roles and responsibilities; second, prioritizing the right 
patients can substantially increase the likelihood of success of a given intervention. 
RD patients at risk of job loss (e.g. longer duration of disease, high self-reported pain 
and disability measured by the health assessment questionnaire) can be prioritized 
leading to better and faster occupational outcomes; third, interventions should 
consider the patients’ role and include an element of patient education, coaching and 
support to enable them to play an active part in the management of their condition in 
the workplace and also improve their self-efficacy perception.    
Some steps have been taken in Portugal regarding this issue, namely the Portugal 
Apto.PT (Fit for Work Portugal),107 however more political engagement should take 
place to ensure impactful nationwide policies and interventions targeting RD-related 
retirement. Hopefully, this article can also contribute to make politicians and other 
relevant decision-makers aware of the relevance of this topic and the possible 
solutions that can be, at least partially, replicated in Portugal.  
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GENERAL DISCUSSION 
In this study, we found that in Portugal self-reported RD and clinically confirmed OA 
are associated with early retirement and broad early exit from work, respectively. 
These associations translate in many years of working life lost as well as high 
indirect costs to society.  
Early retirement is likely to decrease the income and wealth of the individual, places 
a burden on government due to the lost income taxation revenue, the net increase in 
benefit retirement payments and translates into a great burden to society due to its 
concomitant productivity loss. Early retirement has become a serious problem 
among the so-called developed countries, which have continued to observe an 
increase in the overall life expectancy and in the share of the population that is made 
of economically dependent elderly people. The old-age dependency ratio is 
progressively growing and early retirement worsens this sustainability problem of 
modern societies. Portugal already has one of the worst old-age dependency ratios 
in Europe and therefore in-depth knowledge about this issue is crucial for the future 
of our country. In addition, it might also represent a case study and a useful 
reference for policies to be undertaken elsewhere, in countries similar from a 
socioeconomic and epidemiologic perspective, such as other Southern European 
countries. Nonetheless, given the complexity and the multifactorial nature of this 
social concern, it might be impossible to have an absolutely identical paradigm 
across all different contexts and environments. Learnt lessons from elsewhere are 
important and worthy of attention, but should always be taken carefully. Moreover, 
different studies, which necessarily have different designs, quality and data sources 
will deliver further heterogeneity on this subject.  
Many factors may rush retirement decisions in individuals. They can be of completely 
dissimilar nature. Some are financial whilst others are health-related. These 
determinants may influence positively or negatively and certainly may interact and 
depend on each other. A given disease, for instance, may push patients away from 
the labour market within a specific legal and financial framework, whilst being 
innocuous in another environment.      
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Ill-health determinants are of particular interest. Most disabling conditions may have 
their progression deferred. Early and effective diagnosis and treatment may 
significantly improve patients’ work participation. On the other hand, universal health 
coverage allows interventions regardless of socioeconomic status, which is 
something untrue for other factors. Also, many diseases (e.g. cancer) are more 
valued by society and employers than other factors (e.g. marital status or lifestyle 
factors), causing more understanding and potentially more action to help sick 
employees willing to remain at work. Undoubtedly, this latter consideration does not 
apply to all diseases, particularly those still stigmatised by society, such as AIDS or 
mental diseases. Finally, many interventions may target illness even at its later 
stages. In this respect, ergonomic work adaptation to support disabling patients is a 
growing field. The obvious potential economic gain makes research in this area 
particularly appealing for countries concerned with long-term sustainability issues. 
However, in general and mostly due to the recognized complexity of this subject, it 
has been difficult to draw any satisfactory conclusions concerning specific 
interventions with the aim of increasing work participation.         
The impact of ill-health on premature retirement has been observed in many 
diseases, such as cancer and heart disease. RD, as a whole, are widely prevalent 
and disabling. Many studies have been performed in order to assess the relationship 
between exposure to these disorders and premature job loss. The heterogeneity 
around this presumed causal chain makes it hard to reach a final conclusion, namely 
by exactly defining the strength of the association. For example, rheumatic patients 
tend to be less educated and to be of lower socioeconomic status. This fact per se 
influences the likelihood of being or not in the labour market. This is why it is so 
important to consider several potential confounders. Interestingly, work itself may 
harm the individual and cause or deteriorate musculoskeletal symptoms, meaning 
that for some cases RD are an intermediate step between being at work and exiting 
from it. For instance, there might be a bidirectional relationship between OA and 
work. On the one hand, several aspects of physical workload have been identified as 
risk factors for developing knee and hip OA (e.g. kneeling work positions, jumping, 
and heavy lifting). 209  On the other hand, people who have OA may perceive 
difficulties in performing work. Regardless the exact origin of a given disabling RD, 
these are medical conditions of great interest for this type of research. RD 
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progression can be adjourned in most situations and certainly its impact in work 
participation. Without any doubt RD are a very good model for research and 
interventions aiming to diminish early retirement.       
This work has used two primary large nationwide datasets: First, the National Heath 
Survey of 2005-2006 (INS); and secondly, the Portuguese epidemiologic study on 
rheumatic diseases of 2011-2013 (EpiReumaPt). Both enabled a fruitful research 
considering several possible confounders of different nature, whilst at the same time 
granting national representativeness from their samples (external validity). Over half 
a decade separates these cross-sectional surveys, a condition of added value to this 
analysis, because it allowed addressing the same topic in different time points 
associated with dissimilar macroeconomic and social contexts despite the same 
geographic and cultural references. Of special note, INS refers to a period in time 
before the Portuguese sovereign debt crisis, which brought socioeconomic changes, 
while EpiReumaPt refers to a posterior moment. It is therefore interesting, for 
example, to observe how the association between RD and formal premature 
retirement has evolved through this austerity period. Other differences can be 
emphasized. For instance, within these time points the National Program Against 
Rheumatic Diseases 2004-2010 was implemented in our country,49 a national effort 
and contribution for the worldwide Bone and Joint Decade 2000-2010 endorsed by 
the WHO,10 which is expected to have helped referral and treatment of RD. Also, 
access to specific rheumatic innovative drugs (e.g. anti-TNF therapy) has emerged 
substantially, thereby producing better disease control and less progression of 
particular disabling forms of RD, such as RA. Using both surveys data did not only 
serve the purpose of comparing different temporal points, but also, and perhaps 
more importantly, allowed to look at the same problem from a different angle. In fact, 
while INS was an appropriate data source as a first approach to understand the 
relationship and impact of RD on early retirement (after adjustment to general 
cofactors), EpiReumaPt allowed the analysis to use some RD-specific data (e.g. 
KOOS) and some other information specific to the adopted model (e.g. pain, 
disability and RD-caused early retirement). It also allowed narrowing the research on 
a particular prevalent and disabling form using clinically confirmed data (i.e. OA).  
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This thesis uses self-reported and clinically confirmed data, from which several 
advantages and disadvantages may be listed. Clinically confirmed data is obviously 
a great source of valid information. It refines the case definition of the studied 
exposure variable and may deliver RD-specific clinical data of significant relevance. 
However, taking in consideration the ultimate goal of this research, which is to 
provide practical and lean orientation to identify and act upon employees at-risk, 
clinically confirmed data may not be always the most adequate starting point, 
particularly for regions and people with difficulties accessing specialized medical 
appointments (e.g. manual workers from rural areas of Portugal). Thus, one cannot 
exclude the usefulness of self-reported data, in particular for some of the types of 
subject under analysis. Self-report is one of the most widely used methods of 
collecting information regarding individuals’ health status and utilization of healthcare 
services.210 Several cost-of-illness studies on RD have used self-reported data in the 
past.75,79,211,212  
The relatively recent development of patient-reported outcomes throughout many 
fields of health research also reveals the recognition of the importance of self-
reported data. Certainly, this sort of data may be vulnerable to misclassification bias, 
but in the case of this study, self-reported RD is more likely to comprise a subset of 
more severe RD cases (possibly underlying the higher HAQ scores and worse EQ-
5D and SF-36 scores observed in this group when compared with the whole 
EpiReumaPt’s clinically confirmed RD group. Appendix 2), rather than including non-
RD cases (over 94% of those who self-reported RD in the EpiReumaPt sample had 
their RD diagnosis clinically confirmed by the rheumatologists). Consequently, self-
reported data, in particular the one used to define the exposure variable of this study 
didn’t include too many false positives (i.e. self-reported RD has high specificity 
[79.9%] and very high positive predictive value [94.9%]. See Appendix 3) and may in 
fact represent a reliable proxy of disabling RD, predominantly composed by more 
severe and advanced disease stages (of note, it delivered many false negatives and 
therefore relatively low sensitivity [49%] and very low negative predictive value 
[17.1%] [Appendix 3] because it misses many less severe RD forms otherwise 
identified by rheumatologists in the last stage of EpiReumaPt, who found a 
prevalence of over 73% of RD in this age-group).  
GENERAL DISCUSSION 
 126 
Most importantly and as already alluded, from a more pragmatic point of view and 
given the explored field, self-reported data can be of special interest for policies 
targeting early retirement on the grounds of ill-health. For instance, it may encourage 
fast and easy identification of vulnerable RD employees. Clinical confirmation of RD 
diagnosis might happen too late for any action aiming to avoid exit from work. Thus, 
despite the need for a final RD diagnosis by a rheumatologist, self-reported 
information about RD should be considered prior to further and more complex 
measures. It may well trigger a faster and more efficient way to detect at-risk RD 
employees than what can be expected from the national health system as it is, 
where gaps in the identification and treatment of RD have been observed.84,85 
Despite all this, obviously we have to recognise the flaws and limitations of self-
reported data when taking conclusions from this study. In addition, we considered 
important to use clinically confirmed data when dealing with specific RD forms, such 
as OA. OA is a frequent and sometimes misdiagnosed condition. It can be easily 
confused with other conditions by the patient, hence further endangering self-
reported data. From an interventionist viewpoint, this disease might be detected 
earlier and managed by the general practitioners. Therefore, widespread access to 
diagnosis and treatment to avoid work disability can be achieved much easier when 
compared with many other rheumatic forms.  
This research was based on large and representative samples of the Portuguese 
population approaching the statutory age of retirement and suggests an association 
between RD and early retirement. RD play a key role in pathways of early retirement 
– first, at younger ages, it seems to affect predominantly more temporary forms of 
exit from work, such as unemployment and then more permanent forms, such as 
official early retirement. In 2005/2006, using the INS database we verified that 
almost half of the studied age-range of the Portuguese population (45.1%) was out 
of work (since then this figure worsened. In the EpiReumaPt 2011/2013 we observed 
more than half of the population in this situation). This group was more likely to have 
a RD than the remaining population (38% vs. 30%, respectively; p=0.02). In fact, in 
the INS survey more than half (52.6%) among those who self-reported to be 
suffering any kind of RD were not employed. It is true that RD itself may be 
associated with occupational risk factors (e.g. low educational level and 
comorbidities), however the relationship between RD and early exit from work 
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remains statistically significant when controlling for relevant confounding (OR 1.31; 
95% CI 1.12-1.52). Not surprisingly, in this study we also observed other factors 
linked with the studied outcome. Lower educational level and poorer household 
income are independently associated with early exit from work. The latter does not 
remain significantly associated to premature retirement when controlled for other 
cofactors. Anyway, conclusions about this cofactor should be taken carefully 
because the outcome (early retirement) itself directly and immediately interferes with 
it, since at least one of the household members had the income reduced due to early 
retirement penalties. Interestingly, comorbidity seems to play a more significant role 
in early retirement, rather than the more general outcome of early exit from work. In 
the EpiReumaPt survey almost half of those who retired prematurely said it was due 
to disease. Major comorbidities may be more influential in permanent forms of work 
withdrawal (i.e. early retirement) than in temporary ones (i.e. unemployment). It 
makes sense to expect that comorbidity may be less influential in the retirement 
pathways that are strongly dictated by external factors, such as the case of 
unemployment. This observation is corroborated by previous research.126,165 The 
female gender appears to have a negative effect on early exit from work, while male 
gender is more associated with early retirement and unemployment. This difference 
may lay on the fact that homemakers (mainly women) were included in the broader 
group of early exit from work. If this is the case, among the employed population, 
men are exiting work more often than women. Indeed, using data from the 
EpiReumaPt survey we observed a worse effect of male gender in official early 
retirement (although female gender was more associated with early retirement due 
to RD). 
In spite of the differences of the time points of both surveys, our analysis using 
EpiReumaPt dataset retrieved results generally consistent with the INS ones. In 
particular, we observed a similar strength of association between RD and early 
retirement (INS: OR 1.24; 95% 1.01-1.52 vs. EpiReumaPt: OR 1.37; 95% CI 1.01-
1.84), which is similar to what was previously found in other studies, such as Ranzi 
TL et al.127 and Alavinia SM et al.,126 but somewhat lower than others, like Schofield 
DJ and colleagues, who calculated an OR of 3.06 (95% CI: 2.52-3.73) when testing 
the association between arthritis and related disorders with being out of the labour 
force, however the adjustment was only done for age-group and sex and the 
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outcome was broader than strict early retirement.162 Also, as previously discussed in 
Section A, a lack of association between RD and job loss was found in some studies. 
For instance, Lund T and Csonka A found that although the initial univariate analysis 
confirmed the association between MSK symptoms and work disability, statistical 
significance was not reached in the multivariate analysis. This contrast with our 
findings might be explained by geographic (Denmark) and temporal (1997) 
differences, as well as the definitions used for the exposure (MSK symptoms), the 
outcome (work disability, defined as receiving a disability pension or being on long-
term sick leave) and the adjustment, which used distinct cofactors (including the 
company size and belonging to the public or private sector).154 
Alike the strength of association, we found only a slight difference on the self-
reported RD prevalence (INS: 37.2% and EpiReumaPt: 34.2%.vii Figure 9), which 
might be due to how self-reporting was collected (i.e. wording of questions used in 
each survey. Section A – Brief Methodology – Case Definitions), rather than a result 
of a hypothetical epidemiological change occurred meanwhile, within the studied 
age-range.  
However, in the EpiReumaPt study we didn’t find an independent association 
between RD and early exit from work (lato sensu).  
 
 
 
 
 
 
 
 
 
 
 
 
                                            
vii In the last Portuguese national health survey (INS 2014) the proportion of people aged 45-54 years self-reporting arthritis was 
18.7%, while 38.8% for those aged 55-64 years. 
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Figure 9 – Comparison between main findings of INS and EpiReumaPt 
 
Dedicated longitudinal data would be essential to better understand what exactly had 
happened, but there could be several non-mutually exclusive reasons for this 
scenario, namely:  
1) In the recent years, some factors (e.g. those more susceptible to the 
sovereign debt crisis) may have become more relevant in the causality of general 
exit from work (thereby taking over the role of RD in this outcome) while perhaps 
less influential in official retirement.  
2) Macroeconomic and social changes might undermine this as well. For 
instance, unemployment rates were up considerably in Portugal and Europe 
regardless of any individual characteristic, lowering the RD effect on early exit from 
work.  
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3) More RD patients may have been allowed to move directly to early 
retirement (bypassing other temporary forms). This would result in the observed 
increment on the strength of association between RD and early retirement while, at 
the same time, a decrement in the association with exit from work (which includes all 
pathways, thereby “diluting” the effect of RD on early retirement).  
4) The pool of RD patients found in 2005/2006, who were already out of work, 
might have moved to official retirement in greater extent than the influx of new RD 
patients exiting work through temporary pathways.  
These last 2 potential reasons could be explained by anticipated decisions of early 
retirement specially among those older and more vulnerable, such as RD patients, in 
order to avoid the foreseen rise in the official retirement age (i.e. 66 years old, 
implemented in the meanwhile), the expected future penalties and worse eligibility 
criteria. Our data supports this hypothesis because there was a sharp increase in 
early retirement from 2005-2006 to 2011-2013 for the whole population (+53%viii) 
and even more when specifically analysing the RD subpopulation (+55% from an 
already high “baseline”. Figure 9), but the opposite was seen when looking for 
overall exit from work, since the increase in the global population (+15%) was higher 
than in the RD subpopulation (+10%). Additionally, we verified that mean retirement 
age due to RD has recently increased, especially in the last 5 years, and so did the 
prevalence of early retirement in the oldest age-group (60-64 years old) in proportion 
to the remaining age-groups, something that didn’t happen for general exit from work 
in the RD subpopulation (Table 3).  
In the absence of more data, it is difficult to understand exactly what has occurred; 
likely all the above hypothesis could partially explain it. However, the recent 
sovereign debt crisis, which likely puts more pressure on those more vulnerable, and 
the subsequent modifications in the laws and rules of retirement, surely had a role in 
the evolution observed.  
 
 
                                            
viii According with oficial data (Eurostat/INE) anticipated old-age pensions have increased by 40.3% between 2006 and 2012 in 
Portugal.  
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Table 3 – Employment Status According to Age-Groups found in INS and EpiReumaPT (%) 
 
 
 INS EpiReumaPT 
Age- Group Global Retired Retired +RD 
Exit 
from 
Work 
Exit 
from 
Work 
+RD 
Global Retired Retired +RD 
Exit 
from 
Work 
Exit 
from 
Work 
+RD 
      50-54 36.5 12.5 9.9 22.8 17.0 34.8 9.2 8.4 22.3 18.8 
      55-59 33.8 30.4 30.4 34.2 34.4 33.1 28.4 29.3 30.8 32.2 
      60-64 29.7 57.1 59.6 43.0 48.6 32.1 62.4 62.3 47.0 49.1 
Sum 100 100 100 100 100 100 100 100 100 100 
 
Another possible reason could be based on overall worsening of the disease control 
of rheumatic patients in Portugal and consequently poorer physical disability, 
pushing RD patients into permanent forms of early retirement (of note, the HAQ 
scale is absent in the INS data, therefore comparisons between surveys about 
physical function is unfeasible). Empirical knowledge weakens this hypothesis, 
because in the last decade RD patients had more access to innovative drugs and to 
primary and secondary care, following, for example, the primary health care reform 
initiated in 2005 in our country213 and the implementation of the already mentioned 
National Program Against Rheumatic Diseases (2004-2010).49 We also don’t 
consider plausible to expect that working conditions in Portugal deteriorated enough 
to lead RD patients into formal early retirement faster than before. Nevertheless, our 
data is insufficient to categorically dismiss this hypothesis. Lastly, it cannot be 
overemphasized that comparisons of the results obtained in these surveys should be 
done carefully, given that differences may lay on their distinct nature, as explained 
before. It is also worth noting that this evolution applies to overall self-reported RD. It 
doesn’t apply to specific forms of RD. In fact, as further explained in more detail, we 
observed that OA is associated with early exit from work while it is the opposite with 
official early retirement (of note, no comparison with INS 2005-2006 was possible to 
be done specifically for OA due to lack of such information in this survey). This might 
mean that forms of RD that are more widespread and/or less valued by society and 
employers, such as the case of OA, were unable to have the same access to early 
retirement as the self-reported RD group, which, as previously explained, probably 
includes more advanced and disabling RD patients. 
The EpiReumaPt study, which directly inquired the participants about the reasons of 
early retirement, revealed that almost half of early retirements were on the grounds 
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of ill-health and about one third of these were specifically due to RD. Thus, 3.9% of 
the Portuguese population aged 50-64 years old (equivalent to 66,953 individuals) 
self-reported RD as the main reason for early retirement. Despite the increase in the 
prevalence of permanent early retirement in RD patients, our data suggests an 
improvement regarding the average age of retirement due to RD. Thus, a positive 
trend on the mean age of early retirement caused by RD was seen, even though this 
situation varies from region to region of Portugal. For instance in the Lisbon region, 
regardless of having a higher frequency of early retirement due to RD (4.3% versus 
the national average of 3.9%) it has a higher average age of this type of retirement 
(58.6 versus the national average of 54.8 years old).214  
A lot remains to be understood about the underlying rational for this specific 
improvement and it goes beyond the aims of this study. However, it would be 
interesting to know if, for example, early retirement caused by RD is being artificially 
postponed in some areas (e.g. excessive penalties unaffordable for those with lower 
income) or if, as detailed before, in the recent years older RD patients found 
opportunities to retire, anticipating imminent harsher retirement conditions, 
something that couldn’t be easily attained by younger RD patients. In addition to this, 
structural policies might have taken place in order to avoid RD disability and promote 
job adaptation, keeping RD patients as much as possible in the work place. However, 
the recent sharp increase of early retirement makes this option less plausible and to 
our knowledge no noteworthy initiatives related to job adaptations for RD patients 
were implemented in our country.  
Lastly and still regarding the observed regional differences, one cannot discard the 
noticeable evolution around the overall management of RD in the last years, but also 
cannot ignore enduring geographic inequalities. The observed regional differences 
may indeed reflect horizontal inequity in the access to diagnosis and treatment. 
Consistent with this observation, Alentejo, likely to be the region with worse access 
to RD treatment, scored worse than the national average on self-reported prevalence 
and age of early retirement due to RD.214 It’s worth taking in consideration that poor 
access to treatment not only precipitates productivity costs, but also may lead to 
higher direct costs following the progression of an uncontrolled disease. These sort 
of economic consequences were estimated on the second part of this study.    
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Still using the INS dataset, we estimated that RD-related productivity losses due to 
early exit from paid employment were potentially associated with annual costs 
between €367 million (if considering strictly official retirement) and €650 million (in 
the case of broader job loss). Thus, considering the timeframe of the survey 
(2005/2006), this type of costs amounts up to approximately 0.4% of the national 
GDP in 2005. However, when access to the EpiReumaPt database was obtained we 
had the opportunity to achieve more accurate and recent results. Thus, we estimated 
that early retirement self-reportedly to be attributed to RD is potentially associated 
with an annual cost of up to €910 million in Portugal, which translates to 
approximately 0.5% of the national GDP in 2013, which seems to be in line with the 
GDP share of other countries.72,75, 215 In this study, we used a different outcome 
compared with the one used for the INS dataset (i.e. early retirement attributed to 
RD according with the participants’ own report), nevertheless it is important to 
scrutinise these two results together. No significant variations at the epidemiologic 
level were seen and, as already noted, the strength of the relationship between this 
health condition and general early retirement progressed modestly (note: some 
cofactors used in the multivariable regression are different between surveys. This 
itself may drive the difference in the respective ORs). However, from a strict 
economic perspective the situation appears to have worsened, considering the 
indirect costs in relation with the GDP and the indirect cost per RD patient. This 
difference may result from several causes. Early retirement has increased 
substantially (note: comparisons about retirement due to RD are unattainable, due to 
lack of such information in the INS survey) so did productivity unit values (+25-30%). 
Mostly, and already highlighted, the EpiReumaPt study participants were for the first 
time directly asked whether they had retired prematurely because of RD. The RD 
effect on early retirement was directly assessed, while with INS we had to use the 
estimated effect through logistic regression and PAF in the general early retirement. 
Even using a more conservative approach (i.e. considering other competing risk 
factors for RD-caused early retirement) the EpiReumaPt obtained indirect cost per 
RD patient is substantially superior to the one using INS (€1359 vs. €504, 
respectively). However, if we are to use the same exact outcome of general early 
retirement in the EpiReumaPt database and the same PAF methodology as INS, we 
observe an increase in the total annual indirect costs and in the cost per RD patient 
(€550M and €982, respectively. Data not included in the article and only presented in 
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Table 4 for comparison purposes with the INS results), but both results are more 
aligned. It is counterintuitive to verify higher indirect costs when we consider the 
outcome of RD-related retirement (i.e. outcome “b” in Table 4), which is a subset 
within all early retirement (i.e. outcome “a” in Table 4). This has to do with the 
contribution of RD to each of the embraced outcomes. While in the retirement 
caused by RD the consequent indirect costs are all or almost all credited to RD, in 
the general retirement there are competing risks and therefore only a small fraction 
of indirect costs can be attributed to RD (given by the resulting proportional change 
in the probability of early retirement after a counterfactual exercise where the 
presence of self-reported RD is artificially eliminated from the sample, which is the 
essence of the PAF methodology, a common approach of cost-of-illnesses studies). 
In addition, when indirect costs are calculated based on the general retirement an 
underestimation might occur, since there might be an improvement on RD symptoms 
after job loss (thereby reducing self-report of RD and artificially “hiding” its previous 
effect on retirement decisions).216 Although in Portugal the retirement decision by 
itself doesn’t seem to affect health status.193,217,218,219  
All this reemphasizes the importance of the more accurate outcome given by the 
EpiReumaPt study and also makes the point that, even considering true variations 
throughout time, we have to acknowledge that INS indirect costs were likely to be an 
underestimation of the real economic impact of RD on early retirement. We cannot 
also rule out an overestimation on the calculation of costs following retirement due to 
RD captured in EpiReumaPt. Nonetheless, regardless the exact amount of indirect 
costs associated with this productivity loss, our research makes it very clear about 
how considerable they are in Portugal, to an equivalent of up to 0.5% of the GDP. 
This fact becomes even more pronounced after examining the specific RD form of 
OA, as further discussed below. As explained, comparisons with the available 
literature are hampered due to several reasons, including adopted definitions of the 
exposure and dependent variables, as well as the used methodologies. However, 
our high estimates are in line or even inferior to the ones found in the 
literature.72,74,75,79  
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Table 4 – Indirect Costs Obtained for Self-Reported RD and Clinically Confirmed OA 
 
 
 Self-Reported RD Clinically Confirmed OA 
Data Source INS EpiReumaPt EpiReumaPt 
Outcome* a b c a** b c a b** c 
Total Annual 
Indirect Costs €367M NA €650M €550M 
€761M 
- 
€910M 
*** 
NA NA €237M €656M 
% GDP 0.2% NA 0.4% 0.3% 0.5% NA NA 0.1% 0.4% 
Cost per RD 
Patient €504 NA €892 €982 
€1359 
- 
€1625 
NA NA €467 €1294 
*Outcome: a) Early Retirement; b) Early Retirement due to RD; c) Early Exit from Work 
**This data is not presented in the articles. It was included here for comparison purposes. 
***Another alternative for this estimate would be considering in the calculations only those RD cases clinically confirmed. In this 
case the estimate decreases to €747M.   
GDP, Gross Domestic Product for the respective year; M, Millions; NA, Not Available; Osteoarthritis; RD, Rheumatic Diseases. 
 
We have used EpiReumaPt data to ascertain the healthcare resource utilization 
made by different groups according with their working status and RD presence. Both 
RD and early retirement were associated with greater costs of this nature. 
Consequently, the RD patients who also retired early have the highest consumption 
among all analysed groups. Dedicated research could specifically study this 
phenomenon. Nonetheless, it becomes quite obvious that RD patients who are work 
disabled should be prioritized and well managed so that social security and NHS 
expenditures can be adjourned. In addition to this, early identification of disabled RD 
patients is of paramount importance. We have seen a strong association between 
disability and early retirement, which is consistent with our conceptual model (Figure 
7) and with some previous studies. 197,198,199 For instance, Lacaile D and colleagues 
have found an increased risk of no paid work due to RA in people with higher HAQ 
(OR: 1.96; 95% CI: 1.2-3.3).197 Indeed, we observed a cumulative risk of early 
retirement when a given RD patient already had high levels of HAQ. This reinforces 
the need to segment RD patients according to disability levels because it is a 
potential straightforward method to set distinct levels of work withdrawal risk and 
healthcare resource consumption. In addition to this, identification of other vulnerable 
groups can be very useful from a policy perspective. In the first work done with INS 
we emphasized the risk among manual workers, who are exposed on average to 
harsher working conditions, and detailed the discussion around a particular potential 
at-risk group composed by manual RD female workers from the North of Portugal. 
This resulted from the examination of specific characteristics and their association 
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with early exit from work (of note, when considering narrowed forms of work 
withdrawal, the North region is not performing worse than the national average). In-
depth analysis of specific populations can be very useful for the decision-making 
process around early retirement. Policies should prioritize special risky groups, while 
being flexible enough to go beyond generalizations. When it comes to such 
multifactorial problem nothing is absolutely inevitable and predictable, therefore 
segmentation based on risk factors can be a relevant exercise but should not dictate 
“blind” policies disregarding the individual variations. In fact, as detailed in the third 
part of Section B of this thesis, this is one of the reasons why much of the research 
dedicated to interventions aiming to reduce early retirement are of qualitative nature, 
using for example interviews or focus groups to understand the perspective of the 
individual and going beyond a strict epidemiological vision and “blind” simplifications 
drawn from the community. This can also explain part of the general lack of success 
verified in the trials testing vocational rehabilitation programs, which necessarily had 
to be conceived from generic epidemiologic knowledge.  
Still regarding subgroup breakdown, the asymmetric gender impact on the different 
forms of early retirement and due costs is very clear. Females tend to be more prone 
to the most and the less specific studied outcomes (i.e. early retirement caused by 
RD and premature exit from work), while males are more susceptible to the in-
between forms (i.e. official early retirement and unemployment). RD are more 
frequent in women and this certainly partly explains the retirement pattern, but it 
doesn’t explain everything. First, female gender remains statistically associated to 
early retirement caused by RD even when adjusted to other risk factors (ceteris 
paribus), including RD itself; second, other factors associated with women can 
additionally push them out of the market, even when RD is the identified main cause. 
Disability can be the most obvious of those factors. Indeed, we observed more 
disability in females versus males within the self-reporting RD group. 
In the second article reporting RD indirect costs associated with early exit from work, 
we could verify that females were responsible for about 60% of these costs, while in 
the article which measures more specifically the indirect costs of RD-related early 
retirement, that share rises to 84%. This could have been the result of a possible 
reduction in the gender wage disparities between the time period of INS (2005/2006) 
and the one of EpiReumaPt (2011/2013) that could lead itself to a higher share from 
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females, but unfortunately in the last decade we did not observe such trend in the 
studied age-range. Therefore, this cannot explain this increase in the relative female 
gender impact. We cannot disregard that the different methodological approaches 
may underlie some of the changes in gender share of indirect costs. For example, by 
using a similar method based on PAF the female share of indirect costs of early 
retirement due to RD becomes lower than 84% (i.e. 79%). Nevertheless, the main 
reason is expected to lie on the studied outcome. It is true that females are more 
likely to be out of work than men and that leads to their higher contribution (female 
gender OR: 2.12; 95% CI 1.80-2.51), but this includes early retirement pathways, 
which actually are more influenced by male gender, as already said. However, early 
retirement specifically caused by RD is much more likely to occur in women (female 
gender OR: 4.12; 95% CI 2.04-8.31), thus the disproportional contribution of female 
gender in this case. Also, we cannot rule out the possible changes that might have 
occurred between the two surveyed time points. Early retirement in Portugal might 
have become restricted to more disabled patients and, as explained before, RD 
female patients have higher disability than male ones, which is in agreement with 
others’ findings.220,221,222 This more severe functional condition might per se push 
females out of work more frequently within a social system less willing to accept 
early retirement of mild health conditions. We could also speculate if couples, 
especially within the recent austerity environment, are favouring RD males to remain 
at work, because they have on average a higher salary, making the overall 
household income less vulnerable to the respective early retirement penalties. If true, 
this situation exacerbates the gender asymmetry on indirect costs. Some literature 
suggests that couples may indeed coordinate their decisions and the partner may 
influence the choice of leaving the labour market.147,148 In this research we didn’t find 
an independent association between marital status and the likelihood of being early 
retired, except when using the OA model. It is true that some studies have shown an 
effect of marital status, but the employment status and probably the income of the 
partner may play a bigger role on this regard. We could not access this level of 
information but further research may address the household and the family context in 
the retirement decisions of their members.  
As a last remark around the gender asymmetry on indirect costs, if gender wage 
disparities had been reduced since 2005 the estimated indirect costs would have 
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been even higher. In fact, we estimated that if we were to assume productivity values 
similar to those of men the indirect costs estimate would raise by about 30%. Further 
research is necessary to understand how these costs will evolve in the coming years 
as a function of the expected evolution of gender disparities.   
The EpiReumaPt dataset made it possible to test the association between pain, 
disability and early retirement, through the use of appropriate instruments (e.g. HAQ). 
Indeed, we have verified a strong association between pain, disability and early 
retirement, building further on the adopted conceptual model that gave rise to this 
study. Persistent musculoskeletal pain is a unifying characteristic across the vast 
majority of rheumatic conditions. It is particularly common in self-reported RD and 
might actually lead RD patients to better remember and to state suffering from a RD. 
We studied pain in more detail using OA, a rheumatic clinical condition particularly 
distressed by pain.  
RD patients have functional limitations that may translate into work disability. We 
observed an additional likelihood of early retirement when a given RD patient had 
higher levels of HAQ. In fact, a “dose-dependent-like” (biological gradient) 
relationship was observed, with an almost linear correlation between levels of 
disability and the probability of early retirement. Furthermore, when comparing 
individuals with same HAQ scores, the ones with self-reported RD were more likely 
to be retired. It may be that besides the main causal chain between RD and 
retirement, which includes disability as a main intermediate step, there might also 
exist an additional “route” independent of physical disability. Understanding this 
potential alternative causal chain was beyond the scope of this research, but it may 
involve psychological factors (mental disability) known to be associated with RD. 
Some RD patients may be vulnerable, not only from a physical point of view, but also 
from a mental one (e.g. chronic anxiety and depression), which itself may predispose 
them to suffer an additional retirement risk.   
All this reinforces the importance of the used proxy of self-reported RD, because this 
group not only has higher physical disability (HAQ scores) against the clinical 
confirmed RD population (a broad group composed by many RD forms at different 
stages, including non-disabling ones – within the studied age-group, over 73% of the 
people had some form of clinically confirmed RD); but also higher levels of mental 
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disability (e.g. 29.0% of self-reported prevalence of mental diseases in the self-
reported RD group compared with 19.7% in the clinically confirmed RD patients), 
added to the fact that RD-related retirement does not seem to be entirely explained 
on the grounds of physical disability. Therefore, this further justifies why self-reported 
RD should be thoughtfully considered. Identification of self-reported RD people shall 
trigger further needed actions (e.g. diagnosis done by a rheumatologist) and 
disability assessment. At least from a physical standpoint and since the HAQ 
assessment is quite simple and inexpensive, employers could periodically survey 
employees regarding their level of disability. This could be a fruitful proactive 
investment particularly for manual workers.  
Studying clinically confirmed OA allowed addressing specific fragments of the 
adopted etiological model in more detail, such as pain and disability. Unsurprisingly, 
we verified that Portuguese OA patients consistently reported more persistent pain 
than others without the condition. In fact, pain is one of the symptoms that should 
validate the clinical diagnosis of OA. It is the most disabling manifestation of this RD. 
Chronic pain has been shown to be a major contributor to increased healthcare 
utilisation, reduced labour productivity, and consequently large direct and indirect 
costs. Another study has estimated that the total annualised chronic pain costs in 
Portugal amounts to €1,977 million for the total annualised direct costs, €2,646 
million for indirect costs, and €4,612 million for the total costs. These estimates 
correspond to 1.2, 1.6, and 2.7% of the Portuguese annual GDP in 2010, 
respectively.223 Due to the high prevalence of OA in Portugal (Knee OA: 12.4%; 
hand OA: 8.7%; hip OA: 2.9%)23 and its increased incidence of persistent and 
disabling pain, it becomes quite obvious that pain control in OA patients is crucial, 
not only for the individual, but also for the society as a whole. However, many OA 
Portuguese patients do not experience adequate pain control.224,225 Along with the 
available literature, our research highlights the potential social consequences of 
inadequate management of OA, specifically when it comes to pain relief.  
Also, and consistently with the previous discussed results in self-reported RD, more 
impactful forms of OA (i.e. worse symptoms measured by KOOS subscale scores 
and/or disability measured by HAQ) were at the highest risk of premature work loss. 
Thus, OA fulfilled the promise of being an appropriate RD to test the adopted 
etiologic model. Interventions may target any relevant intermediate step (as earlier 
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as possible) in order to break the chain between OA onset and work withdrawal. 
Depending on how soon and at which level one desires to act upon, these 
interventions may target directly pain and inflammation (e.g. analgesics, NSAIDs and 
knee arthroplasty) and/or the work situation, such as adapting hours, tasks, 
workplace, and the use of aids, as further described in the third part of Section B of 
this thesis. By doing so, many years of working life lost may be spared.      
As before with self-reported RD, we estimated many years of working life loss 
attributable to OA and even a higher number of potential years to be lost if no return 
to work happens until the official retirement age in the OA population. As with RD, 
this data highlights the need to also consider interventions fostering return to work, 
whenever possible. The overall inactivity ratios, measured by the time the individual 
stayed (and potentially will remain) out of work as compared with its potential 
working life span, are also elevated. On average up to almost a quarter of the 
working age-range is lost in this group of early retirement OA patients, which 
translates in large indirect costs to society.      
An annual cost of €656 million (i.e. 0.39% of 2013 GDP) attributable to OA through 
early exit from work was estimated. Once again the female contribution was 
meaningful (~62%) although the cost per OA male patient is much higher, mainly 
due to the fact that wages are larger in men.   
No measurement of indirect costs was done specifically for the official premature 
retirement route because we didn’t find a significant association of this outcome with 
OA. OA seems instead to drive the labour force out of paid employment mainly 
through unemployment, which may prevail over official early retirement (competing 
outcomes), especially in the youngest ages. Notwithstanding, this doesn’t fully 
explain the lack of significant relationship of OA with official retirement, because 
long-term unemployment can usually be converted into premature official retirement 
(as a matter of fact in the first figure of the forth article it is possible to observe the 
interchangeability between unemployment and retirement rates, in which the former 
seems to be “overtaken” by the latter. Of note, the lack of significance in the 
multivariable regression with official retirement as the outcome may also be partly 
due to less statistical power compared with the analysis of all sorts of exit from work, 
which necessarily accounts for more events to be evaluated). As already discussed, 
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further research should investigate if policies are somehow restricting early 
retirement in these patients, on the grounds of a less valued RD form. Alternatively, 
other causes may prevail, such as the rejection from OA unemployed patients to 
retire before the official age. Regardless of the cause, unemployment is a route of 
special interest that should be tracked more closely in future studies. It is possible 
that OA patients are perceived by employers as less fit for work, therefore being first 
on the layoff list, while at the same time not disabled enough to be eligible for early 
retirement (although mean HAQ levels are superior on those suffering from OA than 
those who self-report RD: 0.64 vs. 0.57, respectively). If this is the case, increases in 
pension age in Portugal, as with many developed countries, may exacerbate this 
situation. OA is a paradigmatic example of the need to engage employers in 
integrated actions to accept and help, whenever possible, patients to remain 
productive at work. 
It is difficult to compare the indirect costs obtained for clinical confirmed OA versus 
self-reported RD. On one side, if we want to compare results from the same data 
source and timeframe then the occupational outcome is distinct (Table 4); on the 
other, if we want instead to analyse OA in relation to RD, the case definition is of a 
different nature, as mentioned before (clinically confirmed data versus self-reported 
data). Therefore, comparisons, if any, must be carried very carefully.    
It is true that OA indirect costs look very high when compared to the results of self-
reported RD, especially those obtained with the INS dataset (Table 4), which is not 
the case when comparing to the YWLL findings (YWLL due to RD retirement in the 
overall self-reported RD group was estimated to be 389,939, while in OA it was 
74,957). In agreement with many previous studies of the same nature (i.e. cost of 
illness studies), our methodological approach to measure the economic impact of 
early exit from work was based on PAF, which takes into account both the strength 
of the association between a risk factor and the outcome and the prevalence of that 
risk factor in the population. Even though self-report of RD was more frequent in the 
INS database (37.2%) than what was found in the clinically confirmed OA in 
EpiReumaPt (18.6% of knee OA, which was the location used to calculate indirect 
costs, given the lack of association of hip and hand OA), the strength of association 
was much lower (OR: 1.31) than the clinically confirmed knee OA (OR: 2.25).  
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These imbalances partly explain why results in the end were so similar, but a 
number of other factors might be playing a role as well, such as the already 
mentioned increase in the unit values and the frequency of the outcome itself (2005-
2006: 45% vs. 2011-2013: 52%). In addition, while OA is undeniably one of many 
RD forms, clinically confirmed OA cannot be seen as a subset of the self-reported 
RD, because the latter itself is a subset of the much broader clinically confirmed RD 
group. In the EpiReumaPt database, within the studied age-range of 50-64, we found 
a prevalence of over 73% of patients with at least one clinically confirmed RD. This 
group is mainly composed by low back pain, periarticular disease, OA and OP, 
almost all of which (i.e. all except OA), were not statistically associated with job loss. 
This might actually be the main reason as to why we didn’t find any association 
between clinically confirmed RD and any sort of exit from work (i.e. even if some RD 
forms, like the case of OA, have an effect it is attenuated within this large and hugely 
heterogeneous group mainly composed by less disabling RD forms, which are not 
strongly related with premature exit from paid employmentix). This lack of association 
made it impossible to measure indirect costs for the whole clinically confirmed RD 
group, which certainly would have made much more sense to compare with the 
herein presented results for clinically confirmed OA. Undoubtedly, other disabling RD 
forms should be further analysed. One limiting step to do so is not having enough 
statistical power to perform multivariable regressions due to the relatively small 
sample size of less frequent RD forms in this age-range. For example, despite being 
out of the scope of this thesis, we explored the relationship between RA and early 
retirement. With our adopted age-range we couldn’t reach any statistical significance 
when testing this relationship, however, once the age restriction was widened to 
adults bellow retirement age (i.e. 18-65 years old), statistical significance was 
attained. Hence, there seems to be a relationship though difficult to explore given the 
low sample size (in the EpiReumaPt sample only 23 people aged 50-65 were 
diagnosed with RA versus 518 with OA). RA is particularly interesting to explore 
given the already mentioned economic impact. Maetzel A et al. observed that per 
capita indirect costs related to RA were up to five times higher than indirect costs 
incurred by patients with OA.226   
                                            
ix In fact, we tested the association of clinically confirmed RD according with different levels of disability, and only RD with HAQ 
levels above the average of the population was associated with early retirement, while all those non-RD or RD with lower HAQ 
scores were non-significant or even inversely associated (Appendix 4). This reinforces the idea that although there is an effect 
of clinically confirmed RD in early retirement, that effect is “diluted” by mild RD cases with none or mild disability.  
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Of note, the chosen age-group for this research was considered the most adequate 
one due to the following main reasons: 1) It is obviously the age group in the vicinity 
of official retirement in most developed countries; 2) The most explored age-group in 
the literature; 3) Narrowing the age-group is itself a method to restrict confounding by 
age; 4) It also reduces some potential overestimation of early retirement due to right 
censoring (i.e. more time for potential return to work until all participants reach the 
official retirement age); 5) Finally, it is the most appropriate age-group to prioritize 
and intervene when it comes to find and act upon employees at risk. Surely, along 
with a smaller sample size, a downside of this restriction is a possible 
underestimation of the association and the impact of RD in early retirement, because 
younger cases of RD-related job withdrawal were excluded. On the other side, it is 
also true that the vast majority of disabling RD forms have their onset of symptoms 
at relatively advanced ages. In fact, this relates with one of the main limitations of 
this sort of cross-sectional studies, which is reverse causation, as further discussed 
below.  
Despite the age-group considered, OA was not independently associated with early 
retirement stricto sensu, however some OA patients (4.7%) indeed reported to have 
retired earlier due to RD (which is above the average of global population and the 
non-OA one [2%, p=0.009], but bellow the self-reported RD group [9.7%], which 
consistently presented a stronger relationship with this sort of premature retirement). 
These findings seem to be aligned with the overall pattern of the literature. In a 
systematic review, Bieleman HJ et al. described on one hand that many workers with 
OA do not reach their optimal productivity during work, which may impact overall 
work participation, while, on the other hand, OA seems to be responsible for early 
retirement only in a small proportion of workers.209 
Surely, OA patients who claimed to have retired earlier due to RD might have done 
so not specifically due to OA, but rather as a consequence of previous or other 
concomitant RD. However, if we are to assume that this productivity loss is fully 
associated with OA, we would calculate a total indirect cost of €237M, a much lower 
figure even adopting a non-conservative assumption and certainly more comparable 
to the €910M figure obtained for the whole self-reported RD in EpiReumaPt (Table 4).  
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As it occurred before with self-reported RD, a higher educational level was linked 
with at-work status (with the exception in the INS database using official retirement 
as the outcome). This finding is consistent with many other previously published 
studies. For example, in 2013 Schuring M et al. observed in a prospective study that 
participants with low to intermediate education had the highest risk of unemployment 
or early retirement.98 In the same year, Robroek SJ and colleagues, using the 
SHARE survey verified that participants with low educational level were more likely 
to exit from work through a disability pension, unemployment, and early 
retirement.120 Higher education generally means higher income and accumulated 
assets which prone the individual to afford retirement penalties. However, it might be 
also associated with better workplace conditions, higher motivation and job 
satisfaction.  
A study has shown that if employees are dissatisfied with their job, the probability of 
retiring earlier is twofold compared with that of satisfied employees.105 In addition, 
less educated workers may be subjected to a more stressful physical and 
psychosocial work environment. Exposure to the latter work environment is typically 
measured by two established theoretical models: the demand–control 227 , 228  and 
effort–reward imbalance models. 229 , 230  In the former, job control denotes the 
employees’ authority to make decisions concerning their own activities and using 
their skills at work, while job demands refer to time pressures and workload. A 
combination of high job demands with low job control is assumed to be stressful. The 
second model focuses on the work contract and emphasizes social reciprocity. 
Rewards received in return for efforts spent at work include income and career 
opportunities. The lack of reciprocity (high effort in combination with low rewards) 
may have a negative impact in retirement decisions, since the basic principle of 
social exchange, reciprocity, is violated under such conditions. Indeed, Siegrist J et 
al. have shown that poor psychosocial quality of work is significantly associated with 
intended early retirement.104 It would be interesting to measure the interplay between 
educational level, quality of work and risk of retirement in Portugal, due to the likely 
connection between them.     
Less educated workers may also have less access to diagnosis and treatment, 
which may lead per se to ill-health pressure in the ability to work, and to reduced 
self-perception about health status and self-efficacy at work. In addition to all this, 
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lower education levels generally lead to manual type of work, which in turn may 
influence work participation levels, although in INS we didn’t find this factor to be 
independently associated with early retirement (unfortunately, registry errors made it 
unfeasible to test this factor in the EpiReumaPt database).   
Findings concerning other cofactors used in our multivariable regression models 
weren’t as consistent as the educational level. Comorbidity, for instance, aside the 
fact of its general unquestionable impact, had dissimilar results in the models that 
were developed in our research when it came to analyse specific diseases. This is 
mostly due to the fact that the set of cofactors, and thus their relationship in the 
multivariable models, didn’t remain the same from INS to EpiReumaPt. Yet, it can 
also be a result of a true change on the effect of a given disease in the work ability 
and/or in the effective retirement throughout time. Cancer, for instance, seems to 
have lost the magnitude of effect over early retirement. This evolution seems 
somehow counterintuitive from an epidemiologic angle, because despite the 
improvements on premature detection and oncology treatment, the overall burden 
and incidence of cancer has increased,231 and from a legal point of view there were 
some legislative steps after 2005-2006 aimed to increase social security for cancer 
patients.232 Once again, a vis-à-vis comparison of EpiReumaPt with INS must be 
done prudently, but it would be important to better understand if for some reason 
cancer patients are facing difficulties to be granted early retirement when needed.  
Still regarding comorbidity, mental diseases (which included depression, anxiety, 
schizophrenia and bipolar disorder) appear to have a role in retirement due to RD, 
but not general retirement. Higher frequency of some mental distress, such as 
anxiety and depression, has been associated with some forms of RD,233,234 but in 
fact EpiReumaPt study only found a significantly higher proportion of Portuguese RD 
patients with anxiety symptoms but not with depressive symptoms.23 In our first 
approach with INS we specifically tested the role of self-reported depression and 
anxiety and didn’t find any independent association with the outcome. Portugal has 
one of the highest prevalence of mental disorders in the western world, 235  in 
particular chronic anxiety and depression, a leading cause of disability 
worldwide.236,237 However, these psychiatric disorders don’t seem to push per se 
sufferers into early retirement, contrary to what occurs in other countries.101,126 
Alavinia SM et al. concluded that in several European countries depression was the 
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most important health problem associated with main labour force exit. Yet, because 
it was out of the scope of this study, we cannot rule out that an in-depth analysis with 
dedicated adjustment could have led to findings in Portugal distinct from ours (of 
note, as with most studied comorbidities, we found significant univariable ORs for 
anxiety and depression). Also, this scenario might have changed after 2005-2006, 
especially following the psychological distress elicited by our sovereign debt crisis. 
Regrettably, antidepressive use and suicidal rates, particularly bellow 65 years old, 
have been rising.238,239    
In EpiReumaPt database we addressed self-reported mental disease as a whole and 
found an independent association with early retirement due to RD. It would be 
interesting to further understand this “additional” effect of psychiatric disturbances 
and to know whether if it was driven by the prevalent forms (i.e. anxiety and 
depression), the severe ones (e.g. schizophrenia and bipolar disorder) or both.  
Anticipating discrimination in the work place240,241 may lead employees with mental 
disability to not disclose their condition and it may well be that our cultural and social 
system is (implicitly) discouraging patients to use mental disability as a primary 
reason for retirement, as a result of shame, stigmatization and lack of societal 
valorisation regarding these health conditions. More attention should take place in 
order to detect eventual cases of RD taken as an “alibi” for the official reason to 
achieve retirement, while the real causation may lay on mental illness, which 
obviously requires a completely different approach in terms of possible interventions 
to postpone work exit.  
Definitely, this relationship between mental diseases and early retirement is 
particularly vulnerable to reverse causation, due to the negative psychological effect 
that retirement may have in some people. Moreover, justification bias can also take 
place if some EpiReumaPt participants justified their retirement on the grounds of 
physical disability when actually the undermining reason was of psychiatric nature. 
All in all a thinner analysis about the role of mental diseases in early retirement 
certainly deserves dedicated research in our country.  
Still on a last remark about comorbidity, neurologic diseases were strongly 
associated with early retirement in the EpiReumaPt study (i.e. both sub-studies with 
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self-reported RD and clinically confirmed OA). This self-reported group of illnesses 
included stroke, which possibly have driven these findings per se, being particularly 
frequent in the Portuguese population242 and highly disabling. Actually, in the INS 
study, where stroke was analysed separately, a strong correlation with early 
retirement was established.  
A major limitation in our research stems from the cross-sectional design of the 
surveys. This did not allow to accurately evaluate the temporal relationship between 
onset of risk factors, namely RD, and time to premature retirement, which is a basic 
element to establish a cause–effect relationship, according with the classic Bradford 
Hill criteria.243 In fact, temporality is the most jeopardized criteria among this list of 
causality criteria. The analysed causal chain has plausibility, as depicted in the 
adopted conceptual model, which in turn is based on the available literature. We 
observed good strength of association between RD and early retirement, which 
showed consistency when using distinct databases, study populations and time 
points; and coherence, with findings compatible with existing theory and knowledge. 
We also found specificity by analysing OA as a particular form of RD. We detected 
dose-response relationship (biologic gradient) in the studied causal chain by 
observing how levels of pain and disability evolved along with the likelihood of being 
out of work. The remaining 2 criteria, analogy and experiment could be found in the 
literature. It is possible to find analogy with other examples of ill-health models where 
the causal-effect with early retirement, through impairment and disability, has been 
established elsewhere, as described in the General Introduction. Likewise, some 
experiments have successfully tested the effect of better disease control of at-risk 
RD patients on early retirement. As mentioned before, the Abásolo L et al.244 study is 
a paradigmatic example of such experiments, as well as others described in the 3rd 
Part of Section B of this thesis.      
It is true that with INS the temporal bias was impossible to eliminate, however the 
EpiReumaPt study obviated, at least to some extent, such limitation, because 
participants were directly asked whether their retirement was due or not to any 
health condition, in particular RD. Conversely, this type of self-reported data might 
be subject to other sorts of bias, such as memory and justification bias, but without 
any doubt it brought a crucial temporal dimension to our research, thereby mitigating 
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potential inferences based on temporal bias. On top of all this, the onset of most 
forms of RD, including OA, are likely to start at an age when people are still working, 
which also reduces the likelihood of reverse causality.  
As previously discussed, our data is mainly self-reported by the participants which is 
an approach limited by its dependence on the subjectivity of responses. Indeed, the 
accuracy of data obtained via self-report questionnaires is relatively low compared 
with that gathered from other sources, for instance medical records or insurance 
claims.245 It may produce misclassification bias, as already discussed regarding the 
case definition of the exposure variable. Also, respondents may overstate symptoms 
in order to make their situation seem worse, or instead may under-report the severity 
or frequency of symptoms in order to minimize their problems (i.e. patients in denial). 
They also may simply be misunderstanding the question, the listed option of 
responses, be mistaken or misremembered. 
Major flaws of memory may be of several types246 and can trigger one of the most 
renowned epidemiological bias, the so-called memory bias. Surely, our findings 
might have been influenced by this systematic error (e.g. age of early retirement), 
but no better alternative can be found in the available Portuguese databases. 
Besides, for comparison purposes, most studies, which set the quality standards on 
this area of research, were also based on self-reporting data and also subject to 
memory bias. For instance, the European study on ageing and retirement, SHARE 
project, was founded on self-reports, including its participants’ work status. Despite 
all this, we also used some clinically confirmed data (e.g. OA diagnosis and KOOS 
scale applied by the rheumatologists) and we verified consistency and reliability in 
the overall results, namely the general conclusions that may be retrieved with self-
reported RD and clinically confirmed OA.  
Other limitations have been specifically addressed in the articles, namely those 
related with the measurement of indirect costs and the adopted human capital 
approach. 
Despite all the addressed cofactors, hidden confounding may have still remained. It 
is possible that both RD and early retirement are being induced by unobserved 
heterogeneity of relevant risk factors, such as particular events, social circumstances 
or health conditions early in life, that were not captured in the surveys. However, 
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virtually, all association studies are subject to this limitation. It is impossible to control 
to every single possible confounder, especially with such multifactorial outcome. 
Given the internal consistency of our results and how they relate with the literature, it 
seems very unlikely that unobserved confounding is dramatically affecting our 
findings. In fact, we realized that our study might be among one of the studies 
examining this subject with higher number of addressed cofactors.  
To our knowledge this is the first study specifically to address the association of 
health and early retirement in Portugal and one of the few in Southern Europe using 
nationwide surveys. Our results are representative of the country’s population and 
the measured consequences or RD-related retirement are to be taken under the 
perspective of the whole Portuguese society (high external validity). Using the INS 
database allowed a first approach with the most prominent health survey performed 
in Portugal, which is a known tool used to set up the national health policies. It gave 
a very good initial sense about the association of ill-health and RD with early exit 
from work and a first result about its impact. While EpiReumaPt, the first nationwide 
RD survey, permitted an in-depth analysis with more RD-specific data. More than an 
update of the INS results, EpiReumaPt provided complementary information and in 
some cases more accurate results, indirect costs being the best example of this. 
EpiReumaPt also serves as a knowledge platform to promote awareness for the 
impact of RD as well as setting the ground for better research on these topics, 
namely through the foundation of the longitudinal project CoReumaPt.51    
Among many other objectives, CoReumaPt will allow better information about RD 
progression and its role on employment transitions in Portugal. It may also serve as 
a platform to test interventions aimed to reduce retirement caused by RD.              
In the last part of this study, we reviewed the current knowledge about interventions 
aiming to reduce early retirement of RD patients. We identified several published 
studies testing pharmacologic and non-pharmacologic vocational rehabilitation 
interventions, but none was specifically identified for Portugal. We found many 
studies addressing the subject but the general low quality of the literature and its 
inconsistency made it unfeasible to draw definitive conclusions.  
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Nevertheless, some broad recommendations were outlined. An effective intervention 
must: 1) act upon different levels (e.g. RD patient, workplace), involving several 
stakeholders; 2) prioritize the right patients (e.g. more disabling RD); and 3) consider 
the patients’ role, for instance by including an element of patient education and 
support.  
Pharmacologic interventions appear to be supported by more compelling evidence 
about their effectiveness than non-pharmacologic ones. Cost-effectiveness analysis 
of new, and in some cases older, drugs should take this in consideration, because, 
as it is recommended by almost all guidelines for economic evaluation, including the 
Portuguese, all possible benefits and cost-offsets should be encompassed in such 
analysis in order to adopt an holistic societal approach, entering indirect costs 
(productivity gains and losses).247  
The non-pharmacologic intervention approach must be taken very seriously by 
healthcare deciders, due to its enormous potential outcome. It is true that it lacks 
compelling evidence about its impact, but “beyond the pill” programs, such as work 
adaptations, allied with an appropriate disease management may deliver optimal 
results in terms of medium to long-term occupational yields. In fact, such multilevel 
approach could be followed-up in the RD patient registry and cohort already in place 
in Portugal - Reuma.pt and CoReumaPt. Leveraging the Apto.PT (Fit for Work 
Portugal)x initiative should occur too, in order to foster potential integrated solutions 
implemented in our country. On the one hand, we have to admit and reiterate the 
need for more evidence around this subject, but on the other, we also have to 
understand that decision-making that waits for the “perfect” information may be too 
costly to afford.  
We presented in this thesis the price of inertia, a scenario that is certainly not going 
to improve if nothing is done otherwise. It seems that a seamless approach would be 
the most appropriate one – Interventions that theoretically may work out, based on 
the available literature (herein listed in the 3rd part of Section B of this thesis) and 
experts’ opinion (e.g. consensus composed by rheumatologists, other healthcare 
                                            
x Apto.PT is the Portuguese coalition of the Fit for Work, which is a multi-stakeholder initiative, driving policy and practice 
change across the work and health agendas in Europe and worldwide (over 35 countries). The vision is to raise awareness of 
the facts of RD and make the case for more investment in sustainable healthcare by promoting and supporting the 
implementation of early intervention practices. Fit for Work is led by The Work Foundation – Lancaster University, which is also 
providing the Secretariat. AbbVie is founding sponsor since 2008. All the research is produced independently by The Work 
Foundation, with full editorial control resting with the think-thank alone.xi 
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providers, epidemiologists, and other relevant public health and occupational 
professionals), should start as soon as possible along with “piggy-back” research, 
which will survey respective effects. Lessons learnt along the way would shape this 
adaptative intervention.         
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CONCLUSIONS & FUTURE PERSPECTIVES 
Our study found that in Portugal self-reported RD are associated with early exit from 
paid work, specifically early retirement. Currently, there is an expressive number of 
people who claimed to be retired prematurely due to RD. This translates in many 
years of working life already lost and many others still potentially to be lost. Indirect 
costs due to self-reported RD are also substantial, equivalent to at least 0.5% of 
GDP. By specifically analysing OA, the most prevalent and disabling joint disorder, 
we realized that the productivity loss due to RD is potentially even higher than the 
one obtained when analysing self-reported RD as a whole. Regardless the exact 
magnitude of the estimates, it seems undisputable that the foregone productivity 
caused by RD is enormous. 
If nothing is done otherwise, this scenario will worsen since the expected increase in 
the prevalence and impact of some forms of RD. In the future, ageing of the 
population is expected to make OA a leading cause of disability worldwide. It is true 
that primary prevention of RD is still difficult to attain, but at least, from a pure clinical 
standpoint, early diagnosis and effective treatment must be guaranteed in order to 
mitigate RD pain, impairment and disability, to improve the individual’s quality of life 
and to adjourn major societal costs, namely as a result of early retirement. The 
current expansion of the rheumatology network in our NHS will certainly have an 
effect on this regard. In addition to the crucial clinical approach, other sorts of 
interventions shall take place beyond but articulated with the NHS. Intersectorial 
collaboration is a key topic embedded in the current National Health Plan (PNS, 
Plano Nacional de Saúde 2012-2016). 248  Several collaborations between the 
Portuguese Ministry of Health and the Ministry of Labour, Solidarity, and Social 
Security were built,249 but none seems to target vocational interventions aiming to 
reduce early retirement and certainly not being specific of RD. This perhaps arises 
from the fact that the Health in All Policies (HiAP) mind-set, endorsed by WHO, 
mostly targets the effects on health from other sectors within the government, rather 
than the opposite. HiAP is an approach to public policies across sectors that 
systematically takes into account the health implications of decisions, seeks 
synergies, and avoids harmful health impacts in order to improve population health 
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and health equity. It improves accountability of policymakers for health impacts at all 
levels of policy-making. It includes an emphasis on the consequences of public 
policies on health systems, determinants of health and well-being.250 However, given 
the joint effort and the synergies built to reach common goals centred on the 
community’s health it would also make sense to take advantage of this timing and 
momentum of political and societal will to include retirement due to illness in the 
agenda as well, particularly for RD. Moreover, in Portugal as in other countries, a 
recent policy response to increasing life expectancy and the sustainability issues 
faced by social security was to rise the age at which pensions can be accessed. 
Delayed access to a pension might be mostly challenging for individuals with poorer 
health. This might be particularly true for those of lower socioeconomic status who, 
in addition to being more likely to have substantial health problems, including 
suffering from a RD, often work in the most physically demanding jobs and have the 
fewest alternative job opportunities. This concern has to be thoroughly addressed in 
the Portuguese political agenda, which should get the compromise from the relevant 
sectors of society and from the Ministries which overrule them, just as recognized by 
the HiAP approach. 
From a tactical point of view, multistakeholder vocational interventions could be 
implemented in a step-wise manner in Portugal. It is somewhat difficult to 
recommend an “already-made” program expected to be inevitably effective, but this 
fact cannot justify inertia in this field – it is overly costly. Thus, pilot projects can be 
conceptualized and implemented by experts in the field, including rheumatologists, 
epidemiologists and occupational specialists, and then, if proof-of-concept is 
achieved, further expansion could occur throughout the Portuguese territory. This 
implies that effectiveness of such interventions must be collected through piggy-back 
studies, preferably of longitudinal design.  
One of the main caveats of our study was the lack of longitudinal assessments within 
the same study population. It is therefore important to build long-term cohorts aiming 
to collect occupational and health information. On this regard we already designed 
the CoReumaPt – the cohort of RD in Portugal. In 2011, anticipating the needed 
longitudinal follow-up of RD patients concerning relevant outcomes, including 
occupational ones, we started the CoReumaPt project (Appendix 5). In the future, 
this will allow understanding more closely the relationship between RD and early 
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retirement throughout the time and the course of the disease. It also may be the 
basis to test the effectiveness of the aforementioned vocational interventions. 
Longitudinal studies may also help to study less prevalent RD, such as RA, and the 
respective impact on the employment status. Multiple within-subject assessments 
might allow overcoming the lack of statistical power which hampers cross-sectional 
studies, especially when multivariable regressions are required. Thus, this might help 
building a final “global picture” about the economic impact of RD, as the sum of 
estimates from the most impactful RD forms, based on the same epidemiologic 
platform.  
In the future, it will also be relevant to study other sorts of costs (e.g. direct costs) in 
order to sum up the whole economic impact of RD in Portugal. Our findings 
contribute with the RD-related early retirement, but a full RD cost-of-illness analysis, 
using a bottom-up approach founded on the individual observations of EpiReumaPt 
and CoReumaPt, is of paramount importance for Portugal and for the prioritization of 
its public health policies. Such data is also critical for other major chronic diseases, 
for which there is still a significant lack of nationwide epidemiologic data. In fact, 
epidemiologic studies like EpiReumaPt for other chronic diseases are still largely 
missing in our country. 
Cost-of-Illness information is essential per se, but it is also fundamental to support 
other kinds of evaluations, such as the cost-effectiveness of new pharmaceutical 
drugs, just as the growing field of Health Technology Assessment (HTA), within a 
system, more than ever, needing for increased efficiency. 
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APPENDIX 1 
 
Linktest of main Logistic Regression Models  
 
Model predicting Early Retirement in INS (Article A):  
 
 
 
 
 
Model predicting Early Retirement in EpiReumaPt (Article B and C):  
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Model predicting Early Exit From Work in EpiReumaPt (Article D):  
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APPENDIX 2 
 
Comparison of Self-Reported RD and Clinically Confirmed RD (Quality of Life and 
Function) 
 
	 Self-Reported 
RD* 
Clinically 
Confirmed RD** 
Score HAQ  
(0-3 from best to worst) 
0.57 0.48  
EQ-5D  
(0-100 from worst to best imaginable health state) 
0.67 0.73 
SF-36 physical function 
(0-3 from worst to best) 
63.9 71.4 
SF-36 role limitations because of physical 
health problems 
56.0 65.6 
SF-36 bodily pain 53.2 59.5 
SF-36 social functioning 79.5 82.9 
SF-36 general mental health 56.3 62.8 
SF-36 role limitations because of emotional 
problems 
67.2 75.7 
SF-36 vitality 47.9 54.6 
SF-36 general health perceptions 44.9 50.0 
RD, Rheumatic Diseases, HAQ, Health Assessment Questionnaire; SF-36, Short-Form Health Survey; EQ-5D, European 
Quality of life Questionnaire;  
*All p-values significant (p<0.001) versus non-RD (self-reported) using the Student’s two-tailed unpaired t test.  
** All p-values significant (p<0.001) versus non-RD (clinically confirmed) 
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APPENDIX 3  
 
Diagnostic Tests of Self-reported RD 
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APPENDIX 4 
 
Results for Clinically Confirmed RD (according with different levels of disability)  
 
 
 
 Clinically 
Confirmed 
RD 
RD 
+ 
­ HAQ** 
RD 
& 
¯ HAQ*** 
NON-RD 
+ 
­ HAQ 
NON-RD 
& 
¯ HAQ*** 
Unemployment 2.4 (1.1-5.1)* 1.5 (0.9-2.3) 0.7 (0.4-1.1) NS 2.0 (0.6-6.6) NS 0.5 (0.1-1.7) NS 
Early Retirement 0.8 (0.4-1.5) NS 1.7 (1.1-2.6) 0.6 (0.4-0.9) 0.6 (0.1-2.6) NS 1.7 (0.4-7.3) NS 
Early Retirement 
due to Disease 2.3 (0.9-5.7) NS 4.3 (2.6-7.1) 0.2 (0.1-0.4) 1.5 (0.4-5.9) NS 0.7 (0.2-2.7) NS 
Early Retirement 
due to RD 5.3 (1.1-26.0) 10.5 (4.8-22.9) 0.1 (0.0-0.2) 1.0 (0.1-7.7) NS 0.9 (0.1-7.0) NS 
Exit from work 1.3 (0.7-2.4) NS 2.4 (1.6-3.6) 0.4 (0.3-0.6) 1.3 (0.4-3.9) NS 0.8 (0.3-2.4) NS 
RD, Rheumatic Diseases (clinically confirmed); HAQ, Health Assessment Questionnaire. 
*All odds ratios adjusted for age and sex using EpiReumaPt database;  
**High HAQ values defined as above the average of the global EpiReumaPt population (i.e. >0.38) 
***Low HAQ values defined as below the average of the global EpiReumaPt population (i.e. <0.38) 
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Methods: An open cohort will be created, initially com-
posed by the randomly selected population of the cross-
sectional National Epidemiological Rheumatic Diseases
study (EpiReumaPt) and afterwards by other sources,
namely through self- and physician’s referral. Follow-
-up with annual self-administered questionnaires will
be performed, in order to systematically collect and
analyze outcomes of interest, mainly patient-reported
outcomes. Data concerning less frequent assessments,
such as radiographs and biomarkers, will also be as-
sembled. 
Conclusions: CoReumaPt will be a valuable resource
for scientific research and will deliver pivotal informa-
tion to improve public health policies concerning the
prevention and the management of RD in Portugal.
CoReumaPt Protocol: the Portuguese 
Cohort of Rheumatic Diseases
ACTA REUMATOL PORT. 2012;37:18-24
ABSTRACT
Introduction: Rheumatic diseases (RD) are conditions
with a variety of clinical manifestations and prognosis
influenced by several factors. Cohorts and registries
have been already established in some countries and
have contributed to important knowledge about the 
disease course and the long-term outcomes of RD. 
This paper introduces the CoReumaPt project and sets
the first step towards the creation of a prospective 
cohort study including the main RD occurring in the
Portuguese population. CoReumaPt will allow outco-
mes research of chronic RD and the assessment of fac-
tors influencing the development and progression of
RD. It will also allow to further evaluate the economic
impact and the burden of RD in Portugal. CoReumaPt
will be linked to Reuma.pt, the National Register of
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INTRODUCTION
Rheumatic diseases (RD) are complex conditions cha-
racterized by a variety of clinical manifestations and
prognosis. Cohort studies are one of the best ways to
assess and understand the course of these diseases. To
complement information obtained from randomized
clinical trials, various cohorts and registries of patients
with specific RD or other exposures have been esta-
blished in the last decade (for instance, the Consor-
tium of Rheumatology Researchers of North America
[CORRONA] and the British Society for Rheumatolo-
gy Biologics Register [BSRBR]). Thus, large prospecti-
ve cohorts have increasingly contributed to pivotal re-
search in the field of RD, which would have been dif-
ficult to obtain from other data sources. Actually, they
constitute one of the major sources of clinical research
publications and communications in rheumatology.
Prospective cohort studies describe the disease course
and management strategies and record long-
-term outcomes of the disease. Moreover, they contri-
bute substantially to better understand the pathoge-
nesis and the mechanisms underlying the disease pro-
gression. Prospective cohorts also enable the study of
associations between disease and treatment interven-
tions. In fact, information derived from such studies
can guide the design of future drug trials1.
Cohorts are organized around conditions or expo-
sures, such as a particular disease, a health care service
(e.g. a new medical procedure), or a product (inclu-
ding medical devices). In fact, registries of cohorts are
mainly either drug based (e.g. patients enrolled after
starting a particular medication) or disease based (e.g.
patients enrolled after being diagnosed with a particu-
lar disease, such as a certain RD)1. They can vary in
complexity, from simply recording a product use, as a
requirement for reimbursement, to more systematic ef-
forts to collect prospective data on several treatments,
risk factors and clinical events in a defined population.
Therefore, prospective cohorts allow complete data col-
lection in a deliberate attempt to gather relevant infor-
mation (i.e. aiming at maximizing measured covariates
and minimizing missing information)4. The duration
of follow-up can range from days (e.g. hospital admis-
sion registry) to decades (e.g. or tho pedic implant re-
gistry or rheumatoid arthritis cohorts)1.
The Portuguese Society of Rheumatology (SPR) al-
ready detains a national register (Reuma.pt) for seve-
ral rheumatic diseases [rheumatoid arthritis (RA), an-
kylosing spondylitis (AS), psoriatic arthritis (PsA) and
juvenile idiopathic arthritis (JIA)], but so far no fur ther
registries of patients with other relevant chronic RD
have been undertaken in Portugal, such as, osteopo-
rosis (OP), osteoarthritis (OA), systemic lupus erythe-
matosus (SLE), polymyalgia rheumatica (PMR), fibro-
myalgia (FM), gout (GO), periarticular diseases (PD)
and non-specific low-back pain (LBP). Several outco-
me research projects on these RD have been published
based on European and North American cohorts. Ho-
wever, different populations have diverse genetic and
environmental backgrounds that influence outcomes,
such as morbidity and mortality rates. Furthermore,
patient’s access to healthcare services and the economic
burden of these diseases in Portugal have clearly very
specific patterns that need to be identified, namely by
measuring the healthcare resources consumption and
by assembling data concerning absenteeism and pre-
senteeism (loss of productivity). This effort will define
the precise social and economical impact of RD, allo-
wing the adaptation of future policies by our National
Healthcare System to the identified needs.
The EpiReumaPt survey, is an ongoing Portuguese
epidemiologic cross-sectional study (2011-2013) and
it has the main aim of estimating the prevalence of dif-
ferent RD in Portugal. The 10000 participants in this
project (a random sample of the Portuguese population)
will be invited for a long-term follow-up, during which
they will be integrated into the CoReumaPt cohort. 
This article presents the CoReumaPt study and sets
the first step towards the creation of a prospective co-
hort for the main RD occurring in the Portuguese po-
pulation. 
OVERVIEW OF COREUMAPT
The overarching principle of the CoReumaPt Project is
to improve public health through the knowledge and
prevention of RD in Portugal. In order to achieve this,
a cohort will be created, including chronic RD patients
(namely OP, OA, RA, AS, SLE, PMR, FM, GO and LBP)
and “non-RD” subjects. This large cohort might be af-
terwards divided in specific cohorts according to the
future development of this project. The link with Reu-
ma.pt will be done; patients with a confirmed diagno-
sis of RA, spondyloarthritis (SpA, including AS and
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PsA) or JIA will be also invited to enroll the ongoing
register of patients with these diseases, in case they are
not already participating. 
OBJECTIVES OF COREUMAPT
PRIMARY OBJECTIVE
To establish open cohorts to further explore outcomes
research of chronic RD and the risk factors for the de-
velopment of RD. 
SECONDARY OBJECTIVES
1. To estimate the incidence of health outcomes in dif-
ferent RD according to clinical and socio-demo-
graphic characteristics. 
2. To evaluate prospectively the impact of different RD
at the individual (clinical and humanistic conse-
quences) and social level (including economic con-
sequences).
3. To estimate the contribution of prognosis factors to
the progression of RD in the Portuguese population.
4. To determine the burden of different RD on the
functional capacity and work participation of the
Portuguese population.
5. To monitor the effectiveness and safety of current
RD treatments in a “real-world” setting. 
6. To identify regional differences across the country
for the abovementioned endpoints.
7. To compare the incidence of relevant outcomes with
other countries.
METHODOLOGY OF COREUMAPT
STUDY DESIGN 
Population-based multi-disease, multipurpose cohort
study. 
STUDY POPULATION
The study population source is described in more de-
tail elsewhere7 and is composed by Portuguese non-
institutionalized adults (≥ 18 years old) randomly se-
lected in the EpiReumaPt study and who voluntarily
agreed to participate by signing a written Informed
Consent. In parallel, other sources of patients might be
used, for instance, physician’s referral or patient’s self-
-referral, as long as validation by a rheumatologist oc-
curs prior to the inclusion in the cohort (Figure 1). 
All enrollees must also be mentally competent, as
defined by the opinion of the investigator or rheuma-
tologist, in order to be able to participate in all study
required assessments and procedures. Subjects unwil-
ling to sign the Informed Consent, unable to speak
Portuguese or with an inability to answer the ques-
tionnaire will be excluded.
PRIMARY OUTCOMES 
This study will be designed to systematically collect
and analyze longitudinal outcomes. Herein is the list
of the “core” outcomes of interest a priori targeted for
this cohort. Later, specific domains will be addressed
for particular groups of subjects (e.g. specific measu-
res of disease activity and physical function). These
specific domains will be detailed in future publica-
tions. 
Thus, a core set of outcome measurements (clinical,
laboratory and imaging) will be assembled at baseline
and follow-up. Questionnaires will be designed to be
mainly self-administered by the participants (i.e. pa-
tient-reported data) and cover most of the outcomes
outlined in Figure 2. Questionnaires will also address
socio-demographic factors, life-style factors and ex-
posure variables.
The selection of primary outcomes for measurement
in this study has been accomplished considering the
CoReumaPt
Main Source: EpiReumaPtPortuguese ≥18 years(7,719,986 subjects)
Interviews:Population surveyed(11,000 subjects)
Other sources: Physician & SelfReferral (validation of RD)
RheumatologistAssessment(validation of RD)
OpenCohorts SPR Register(Reuma.pt)
Non-RDparticipants RD & Non RDparticipants
CoReumaPt will be a scientific platform with a reservoir of participants (RD and non-RD)continuously functioning in close interconnection with the SPR register and with the specific open cohorts which will be created in the future
CoReumaPt
Main Source: EpiReumaPt
Portuguese ≥18 years
(7,719,986 subjects)
Interviews:
Population surveyed
(11,000 subjects)
Other sources: Physician & Self
Referral (validation of RD)
Rheumatologist
Assessment
(validation of RD)
Open
Cohorts
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OMERACT (Outcome Measures in Rheumatology Cli-
nical Trials) consensus process.
STUDY PROCEDURES
INITIAL PATIENT ENROLLMENT AND PHYSICIANS’
PARTICIPATION
Following each subject’s selection and participation in
the EpiReumaPt cross-sectional study, an assessment of
the willingness to be followed-up and due involvement
in the subsequent cohort phase will be done, which
includes an Informed Consent and collection of infor-
mation contact. Within 3-6 months, the participant
will be contacted again by the study staff via phone call
in order to confirm willingness to be followed-up and
to obtain additional data. The enrollee will also be in-
quired about his preferred method of contact (phone,
paper-based or web-based). Repeated unsuccessful
contacts may lead to the participant’s dismissal from
the cohort. 
In this first assessment, the participant will be given
details to access a web-based platform (including a
username and a password), which is meant to be the
preferred method for patient-data collection during
the follow-up period. Phone calls and questionnaires
sent by post during follow-up will be alternative ways
to collect data if requested by the participant or to com-
plete information provided via online questionnaires
(Figure 3). 
Identified physicians clinically in charge for a given
participant will also be invited to participate in this
study; thereby receiving details for the access to the
web-based platform, and also getting their patients’
identification codes. Physicians will be requested to
complete some baseline information (e.g. disease acti-
vity) and also yearly updates on other relevant clinical
information, complementary to the patient-reported
data (see below Annual Questionnaire). Physicians will
also be requested to validate some patient-reported
outcomes (PRO) (e.g. hospitalizations and serious ad-
verse events). 
FIRST CONTACT - BASELINE ASSESSMENT
The majority of the baseline data will be provided by the
EpiReumaPt study, however CoReumaPt baseline as-
sessment will collect more detailed medical history,
such as past hospitalizations, past and current comor-
bidities, medications and adverse events. Any hospita-
lization occurring within the past 12 months and self-
-reported by the participant should be validated
through medical records or by contacting the respecti-
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Figure 2. Primary Outcomes to be addressed in the CoReumaPt study
QoL: Quality of Life; SF-36: Short Form (36) Health Survey; EQ-5D: EuroQol-5D 
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ve hospital or the physician. Other up-to-date PRO will
be addressed, such as health-related quality of life, func-
tional status and work disability. For further economic
analysis, healthcare resources utilization (such as me-
dical encounters and exams) should be registered at the
baseline assessment. After finishing this contact, sche-
duling of the next one will be done (Figure 3).
ANNUAL QUESTIONNAIRE – PRO AND 
PHYSICIAN-REPORTED DATA
At 12-month intervals, CoReumaPt participants will
be surveyed by a self-administered questionnaire. This
questionnaire shall bring together information regar-
ding PRO and the clinician-reported data (Figure 3).
All physicians will be reminded to include data 
concerning the closest visits of their patients. Physicians
will be requested to revise all patient-reported fields (in-
cluding medication and adverse reactions) and, more
importantly, will be asked to fill in clinical data related
with the physician’s evaluation (including disease acti-
vity). Both patients and physicians (if applicable) will
also be requested to record all hospitalizations, medical
encounters and other relevant healthcare resource con-
sumption occurred in the past 12 months. 
New RD cases among the “non-RD” participants will
be captured through self-report of RD diagnosis or
rheumatic symptoms. This must be further validated
by a rheumatologist. 
>12-MONTHS ASSESSMENTS (BIOBANK 
AND IMAGING EXAMS)
In order to address some outcomes of interest and to
further assess the evolution of RDs, some exams will
be periodically required (e.g. radiographs to assess
structural damage, BMD as measured by DEXA, and la-
boratory tests). These assessments are disease-specific
and their periodicity will depend on the outcomes se-
lected for each specific cohort, which will be described
in more detail in dedicated publications. Moreover, for
future genetic and biomarkers analysis, blood samples
will be drawn at baseline from participants during the
EpiReumaPt procedures and afterwards at different
time-points along their follow-up. All these samples
will be stored at the Biobank of Instituto de Medicina
Molecular, Lisbon. 
OTHER ASSESSMENTS
Patients and physicians might be asked by the Co-
ReumaPt staff to send the results of some exams with
the purpose of validating outcomes of interest (for
example, radiographic evidence of OP fractures). This
will be done ad hoc and driven by the Steering Com-
mittee of the CoReumaPt team (see below Steering
Committee section). Other data might be requested
upon a new scientific question requiring additional
data not captured in the original questionnaires. This
should also be previously approved by the Steering
Committee.
DEFINITION OF RHEUMATIC DISEASES
The participant’s exposure to any RD will be assessed
by the rheumatologist who will validate the final diag-
nosis of each participant. This diagnosis of a given RD,
either active or in remission, will be based on the in-
ternationally accepted classification criteria of that RD
and should be aligned with the EpiReumaPt study7.
INTERNAL/EXTERNAL VALIDITY AND 
QUALITY CONTROL
An essential requirement for the use of a longitudinal
dataset is the internal and external validity of the co-
hort. Patients without RD should be representative of
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Figure 3. Flow diagram of CoReumaPt processes and 
follow-up assessments
IC: Informed Consent; PRO: Patient-Reported Outcomes
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the population from which they are drawn, using a
random sampling and avoiding selection bias. This is-
sue has been carefully handled in the EpiReumaPt stu-
dy, which is the primary source of the CoReumaPt, and
thus representativeness of the Portuguese Population
is expected to be maintained concerning that source of
participants. This will be tested by comparing the de-
mographic characteristics of the overall EpiReumaPt
population versus the Portuguese population, accor-
ding to the National Institute of Statistics (INE). Ne-
vertheless, CoReumaPt is an open cohort which will al-
low further entry of new enrollees. Therefore it is pos-
sible that selection bias occurs along the project. This
bias and any other eventual deviation will be handled
ad hoc by the Steering Committee.
In an attempt to avoid any bias based on socioeco-
nomically status, paper-based questionnaires will be
sent to those participants without phone or computer
devices or; for those who simply prefer to send their
responses by post (free-of-charge). 
In order to increase internal validity and to provide
complete and accurate data, the methods of observa-
tion will be clearly defined and the measurement tools
will be valid and reliable. All procedures will be stan-
dardized and properly documented. The activities de-
signed to achieve proper quality control will encom-
pass all aspects of the study, including: clear, pretested
data collection forms; measurements that are validated;
central and local training of staff; monitoring of re-
cruitment and retention; surveillance and evaluation of
data quality as it is collected. Supervision and ultima-
te responsibility of quality assurance will rest with the
Steering Committee. 
Follow-up maintenance is crucial for the success of
any cohort study10, therefore attrition bias will be avoi-
ded by using reminders for scheduled visits and im-
plementing specific activities to motivate participation
(e.g. periodic newsletters and reminders sent to parti-
cipants). A specific task-force reporting to the Steering
Committee will deal with this bias and will be respon-
sible for activities designed to increase participants’ re-
tention in this study. Non-respondents will be tracked
in order to ascertain reasons of discontinuation and to
fill, whenever possible, a short “end-of-study” ques-
tionnaire. Lost to follow-up population will be cha-
racterized to detect eventual factors asymmetrically
prevalent when compared with more adherent parti-
cipants. If possible, death records will be consulted for
all participants to whom long-term unsuccessful con-
tacts have occurred.
All assessment dates will be reminded to patients
and physicians upfront and missing assessments will
be followed-up via phone directly by a member of the
CoReumaPt staff. Missing data within one assessment
will generate automatic reminders both to patients and
physicians so that completion could be fulfilled. 
Concerning the quality of the database, its content
will be audited visually by a person trained to process
the forms and a web-based platform will be designed
to detect out-of-range values, inconsistencies and mis-
sing data, thereby triggering alerts to the CoReumaPt
staff.
Any event that results in hospitalization or any cri-
tical medical event will be validated by obtaining me-
dical confirmation. Exposure variables will be subject
to frequent validation by the Steering Committee of
the CoReumaPt, namely the RD exposure. Primary
Outcomes will also be subject to the Steering Com-
mittee’s evaluation, especially those requiring radio-
graphic confirmation. 
REGISTRY SIZE AND DURATION 
There is no limit set regarding the cohorts’ size. For
the time being, size will depend on the EpiReumaPt
participants’ willingness to be followed-up. Since this
is a multipurpose cohort study there is no a priori de-
finition for its duration. It will depend on several fac-
tors, including funding and enrollees’ availability and
willingness to persist on study.
ETHICAL CONSIDERATIONS
This project was approved by Comissão Nacional de
Protecção de Dados, the Portuguese data protection
authority (in accordance with the Portuguese law num-
ber 67/98, October 26th, regarding protection of per-
sonal data) and was submitted to the Ethics Commit-
tee of the Faculty of Medical Sciences from the Uni-
versidade Nova de Lisboa. The study will be conduc-
ted in accordance with the applicable laws and
regulations including, but not limited to, the Guideli-
ne for Good Clinical Practice (GCP) and the ethical
principles stated in the Declaration of Helsinki. 
Participants’ confidentiality will be safeguarded by
the nonexistence of identifiers on the database (only
unique ID participants’ codes). Their names and con-
tacts will be stored separately from study data trans-
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mitted to the coordinating center (based on the head-
quarters of the SPR). Thus, all data for future analysis
will be kept anonymously and securely by the CoReu-
maPt authorized staff. 
All participants will sign an Informed Consent be-
fore enrollment, thereby authorizing further follow-
-up for collection of personal and clinical data. For the
Biobank future research purposes, a specific Informed
Consent will also be signed by those accepting to par-
ticipate in this part of the CoReumaPt study. 
For all paper-based questionnaires, transcription for
the electronic system will be done by authorized per-
sonnel complying with all confidentiality procedures
of the study. The electronic dataset will then be asso-
ciated with the participants’ ID code. 
There will be absolutely no disclosure of individual
health information to the general public. Thus, publi-
cations will be strictly confined to aggregated data.
STEERING COMMITTEE 
The Steering Committee will be the primary governing
body of the study and provides its scientific leadership.
It will have responsibility for the overall study design,
policy decisions and operations of the CoReumaPt stu-
dy. As abovementioned, the Steering Committee might
decide upon the request of additional data (e.g. labo-
ratory exams, imaging) as needed. Members of this
Steering Committee will include national rheumato-
logists, epidemiologists and statisticians, as well as in-
ternational consultants thoroughly experienced with
previous cohort studies. 
Among the Steering Committee there will be inves-
tigators responsible for future specific cohorts. Thus,
a given leading coordinator will be accountable for the
oversight and the selection of the outcomes assigned
to each specific cohort. Nominations for this coordi-
nation and all changes in the protocol will be subject
to majority vote of the Steering Committee. This Stee-
ring Committee will be chaired by the SPR board and
a record of changes and decisions will be maintained
by SPR. 
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